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The united Nations Scientific committee on the 
Effects of Atomic Radiation 1988 Report revealed 
that the dose per caput arising from diagnostic 
medical exposures was from O. 4 to 1. 0 Sv. The 
collective dose commitments for the whole world 
amounted to about 2 - 5 million man Sv. It was 
forecast that the frequency and the total number 
of p~ocedures involving medical radiation would 
increase substantially due to : (1) ageing of the 
population, (2) the total number of 
examinations would also undoubtedly . · l.ncrease 
simply as a result of population 
(3) the number and frequency of 
increase and, 
examinations 
would increase as a result of growing urbanization. 
The author's M.Phil thesis also revealed 
that the total colJ ~"'+:ive effective dose arising 
from artificial exposures in Hong Kong in 1986 
amounted to 308 man Sv of which 245 man sv was 
contr ibuted by the diagnostic X-rays. ,This 
exposure is expected to be further increased in the 
coming year~ following the world-wide trend, 
probably due to the increase in popu~ation, the 
implementation of hospital authority and the 




use of medical 
impose radiation 
of the benefit 
radiology will 
risks onto patients 
obtained. This study 
suggests there may be from 19 to as many as 62 
excess fatal cancers cau~d in Hong Kong from the 
use of simple radiography alone. To cope with the 
ICRP principle, As Low As Reasonable Achievable, 
it is therefore important to to be able to relate 
reasonable cost to reasonable radiation protection. 
S 1 
In order to be aware of the radiation hazard 
arising from the local medical exposures, survey 
were conducted at six categories of radiological 
centres for 15 projections of eight regions from 
plain film studies. 
with the use of a tissue-equialent thermo-
luminescent dosimeters (Li2B407 :Mg,Si) fixed onto 
the patient's skin at the centre of th~ X-ray beam 
during an exposure, the entrance skin doses (ESO) 
were measured. The organ doses were estimated using 
the Monte Carlo simulation on a local 
anthropomorphic phantom model taking into account 
the measured ESOs. 
A cumputer programme was established to 
present the organ and effective doses numerically 
and graphically with colour codes. The ESOs, phase 
of generation, total tube filtration and tube 
voltage have been taken into account in the 
calculation. 
The results show that with an identical , ESO, 
the organ doses calculated using the NRPB 
mathematical phantom, which has larger dimensions 
than the local one, were under-estimated by 
about 50% . It is anticipated an extensive use of 
this local phantom in medical dose calulations in 
future. 
Generally, the radiation risk induced in the 
local local population was of the order expected 
from global calculations, however, those organs 
with high radiosensitivity should be given the 
first priority of dose optimisation, such as the 
breast. 
S 2 
The technique used in this study indicates 
emphatically the studies that require particular 
attention and would be most cost-effective in 
reducing radiation burden. 
S 3 
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Almost from the time radiation was discovered 
about 90 years ago, the harmful effects of 
radiation became evident and radiation protection 
has been a developing science ever since [1. 1] . 
Radiation, in alomost all of its forms, has been 
publicly perceived as one of the hazards of the 
last few decades. This perception appears to be 
related to the production of radiation and 
radioactive fallout by atomic weapons. The 
association of ionizing radiation with such weapons 
has been transferred in the public mind to 
associations with power reactors and medical 
imaging. Because of this chain of thought the 
general perception of radiation hazard is far 
greater than the real hazard. Such overestimates of 
radiation risk certainly encourage public and 
professional policies of minimizing exposure to 
radiation [1.2]. 
RADIATION EXPOSURES OF THE POPULATION 
Introduction 
People are exposed to various sources of 
radiations, mainly the natural background and 
man-made radiations. A detailed description of 
radiation quantities is presented in Appendix A for 
reference. The average annual dose to the Uni ted 
Kingdom population from all sources of radiation is 
currently estimated to be 2.5 mSv, 87% of which is 
due to natural radiation. The contribution from 
each sources is given in Table 1.1. By far the 
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1.2.2 





which is about 12% of the overall 
~indings for the United Kingdom are 
line with the latest UNSCEAR review 
Table 1.1 Average annual dose from radiation sources 
Source Dose, Jj.Sv ~ 0 
Cosmic rays 300 10 
Gamma rays 350 14 
Natural Internal 300 12 
Radon 1200 47 
Thoron 100 4 
Medical 300 12 
Miscellaneous 10 0.4 
Man-made Fallout 10 0.4 
occupational 5 0.2 
Discharges <1 <0.1 
Total (rounded) 2500 100 
The Projected Expansion of Medical Exposures 
According to the united Nations Scientific 
Committee on the Effects of Atomic Radiation 1988 
Report, the dose per caput arising from diagnostic 
medical exposures was estimated to be 0.4 - 1.0 sv. 
The collective dose commitments for the whole world 
amounted to about 2 - 5 million man Sv [1.4]. 
The Committee reported that over the past 
decade there had been many technological advances 
that might be affecting the medical exposure. 
These include 
2 
(1) traditioDal techniques were being replaced 
by new ones, 
(2) additional examinations were being performed 
and, 
(3) procedures were being carried out with 
different types of equipment leading to 
both increase or decrease in the mean 
absorbed doses in organs in the course of 
exminations. 
It was concluded that, globally, the extent of 
medical 
[1.5] . 
radiation utilization was increasing 
It further stated that the previous 
estimates of absorbed dose to 
population might be low because of : 
the 
(1) the widespread use of fluoroscopy in 
developing countries and, 
world's 
(2) the large number of malfunctioning machines 
producing high absorbed doses [1.6]. 
Another reason for this underestimation may be 
due to the increased use of eT scanners in the 
recent years. The world-wide average annual 
frequency of eT examinations is estimated to be 9 
per 1,000 population which is about 1% of the total 
diagnostic procedures [1.7]. In Hong Kong, the 
total number of eT cases conducted in all 
government hospitals in 1986 was only 17,357. It 
was increased to 28,231 in 1990 which was about 1.6 
times of that in 1986 [1.8]. This figure is 
expected to be further increased with the 
installation of more eT scanners in the private 
sector in future. 
3 
It was expected that there would be changes in 
the magnitude of medical exposure through the year 
of 2000. The Committee recognized that there would 
be 
(1) a significant increase in the total 
population of the world, 
(2) a marked ageing of the population in many, 
mostly developed countries, with increased 
proportions of the population over the ages 
of 60 and 80, 
(3) an increase in the population of the world's 
population residing in cities and, 
(4) a shift in the spectrum of diseases. 
These factors were expected to play a 
significant role in the future use, availability 
and need for medical radiation. 
The results of sequential surveys in several 
countries confirm that the number of diagnostic 
X-ray examinations was increasing [1.9]. 
The average number of examinations performed 
per year and per X-ray machine ranged from 3,000 to 
5,500 for all levels of health care [1.10]. The 
annual growth rate for examinations from 1955 
through 1983 ranged from 0% to 10%, with an average 
of 3% over the decade 1970-1980 [1.11]. 
In general,the less developed a country, the 
younger the mean age of the population and the 
younger the population exposed in diagnostic 
radiology [1.12]. 
4 
UNSCEAR concluded that the frequency and the 
total number of procedures involving medical 
radiation would increase substantially, because 
of : 
(1) ageing of the population, 
(2) the total number of examinations would al~o 
undoubtedly increase simply as a result of 
population increase and, 
(3) the number and frequency of examinations would 
increase as a result of growing urbanization. 
By the year 2000, the collective dose will 
probably increase by 50% and by the year 2025 it 
may more than double [1.13J. 
In 1986 there were about 1.5 million 
diagnostic X-ray examinations conducted in Hong 
Kong. The total collective effective dose amounted 
to 1,000 man Sv [1.14J. This contributed 92.4% of 
the per caput collective effective dose arising 
from the total artificial exposures including 
diagnostic radiology, nuclear medicine, radioactive 
fallout and occupational exposure. This being of 
the order of the findings for the united Kindgom 
(Table 1.1). 
Apart from the increase and ageing in the 
local population, more X-ray facilities have been 
installed in hospitals and laboratories. There 
will be, without doubt, a greater demand for 
radiological procedures in the future resulting 
in a higher collective dose. More risk will be 
imposed on patients, working personnel and the 
general public. 
5 
1.3 RADIATION HAZARDS 
1.3.1 
There are two major categories of radiation 
hazards named, deterministic and stochastic effects. 
Deterministic Effects 
Deterministic effects are non-random, and 
occur only when a threshold dose is received. 
Examples are radiation-induced cataract and 
erythema. The real hazards resulting from large 
doses of radiation have been known for at least 
eighty years. An appreciable number of early 
radiation workers were killed by inadvertent 
exposure to very high levels of ionizing radiation 
in the first decade of this century [1.2]. 
A nuclear disaster happened at the 4th 
RBMK nuclear reactor at Chernobyl on 26 April 1986 
with 31 firemen died on site during rescue. 
About 200 workers were brought to hospitals and it 
was reported that 18 of these had been exposed to 
such high radiation doses that their situation was 
severe [1. 15]. outside the USSR radiation levels 
from the accident, as reported, were too small to 
cause any acute radiation effects. However, the 
additional annual effective dose equivalents in the 
central Europe were estimated to be O. 07 mSv in 
Austria, 230 JJ.Sv in Federal Republic of Germany, 
1.5 - 2 mSv in switzerland, 150 JJ.Sv in Hungary and 
180 JJ.Sv in Italy. The remaining possible biological 
effects were therefore stochastic effects, namely 
cancers, genetic and teratogenic effects [1.16]. 
, 
It was reported recently that there were 23 
overexposed cases from external radiation in 
6 
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Mainland China. The doses ranged from 60 mSv to 
120 mSv which far exceeded the annual dose limit of 
50 mSv. They suffered from various kinds of 
radiation-induced diseases and injuries including 
heart disease, dyspnoea, hypertension, hepatitis, 
tuberculosis of lungs, gastric disorder, radio-
dermatitis and acute skin injuries of hands [1.17]. 
Stochastic Effects 
Stochastic effects are random effect whose 
probability of occurence in an exposed population 
(rather than the severity in an affected 
individual) is a direct function of dose. For 
public health purposes, one usually takes a very 
conservative approach to estimating the radiation 
risk from an exposure. Therefore a zero threshold, 
linear, no repair model is customarily used to 
relate dose to risk. This model gives an upper 
limit to the risk associated with low doses of 
radiation [1. 2]. These are usually divided into 
somatic and genetic effects. 
(1) somatic Effects 
Cancer induction is the most important somatic 
effect of low-dose ionizing radiation. The 
induction of cancer by radiation is detectable 
only by statistical means, i.e., the cancer of 
any given person cannot be attributed with 
certainty to · radiation, as opposed to some 
other cause. Despite the difficulties and 
uncertainties, a clear-cut increase in 
incidence or mortality with increasing 
radiation dose has been demonstrated for many 
7 
types of cancer in human populations as well 
as in laboratory animals. 
The estimate of lifetime mortality in a 
population of all ages from specific fatal 
cancers after exposure to low doses 
(10- 1Sv-1 ) is given in Table 1.2 [1.18]. This 
was compounded from an analysis of multiple 
sources. 
Table 1.2 Lifetime mortality in a population 
of all ages from specific fatal 
cancer after exposure to low doses 
Fatal probability coefficient 
(10- 4 SV- 1 ) ICRP (1990) 
Bladder 30 
Bone marrow 50 












(2) Genetic Effects 
Genetic effects of radiation is to produce 
gene mutations and chromosome aberrations. The 
effects of radiation on the well-being of 
future population is a consequences of these 
8 
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changes. Because mutations and chromosome 
aberrations also occur spontaneously, or as a 
result of other factors, it follows that the 
consequences of radiation are not sometimes 
new but rather an increase in frequency of 
various deleterious traits with which we are 
already beset [1.19J. 
Currently, genetic risk estimates are made 
using the so-called " doubling dose method" 
and the "direct methods" . The doubling dose 
method is used to estimate risks to population 
under continuous radiation. In direct methods, 
the rates of induction of dominant mutations 
affecting the skeleton or causing cataracts in 
the eyes of the mouse is used. Table 1.3 shows 
the results of fitting the the aD + ~D2 model 
in X-rays [1.20J. 
Table 1.3 Results of fitting to the aD + ~D2 model 
ex ± SE ~ ± SE X2 
Aberration 
(10-2Gy-1) (10- 2Gy-2) 
X-rays Dicentrics 3.64 ± 0.53 6.67 ± 0.22 15 
Pre-natal Irradiation 
If the exposed individual is pregnant, the 
foetus may be regarded as an additional individual 
who may also suffer somatic and genetic radiation 
effects. For the foetus deterministic effects take 




evident as mental retardation or stochastic, 
somatic effects such as increased probability of 
childhood cancer [1.21J. 
1.4 THE LOCAL SITUATION 
There were 1,403 cancer deaths in the year of 
1990 in Hong Kong, l.e., about 250 cancer deaths 
per m~llion population [1.22J. From Table 1.2, 1 Sv 
of exposure would resul t in a maximum of 
lifetime mortaility of 500 fatal cancers per 10,000 
population. If the global figures from Table 1.2 
are assumed appropriate for the local 
estimation, then one would 





arising from natural background and 86 fatal 
cancers from medical exposures of the whole 
population in Hong Kong (1990). 
1.5 JUSTIFICATION OF THE STUDY OF LOCAL PATIENT DOSE 
The natural background exposure is more or 
less constant in each locality and does not 
change over an extensive long period of time. 
The number of fatal cancers estimated using the 
global figures is obviously of an order that 
justifies concern. 
However the global figures do not allow for 
anthropomorphic differences of the local racial 
characteristic. Furthermore, different radiographic 
habits and protocols may significantly alter the 
calculations. In order to perform this study it was 
necessary to obtain local anthropomorphic data and 




THE MEDICAL' EXPOSURES IN HONG KONG 




Mankind is exposed to various sources of 
radiations, including the natural background and 
man-made radiations. According to Table 1.1, 
man-made radiation accounts for about 13% of the 
total dose in the united Kingdom. A study on the 
local man-made exposures conducted in 1986 revealed 
that there were four major categories, namely, 
occupational exposure, radioactive fall-out, 
nuclear medicine and diagnostic radiology. The 
results of this study are presented in the 
following sections [Ref. 2.1]: 
MAN-MADE RADIATION IN HONG KONG 
occupational Exposure 
There were totally 2,735 registered radiation 
workers ln 1986 who were subject to personnel 
radiation monitoring provided by the Radiation 
Board of Hong Kong. These radiation workers were 
from various professions, including radiologists, 
radiotherapists, radiographers, other allied 
medical professionals, industrial radiographers and 
workers, academic staff and servicing technicians. 
The mean annual effective dose was 0.5 mSv 







Radioactive fall-out are those fission 
products of long half-lives, mainly Cs-137 injected 
as a result of nuclear weapon tests conducted in 
the atmosphere. Before the implementation of the 
Control of Nuclear Weapon Tests in 1963, there were 
totally 360 tests conducted by the united states, 
united Kingdom and the former U.S.S.R. During the 
period of 1964 to 1980, Mainland China and France 
undertook 63 tests above the North-west area of 
China and the Southern Pacific Ocean respectively. 
Together with the previous tests conducted before 
1963, a total of 960 PBq of Cs-137 were injected 
into the atmosphere. The nuclear power plant 
accident in Kiev gave an extra of 210 Bq per m2 
of Cs-137. This, together with the previous 
cumulated activity, imposed a collective effective 
dose of 14.3 man Sv onto the local population 
in 1986. 
Nuclear Medicine 
There were only three regional hospitals in 
1986 equipped with nuclear medicine facilities. 
5,908 investigations were conducted using Tc-99m, 
I-131, Ga-67 and TI-201 with a total activity of 
1,502 GBq. This resulted in 47.4 man sv collective 
dose to the patients under investigation. 
Diagnostic Radiology 
As compared with occupational exposure, 
radioactive fall-out and nuclear medicine, the 
doses arising from diagnostic radiology dominated 
12 
all the others. The total number of investigations 
including plain film and contrast studies, 
conducted in 1986 amounted to 1,436,638. Ten 
popular examinations responsible for the major 
somatic effects, were studied for the radiation 
doses induced. These included skull, chest, 
thoracic spine, lumbar spine, abdomen, pelvis, IVC, 
IVU, barium meal and enema. The total collective 
dose amounted to 245 man Sv, which became the 
lion's share of the total per caput dose (92.4%), 
while the rest were nuclear medicine (4.3%), radio-
active fall-out (3.2%) and occupational exposure 
(0. 1%) . 
2.3 THE FUTURE TREND 
As mentioned in section 1.2.1, it is projected 
that the number of procedures involving medical 
radiation would increase substantially. It was 
further forecast that the collective dose will 
probably increase by 50% and by 2025 it may more 
than double. Hong Kong, for the past decade or so, 
because of a much better economic situation, is 
following this global trend. 
Fig. 2. 1 presents the annual frequencies of 
diagnostic procedures from 1986 to 1990. It can be 
seen that there has been an increase of 18% of that 
in 1986. This is partly due to the increase in 




































































































































2.4 THE CURRENT STUDY 
The collective dose of 245 man Sv arising from 
diagnostic radiology as mentioned in section 2.2.4 
were shared by 10 popular examinations in the 
following order : 
Examination ~ o 
Abdomen 17.6 
IVU 15.2 
Barium Meal 13.6 
Pelvis 13.2 
IVC 12.7 
Lumbar spine 7.2 
Barium enema 7.8 
Chest 6.2 
Skull 5.9 
Thoracic spine 1.5 
However, only five of the above examinations 
were selected for this current study, namely, 
skull, chest, thoracic spine, lumbar spine, abdomen 
and pelvis. In addition, radiography of the 
cervical spine was also included in the study. 
The reasons of the exclusion of contrast 
studies such as barium meal, barium enema, IVC, IVU 
and other special examinations involving 
fluoroscopy are : 
15 
(1) The dose estimation in fluoroscopy involves 
the measurement of Exposure-area Product (EAP) 
( described in Appendix A ). This has to be 
done with a Diamentor in which a radiolucent 
ionization chamber fixed to the tube port 
during the whole examination. 
The preparation of this system is time-
consuming and 
induced much 
the procedure would have 
inconvenience both to the 
radiological staff and the patients. 
(2) eT scans, because of its powerful density 
discrimination and capability of" analysis has 
taken over, to a certain extent, conventional 
radiology. Despite the highly collimated X-ray 
beam in the scanner, the typical levels of 
patient dose from CT are relatively large 
compared with those for many conventional 
X-ray examinations of similar regions of the 
body [2.2]. It is estimated that the average 
effective doses are at least three to ten 
times more. There is a need to investigate 
this high dose imaging modality for public 
interest. However, the great workload involved 




METHODS OF OPTIMISATION 
'. 
3. METHODS OF OPTIMISATION 
3.1 INTRODUCTION 
The benef it of diagnostic radiology has been 
well appreciated for a long time. Accurate 
diagnoses can be provided to physicians , health 
and lives are protected and general public health 
is much improved. However, the exposures associated 
with this imaging modality impose radiation 
hazards on patients, medical staff and the public 
for instance the excess 86 fatal cancer deaths as 
calculated in section 1.4. There is therefore a 
need to justify and optimise these diagnostic 
radiation exposures. The hazards should be reduced 
to a level which is considerably below that of the 
level of morbidity and mortality. Many techniques 
for optimisation are long established. New 
techniques are still being created and marketed. 
The implementation of all available techniques 
obviously increases the costing of health care. 
Therefore it is important to be able to relate 
reasonable cost to reasonable radiation protection. 
Quality assurance, 
analysis together form 
dose reduction and rej ect 
the framework of radio-
logical protection for workers, patients and the 
general public. Relevant papers on these topics 
with detailed description and elaboration are 
presented in Appendices B, C and D for reference. 
3.2 JUSTIFICATION OF DIAGNOSTIC RADIATION EXPOSURE 
The ICRP publication 33, paragraph 32 states 
that 
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" The professional judgement of the referring 
physician and radiologist singularly or 
jointly that a proposed medical radiological 
procedure may be of net benefit to the 
recipient patient will normally constitute 
justification." 
However, there are dangers in this 
justification procedure. 
(1) The referring physician may also be the person 
who controls and profits from the use of the 
X-ray equipment. 
(2) Retrospective analysis for the correctness of 
the decision to X-ray a patient should always 
be undertaken at regular intervals, so that 
the indications and non-indications for future 
patients may become clear. Referring 
physicians should remember that there are many 
examinations which have been shown to have a 
low yield or even negative yield [3.1]. 
(3) The justification of chest survey examinations 
is not for the good of the individual patient, 
but for the improvement of the health status 
of the population as a whole. 
3.3 OPTIMISATION OF DIAGNOSTIC RADIATION EXPOSURE 
In view of · the projected demand for 
radiological procedures and the potential hazards 
arising, the ICRP has established the principle of 
optimisation of protection as a major objective of 
practical radiological protection. It requires all 
exposures to be reduced to levels which are As Low 
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As Reasonably Achievable or "ALARA" within the 
constraint of dose limits [3.2]. 
optimisation is formally defined as the 
process of maximising the net benefit from a 
practice, which involves an assessment of whether a 
given practice is being performed at a sufficiently 
low level of exposure, so that any further 
reduction would not justify the increased costs, 
financial and otherwise, required to accomplish it. 
3.4 THE CONTROL OF EXPOSURES [3.3] 
3.4.1 
To cope with the principles . of 
justification and optimisation as described in 
sections 3 . 2 and 3. 3 , supporting documents such 
as regulations, local rules, guideline, 
recommendations and code of practice have been 
established and implemented locally and or 
internationally. The following sections are a 
summary of these documents. 
The Control of occupational Exposure 
An important feature of optimisation is the 
choice of dose constraints, the source-related 
values of individual dose used to limit the range 
of options considered in the procedure of 
optimisation. The Commission recommends a limit on 
effective dose of 20 mSv per year, averaged over 5 
years, with further provision that the effective 
dose should not exceed 50 mSv in any single year. 
Separate dose limits are 150 mSv for the lens and 
500 mSv for the skin, averaged over any 1 cm2 , 




The dose limit forms only part of of a system 
of protection aimed at achieving levels of dose 
that are as low as reasonably achievable, economic 
and social factors being taken into account. It is 
not to be seen as a 





occupational exposure can reasonably be regarded as 
tolerable. 
The Control of Public Exposure 
The control of public exposure in all normal 
situations is exercised by the application of 
controls at the source. It is achieved almost 
entirely by the procedures of constrained 
optimisation and the use of prescriptive limits. 
The ICRP recommends that the dose limit for public 
exposure should be expressed as an effective dose 
of 1 mSv in a year. However, in special 
circumstances, a higher value of effective dose 
could be allowed in a single year, provided that 
the average over 5 years does not exceed 1 mSv per 
year. The Commission also recommends annual dose 
limits of 15 mSv for the lens and 50 mSv for the 
skin averaged over any 
area exposed. 
2 1 cm , 
The Control of Patient Exposure 
regardless. of the 
Medical exposures are usually intended to 
provide a direct benefit to the exposed individual. 
If the practice is justified and the protection 
optimised, the dose in the patient will be as low 
as is compatible wi th the medical purposes. The 
Commission therefore recommends that dose limits 
should not be applied to medical exposures. 
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There is considerable scope for dose reduction 
in diagnostic radiology using the techniques of 
optimisation of protection, such that the principle 
of ALARA is achieved '. Efforts are made towards this 
goal which is further enforced by the following 
supporting statutory documents : 
(A) The Radiation Protection Guidance For 
Diagnostic X-rays stated that 
(1) The distributions of Entrance Skin 
Exposure (ESE) are widely varying and 
generally cannot be described in terms 
of conventional distributions. 
(2) For each distribution~ there is a point 
above which the exposure is likely to 
be avoidable due to poor equipment or 
less than optimal technic factors. 
(3) The choice of the point in the 
distribution where exposures become 
unacceptably high is difficult since 
it is necessary to allow for a normal 
range of diagnostician preference and 
state-of-the-art variations in X-ray 
and ancillary equipments and technical 
factors. 
(4) Careful consideration of these factors 
and the ESE data suggests that exposures 
above the 3rd quartile probably represent 
avoidable exposure. 
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(B) The Ionising Radiations (Protection of Persons 
Undergoing Medical Examinations or Treatment) 
Regulations 1988 [3.5] stipulated the Core of 
Knowledge as to Radiation Protection of 
Patients Requiste for Persons Directing 
Medical Exposures 
(3) The ranges of radiation dose that are 
given to a patient with a particular 
procedure~ the principal factors which 
affect the dose and the methods of 
measuring such doses. 
(4) The principles of quality assurance 
and quality control applied to both 
equipment and techniques. 
(5) The principles of dose limitation and 
the various means of dose reduction to 
the patient including protection of 
the gonads. 
(C) The Joint commission on Accreditation of 
Health Organisation (JCAHO) DR22.10.2 [3.6] 
stated that it was essential for diagnostic 
radiology services to provide a table of 
patient exposure for all procedures performed 
with all X-ray generators within a facility. 
It was concluded that if 75% of the exisiting 
facilities can obtain a clinically acceptable 
radiograph by exposing patients below that level, 
then the other 25% of facilities should be 
able to alter their technique to reduce avoidable 
high radiation exposure. 
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3.5 A PRACTICAL APPROACH TO CONTROL PATIENT EXPOSURES 
3.5.1 
There is a marked discrepancy in patient 
exposures for the same investigation, in the order 
of ten or even more [3.4]. Patient doses are 
subject to change substantially from 





controlled from three different approaches, namely, 
instrumental, technical and administrative. 
Instrumental Approach 
(1) X-ray Equipment and Accessories 
X-ray equipment plays a very important role 
in patient dose optimisation because the 
actual exposure delivered to the patient is 
governed by : 
(a) Design of X-ray equipment, 
(b) single or three phase generator, 
(c) Total filtration, 
(d) Image intensifier, 
(e) Automatic Exposure Control, 
(f) Time alarm device and, 
(g) Sundries of facilities for dose reduction 
The installation and selection of an 
appropriate combination of these will 




(2) Recording System 
For a given X-ray system and a particular 
patient, the exposure required depends very 
much on the speed of the recording system. 
Examples are given below : 
(a) Rare earth screens 
(b) High speed films 
(c) Carbon fibre (CB) cassette front 
(d) Automatic film processing 
The choice of these high speed film-screen 
combinations together with energetic 
processing chemicals will reduce the patient 
absorbed dose to a great extent. The dose can 
be further reduced with the use of low 
absorption materials such as carbon fibre for 
making the X-ray table top and cassette front. 
Technical Approach 
(1) Radiographic Technique 
Radiographers are persons who deliver the 
actual exposure to patients. Their technical 
standard and professional ethics are therefore 
crucial to patient dose optimisation. The 
mastering and execution of the following 
during daily practice should be reinforced. 
(a) Accuracy in positioning 
(b) Accuracy in exposure parameters 
(c) Use of beam collimators 
( d) Use of gonad shield 
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3.5.3 
(2) Radiological Technique 
Radiographers concern with the delivering of 
exposures to patient, while radiologists are 
those who should have a final say on how many 
exposures are required. The number of 
films/projections per examination and 'the 
preference for over- or under-exposed films 
are the pre-dominant factors of patient dose. 
Administrative Approach 
Apart from instrumentation and technology as 
described in Sections 3.5.1 and 3.5.2, 
administration also plays an important role in 
optimisation of patient dose. This can be 
achieved by implementation of the following 
measures 
(1) Quality Assurance Programme 
With the implementation of a suitable quality 
assurance programme, the worker can be assured 
that the facilities are functioning correctly 
and accurate exposure can then be given. 
(2) Dose Reduction 
It is the responsibility of radiographers to 
ensure that a satisfactory balance between 
risk and benefit is maintained, i. e, making 
images of good diagnostic quality, while 
minimising the patient dose in line with the 
principle of As Low As Reasonably Achievable. 
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(3) Reject Analysis 
The avoidance of repeat X-ray examinations can 
reduce exposure to patients. Reject analysis, 
may identify the reasons for poor films and 
avoid unnecessary repetition. 
Obviously, it is impossible and impracticable 
to apply all at a time not only because of a tight 
budget, but a cost-benefit balance is not reached. 
A good combination of these options is therefore 
important in order to maximise their overall 
benefit. 
3.6 CONCLUSION 
This brief review (expanded in Appendices B, C 
and D) has been given in order to show that many 
optimisation procedures are readily available and 
employable. Therefore optimisation will be limited 





4. METHOD OF STUDY 
4.1 INTRODUCTION 
4.2 
As mentioned in section 1.5, the local 
situation in Hong Kong could be different from the 
global. In order to provide more accurate 
information for optimisation of diagnostic 
radiation exposure, a series of studies have to be 
conducted. 
There have been a number of articles on the 
methods of patient dosimetry published in 
professional journals. A summary is presented in 
Appendix E for reference. 
In view of the inaccuracy of indirect methods 
and time consumption of direct methods (Appendix E) 
a modified combination of direct and indirect 
methods was adopted in this study. A working scheme 
and detailed procedures are described in the 
following sections. 
A WORKING SCHEME 
A step-by-step procedure is described in the 
following : 
(1) Direct measurement of entrance skin dose (ESD) 
during X-ray exposure with the use of 
thermoluminescent dosimeters (TLD). 
(2) A mathematical anthropomorphic phantom is 
established to simulate a local adult patient. 
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(3) The measured ESDs are extrapolated into organ 
doses using the Monte Carlo simulation on the 
established mathematical phantom. 
(4) The organ doses are multipied by the 
corresponding tissue weighting factors ,to give 
the effective dose. 
(5) The annual collective doses are worked out 
taking into account the frequency of 
each radiological procedure. 
The fore-mentioned steps are summarised in the 
following flowchart : 
Dose per projection 
Dose per examination 
Collective dose 
for specific exam 
Grand total 
collective dose 
Entrance skin dose (1) 
1 Normalisation 
Individual organ doses (2) 
1 (2) x Tissue weighting factor 
Effective dose (3) 
x No. of projections 
Total effective dose (4) 
x No. of examination 
Collective dose (5) 1 The sum of (5)s 
Total collective dose (6) 
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4.3 THE MEASUREMENT OF ESD 
4.3.1 
Thermoluminescent dosimeters (TLDs) were used 
to measure the ESDs directly on patients undergoing 
the radiographic examinations. The superiority of 
thermoluminescent dosimetry and the choice of TL 
material are presented in the following sections. 
Thermoluminescent Dosimetry 
(The physical properties and characteristics of 
TLD are covered in Appendix F. There the reason for 
choosing this system outlined below is presented in 
greater detail. ) 
Thermoluminescent dosimeters have a number of 
useful features which make them particularly 
suitable for patient dosimetry. One of the most 
important is their small physical size which 
enables them to be conveniently and unobstructively 
attached to patients with very little interference 
with patient mobility or comfort. Moreover, in 
routine radiography of most body sections -it is 
unlikely that a TLD will obscure useful diagnostic 
information. These advantages are in sharp contrast 
with the use of ionization chambers, which are more 
bulky and usually requiring permanent connection to 
an electrometer, - and are difficult to attach 
to patients, severly restrict mobility and cast 
interfering shadows on radiographs. 
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4.3.2 The TL Material Adopted 
The TL material adopted in all the 
measurements throughout this study is lithium 
borate (Li2B407 :Mg,Si) Type 20 pellets provided by 
the National Radiological Protection Board of the 
united Kingdom. 
The TLDs are manufactured by the Alnor 
Instrument AB, Nykoping, Sweden, packed in pellets 
with 4.6 mm diameter x 0.8 mm thick; weight 25 mg 
and heat-sealed in sachets about 1 cm2 made from 
0.12 mm thick sheets of black polythene. 
The radiations detected include beta, gamma, 
X-rays and thermal neutrons with d measuring range 
from 50 IJ.Gy to several grays. The TL emmission 
spectrum is from 530 to 630 nm with a peak at 605 
nm. The temperature of main TL glow peak is at 
220 °c. 
Its effective atomic number for photoelectric 
absorption is 7.4 which satifies the criterion 
mentioned in Appendix E, 4.2(1). Since energy 
correction is not required, it is therefore highly 
recommended for patient dosimetry. 
The energy dependence for pellets covered by 
polythene is within 10% of correct response from 20 
keV to 8 MeV. This satifies the criterion 
stipulated in Appendix E, 6.1(2). 
The dose response linearity is less than 10% 
supralinear for exposures less than 10 Gy. 
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The fading on 7 days after irradiation is 5% 
of initial TL value at 25 °C, while 80 days after 
irradiation is 10%. As compared with other TL 
materials, this fading is the smallest. 
There is one disadvantage of this TL material, 
namely, its relatively low sensitivity. Lithium 
borate has a threshold dose between 50 to 100 ~Gy 
which is at least 50 times greater than caso4 and 
Mg2Si04 . However, this disadvantage is outweighted 
by the fore-mentioned advantagaes which are crucial 
for patient dosimetry in diagnostic radiology. 
Photo 4.1 shows a TLD pellet and its plastic 
envelop. 




Irradiation of TLDs 
A TLD pellet in plastic envelope is adhered 
to the patient's skin surface at the centre of 
X-ray primary beam during radiographic examination. 
Because of its good tissue equivalence, the dose 
absorbed by the TLD represents the ESD with back 
scatter. 
Readout of the Exposed TLDs 
After the exposures, the TLDs are returned to 
the NRPB for reading on a TOLEDO 654 TLD Reader 
with an automatic sample changer under the 
control of a suitably programmed Commodore 
CBM Model 8032 microcomputer. 
However, there are two problems which will 
affect the accuracy of the readings. Firstly, the 
TLDs are subject to gamma radiation during transit 
to and from NRPB and Hong Kong. secolldly, fading 
will occur as a result of time lagging as mentioned 
in Appendix F, 4.2 (3). In order to tackle these 




Ten non-dosed TLDs are used 
background at NRPB, i.e., 
Control (Ro ). 
to register the 
NRPB Background 
Ten TLDs are exposed to 10 mGy to ICRU muscle 
from an automatic jig containing a 90sr 
source, which has been previously calibrated 
relative to radiation from 137cs by the NRPB. 
This serves as Dosed TLD control (R1 )· 
32 
(3) Another ten TLDs exposed by step (2) are 
used to calculate the fading factor at the 
NRPB, i.e. ' . NRPB Fading Control (R2 ). 
(4) Ten Don-dosed TLDs are used to register the 
background signal during the period of ,transit 
to and from NRPB and Hong Kong, i.e., Transit 
Background Control (R3). 
(5) Ten dosed TLDs exposed by step (2) are used to 
calculate the fading factor during transit and 
before readout at NRPB, i.e., Transit Fading 
Control (R4 ). 
(6) Undosed TLDs from NRPB are used to measure the 
ESOs during X-ray examinations (R5). 

































of Beam on 
Skin Surface 
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Sensitivity Factqr (SF) = ( Rl - R )/D 0 
NRPB Fading Factor (FFNRPB ) = ( Rl - R )/R1 2 
Hongkong Transit Background (BGHKT ) = ( R3 - ' R )/SF . 0 
Hongkong Fading Factor (FFHK ) = ( R4 - R )/R1 1 
The actual measured entrance skin dose is 
therefore, given by : 
ESD = [( R5 BGHKT ) x FFHK ] / SF (Eq. 4.1) 
Accuracy of Readings 
The overall uncertainties at 95% confidence 
for dose above 1 mGy and 10 mGy are < ± 15% and 
± 10% respectively. Since most of the readings 
lay between 1 mGy and 10 mGy, the accuracy can be 
considered less than ± 15% at 95% confidence. The 
threshold dose is 0.05 mGy at 95% confidence level 
with standard deviations of < 10% and < 5% for non 
doses and doses pellets respectively. 
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4.4 MONTE CARLO SIMULATION 
4.4.1 
[4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 4.10, 
4.11] 
Introduction 
As has been indicated the most significant 
measures of radiation dose hazard are in actual 
organ doses as distinct from an overall dose 
estimate. 
To be able to do this for some of the 
internal organs (let alone all!) is obviously 
impossible by direct measurement in the living 
body. Therefore an indirect method is required. 
The actual dose deposited in each organ is the 
end result of many factors, the major ones being : 
the actual exposure, the quality of the beam, the 
depth and size of each organ, the distribution of 
body fat, scatter within the body and back scatter. 
Each of these factors is itself the result of 
several others. The system is complex. 
If we were to take the path of a single photon 
and imagine its possible fate on traversing the 
body there would be many possibilities as shown in 
Figure 4.1. These include energies, directions, 
points of incidence, distance to collision and type 
of interactions etc. 
A computation of the possibilities of many 
such photon paths will result in an acceptable 
measure of possible dose given a particular 






Points of Incidence 
Distances to Collision 
Interactions 
Photo-electric Effect Compton Scattering 
Energy deposited 
Figure 4.2 The Possibilities of a Single f-not'""u .k'dCnS 
In this work so far we have already described 
the acquisition of mean exposure data. If we could 
apply this to a mean racially appropriate 
anthropomorphic phantom then a more accurate 
estimate of effective dose for the local population 
could be achieved. 
However, this would require a computational 
technique for a large number of random but 





The acquisition of this phantom will be 
described in Section 4.5. which will deal with an 
available mathematical model appropriate for the 
computation. This is the Monte Carlo simulation. 
History 
The earliest use of the Monte Carlo simulation 
technique was around 1873, involving a method for 
the calulation of the constant pi. The 
popularization of the technique and the term Monte 
Carlo was generally attributed to the work of J. 
von Neumann, S. Ulam, and E.Fermi during World War 
11. The term Monte Carlo was given by von Neumann 
to a secret Los Alamos project concerning neutron 
diffusion and reflected the idea that a conceptual 
roulette wheel could be employed to determine 
neutron absorption. The number of events to be 
analyzed was quite enormous, so a computer was 
sUbstituted for an actual roulette wheel. 
The Principle 
(1) Input-output Device 
The Monte Carlo simulation can be considered 
as a two-input, out-put device. It makes use 
of random sampling as shown in the following : 
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Random ~ _____ >I Monte 
Numbers . Carlo 
Probability 
Distribution 
Inputs • A large source of high-quality random • 
numbers and some probability law. 
Output 
· 
Result of random sampling of the 
· 
probability distribution. 
(2) Estimation of f.~e~EY Deposited 
To calculate the energy deposited in each 
organ, it is necessary : 
(a) to know in which organ the interaction 
sites lay and, 
(b) that the mathematical phantom should 
unambigously define the organ bounderies. 
For small organs, or organs which are many 
photon mean free path · (average distance between 
collisions) lengths away from the X-ray beam 
entrance window, a large number of histories should 
be followed. About one million or more histories 
are used to simulate diagnostic X-ray exposures in 
order to reduce the statisttcal uncertainties in 
the Monte Carlo process to reasonable levels. 
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4.4.4 
The foregoing introduction can be summarised 




Development of Computer Codes 
1 
OUT 
Organ Dose Information 
Photon His·tory 
The Monte Carlo simulation is used to 
track the paths of many photons through the 
mathematical phantom, and calculate the amount of 
energy deposited in the organs and following the 
photons until they are absorbed or escaped. This 
.. 
can be explained with a flowchart shown in Figure 
4 . 3 . 
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~---------> Selection of Initial Photon Energy 
1 
Selection of Photon Direction 
1 
Determination of the Point of Incidence 
on the Phantom 
1 
Selection of the Distance to Collision 
(Collision point out-
side the phantom) 
<------------------------~ 1 
Selection of Type of Interactions 
Photo-electric Effect Compton Scattering 
1 
Selection of Scattering ~gle 
Calculation of Outgoing Photon and Electron Energies 
1 
Test to Decide whether to Continue 
or Terminate the History 
(Terminate) (Continue) 
<------------------------~ 
Calculation of the Direction Cosines of 
the Scattered Photon 
Figure 4.3 A Flowchart of Photon History 
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(1) Selection of Initial Photon Energy 
(a) There is considerable overlap between 
the various spectra. 
(b) It is efficient to select the initial 
energy from a composite spectrum which 
is the spanning energy range of all the 
X-ray spectrum. 
(c) The photon energy is selected 
systematically from this master 
spectrum. 
(d) The results for each energy group are 
stored. 
(e) At the end of the run, the values are 
integrated over each individual spectrum. 
(2) Selection of Photon Direction 
The direction of photon is determined by 
the following factors . . 
(a) The size of the X-ray field, 
(b) The distance from the source and, 
(c) The angular limits of the emitted rays. 
These three factors, though do not concern 
with the ESDs, yet they will affect the actual 
doses received by individual organs. 
The selection is done by a 2-step process : 
(a) To select a vertical plane through the 
source. 
(b) To select the angle of elevation of the 
ray in the plane. 
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of incidence on the phantom 
(a) The chosen position of the source with 
respect to the phantom and, 
(b) The selected photon directions. 
The number of photons not striking the phantom 
is recorded. 
(4) Selection of the Distance to Collision 
~--> Selection of the No. of Mean Free Paths < 
No. of Mean Free Paths 
x 
Smallest Value of Mean Free Path 
in any of the Media 




Procedure is repeated 
with new value of 
distance until the 







Procedure is repeated 
(5) Selection of type of Interactions 
(6) 
(a) A wei~ht of measure of importance is 
assigned to each photon. 
(b) At each collision, the probability of 
a photoelectric interaction occurring 
is determined. This fraction of the 
weight is devoted to photoelectric 
interaction. 
(c) The remaining weight is used for 
Compton scattering. 
(d) At the end of the run, weights rather 
than number of photons are tallied. 
Selection of Angle 
Calculation of Outgoing 
Energies 
of scattering and 





sets of numerically 
integrated probability 
functions 1 Multi-step Rejection Technique 
RejPcted or Accepted 
The acceptance or rejection depends on 
the relative magnitude of the incoherent 
scattering function, at this angle compared 
to the maximum value of this function at 
the same incident photon energy. 
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(7) Test to Decide whether to continue 
Terminate the History 
The history will be terminated, if 
(a) The photon energy is less than 5 keV, 
the energy will be absorbed at that point 
because of extremely low penetration 
power. 
(b) The weight or photon importance is less 
than some lower limit, such that 
following the photon energy further will 
have very little effect on the results. 
The limit chosen = 
At this point, most 
Photon energy in units of 
electron rest mass 
of the histories 
are terminated, but a few are randomly 
selected to continue with an enhanced weight 
so that the overall weight is conserved. 
If the history is terminated, the 
procedure returnes to step (1), and continues 
until the set number of histories is 
completed. 
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(8) The Calculation of the Direction Cosines of 
the .Scattered Photon 
(a) The scattered photon lays on a cone 
about the original direction. 
(b) The half angle of the cone is equal to 
the angle of scatter and the azimuthal 
angle of the ray is assumed to be 
randomly distributed over 2rr radians. 
(c) The selected direction is transformed 
to the Co-ordinate system and the 
procedure continues at step (4). 
The foregoing steps could be summarised in the 









1 Random sampling of probability distribution 
and selects the locations of successive 
events. 
2 Similar probability distributions was 
established relating to the type of event 
that would occur and the direction in which 
interaction products would proceed. 
3 A photon's history was simulated by further 
random sampling. 
4 The history was terminated when the total 
energy was deposited or, the photon escaped 
from the body. 
The Use of Monte Carlo simulation in Organ Doses 
Estimation 
(1) The X-ray Source 
The X-ray source is represented by a point, 
emitting photons isotropically into the solid 
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angle defined by the X-ray set diaphragm. In 
this . case, the dose-rate and energy spectrum 
are constant over the cross-section of the 
beam. 
Two assumptions are made : 
(a) a uniform distribution across the field 
and, 
(b) the air which separates and surrounds 
both the patient and tube is neglected in 
the calculations. 
(2) simulation of the X-ray Examinations 
The parameters which could be specified in the 
programme are : 
(a) the focus to skin distance (FSD) , 
(b) the X-ray field size, position, 
projection and, 
(c) the X-ray spectrum. 
(3) Interactions in the Phantom 
(a) Photoelectric absorption 
This is the most important effect in 
tissue for photons with energies up to 
about 25 keV. The cross-section for the 
reaction increases rapidly with 
decreasing energy and at energies of a 
few keV the mean free path is so short 
that photons are effectively absorbed 
where they were produced. In this 
calculation, the simulated photon tracks 
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are terminated when the energy falls 
below 5 keV. 
(b) Rayleigh scattering 
In Rayleigh scattering the X-ray photon 
interacts with the atom as a whole and 
the process is only of importance at low 
energies where the wavelength of the 
photon is at least of the order of atomic 
dimensions. Effectively, no energy is 
lost in the interaction, but the 
direction of photon is changed. However, 
as the scattering is predominantly 
forward and increasingly so with 
increasing energy, the overall effect of 
including this scattering in the 
calculation is quite small. 
(c) Compton scattering 
Compton scattering is the dominant effect 
over most of the energy of diagnostic 
X-rays. The interaction is essentially 
between photons and free electrons; an 
electron is ejected and the photon is 
deflected and continues with reduced 
energy. 
(4) The Cross-section Data 
The cross-section data for the calculations 
are taken from the following references : 
(a) HUBBELL (1977) [4.8] 
(b) STROM and ISRAEL (1970) [4.9] 
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(c) HUBBELL et al. (1975) [4.10] 
(d) HUBBELL (1982) [4.11] 
(5) Calculation of Organ Doses 
The Monte Carlo calculations give~ the 
fraction of incident beam energy that is 
d~posited in each organ. This is converted to 
fraction per unit organ mass and the beam 
energy is expressed in terms of either 
kerma-in-air or the exposure in free air at 
the position where the X-ray beam enters the 
phantom. 





at the beam 
entrance position to kerma-in-tissue and 
correcting this for the effect of radiation 
back-scattered from the phantom. 
(6) Back-scatter 
The back-scatter fraction is determined by 
'designing a small area on the surface of the 
phantom directly surrounding the centre of the 
beam as the detector. Then the dose to a thin 
layer of this area is calculated, firstly for 
directly incident photons, and secondly for 
photons either escaping through this area or 
being scattered back in through it from other 
parts of ' the phantom. Organ doses are 
calculated in terms of entrance skin dose with 
back-scatter. 
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4.4.6 The Electron-Gamma-Shower (EGS4) Code System 
A EGS4 (Electron-Gamma-Shower) code system 
tape is provided by the Stanford Linear 
Accelerator Centre of the stanford University 
together with the lecture notes of a Four-day 
Hand-on Course on Electron and Photon Transpost 
Using the Monte Carlo System This syste~ 
provides a programme to . computerise the organ 
doses using the Monte Carlo simulation. It is 
installed in a Vax cluster system at the Computer 
Centre of the Hong Kong Polytechnic (Photo 4.2). A 
local mathematical phantom which is described in 
the following sections, is incorporated into this 
code system to workout the individual organ doses. 





A LOCAL MATHEMATICAL PHANTOM 
Introduction 
As mentioned in section 4.2 (2) the organ 
doses arising from diagnostic radiological 
procedures are estimated by the use of the Monte 
Carlo calculation together with a mathema~ical 
phantom. It is therefore necessary to establish a 
mathematical model which simulates a racially 
appropriate patient. The photons from the X-rays 
are assumed to enter this phantom and experience 
a number of interactions such as photoelectric 
effect and Compton scattering. As a result of these 
interactions, energies of different values are 
deposited in various organs which give rise to 
individual organ absorbed doses. The process of 
this simulation comes to an end when all the 
energies are totally absorbed by the organs or the 
photons are out from the phantom. 
An Ideal Mathematical Phantom 
In order that the mathematical phantom 
established can reflect a real patient who 
undergoes radiological procedures, the following 
parameters should be taken into consideration: 
(1) Body height and body weight; 
(2) Circumferences of the trunk at various levels; 
(3) Individual organ location, size, shape, volume 
and weight; 
(4) Composition of tissues. 
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4.5.3 
These parameters were taken from a mass survey 
on heal thy adul ts and corpses. Hence I the 
established phantom could only reflect an average 
healthy adult but not any individual patient. 
However, since it was impractical to take into 
account every single case's parameters, this 
phantom and the doses derived would represent to a 
great extent, the organ doses absorbed by an 
average adult Chinese patient during diagnostic 
X-ray procedures. 
Choice of Mathematical Phantom Model 
[4.16, ' 4.17, 4.18, 4.19, 4.20, 4.21, 4.22, 4.23, 
4.24, 4.25, 4.26, 4.27, 4.28, 4.29, 4.30, 4.31] 
There were several pLantom models which 
had been established in the past for internal and 
external dosimetry applications. They were all 
based on the distinguished work of SNYDER et al. 
who established a phantom 
later adopted by the Medical 
in 1969, which was 
Internal Radiation 
Dosimetry (MIRD-5) for internal dose estimation. 
The characteristics of this pioneered model 
were listed in the following 
(1) Anthropomorphic, but not accurate in the 
finer details. 
(2) No distinct arms, neck, hands and feet. 
(3) Parts of phantom was described in terms of 
algebraic functions. 
(4) General soft tissue (S.G.= 1.0) 
Bone and marrow matrix (S.G.= 1.5) 
Lung material (S.G.= 0.3) 
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(5) 1969's version: Solid only. 
(6) 1974's version 
Distinction made between the walls and 
contents of hollow organs of the 
gastrointestinal tract and bladder. 
CRISTY M. of the Oak Ridge National Laboratory 
modified the MIRD-5 model in 1980 and supplemented 
by various ages models ' on top of the adult 
phantom. Some distinct modifications were given 
below : 
(1) Distribution of 
the skeleton. 
active marrow throughout 
(2) The size and shape of the organs and head 
region were improved. 
(3) The volumes of the organs were 
related to the ICRP Reference Man. 
SNYDER and CRISTY's models were 
closely 
further 
modified by JONES and WALL of the National 
Radiological Protection Board in 1985 with the 
following characteristics 
(1) Hermaphrodite. 
(2) The breast composition was taken to be 50:50 
mixture of fat and water rather than the 
standard soft tissue composition used in other 
phantoms. (This may not be appropriate for 
the Chinese breast.) 
(3) Arm bones and immediately surrounding soft 
tissues were removed in some lateral 
projections. 
(4) The head was remodelled to incoporate a neck 
so as to place thyroid at a more realistic 
depth according to KRAMER's modification. 
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4.5.4 
In this current study, the JONES and WALL's 
model was adopted because it reflected more 
accurately a human being in terms of tissue 
compositions and more organs were included for dose 
estimation such as the thyroid. However, most of 
the parameters included in this model were based on 
ICRP Pub. 23 Reference Man who was a Caucasian. It 
was most likely that the dose estimation on the 
local Chinese with this western phantom would be 














conducted. It was 
phantom 
radiological science It was 
a joint venture between the 
author and Professor C. Metreweli and was funded by 
the University Polytechnic Grant Committee of Hong 
Kong. A large . scale survey on the parameters of 
Chinese population was conducted in Mainland 
China and Hong Kong. The parameters collected in 
this survey were adopted , the JONES and WALL's 
model was then amended accordingly, and a Chinese 
phantom both anthropomorphical and mathematical was 
established for patient dose estimation in Hong 
Kong. 
The Development of a Chinese Mathematical Phantom 
(1) Data Collection and statistical Analysis 
since Han nationality accounted for 96% of the 
Chinese population, the survey was confined to 
this category of age group from 20 to 35 years 
old. This overlapped the Hong Kong patient 
population. The occupations of the people 
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4.5.5 
surveyed included workers, farmers, business 
persons, civil servants and current university 
graduates. Their main diet were rice and 
vegetables, and corresponded with normal local 
dietary habits. 
The measurements of the height and weight of 
Chinese healthy adults were carried out by 
means of a combination of stratified sampling 
and random sampling in four provinces, two 
municipalities and Hong Kong as well. 
The heights were measured from the vertex 
along the mid-sagital plane to the sole of 
foot in the natural standing posture. The 
weight was measured with bare feet but 
wearing underwear at room temperatures from 
20 °c to 23 °c in the month of May and June. 
Data of twelve organs were collected from the 
pathologico-anatomic records from 532 acute 
deaths (18 - 55 years of age). 
The elemental composition of body tissues, 
mainly skeletal, lung and soft tissue were 
studied. Thesp. composition will affect . the 
absorption coefficients and eventually the 
organ doses. 
Results 
Tables 4.1, 4.2 and 4.3 present the body 
height and weight, twelve organ mass and elemental 
composition of Han nationality of Chinese 
respectively. 
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Table 4.1 Body height and weight of Han nationality 
Sample Male Female Total 
Location Size 
------ Ht wt Ht wt Ht wt 
M F (cm) (kg) (cm) (kg) (cm) (kg) 
Beijing 576 568 167.2 57.5 156.9 49.5 162.1 53.5 
Ganzu 586 567 166.9 57.3 156.6 48.7 161.8 53.1 
Guangzhou 22 33 166.3 56.4 154.3 50.8 159.1 53.1 
Guangxi 597 576 163.3 55.6 152.2 45.0 157.8 50.4 
Hong Kong 63 149 164.8 58.5 153.9 52.7 157.1 54.4 
Liaoning 578 522 167.5 57.6 156.7 50.4 162.4 54.2 
Shanghai 629 626 167.4 57.2 156.3 47.6 161.9 52.4 
Sichun 598 592 163.6 55.2 151.4 45.3 157.5 50.3 
Total 3649 3633 166.0 56.8 154.9 47.9 160.5 52.4 
Table 4.2 Organ mass of healthy males of . 
Han nationality 
Organ/Tissue Sample size Organ mass (gm) 
Adrenals (2) 23 11.2 ± 5.4 
Brain 270 1398.8 ± 19.6 
Heart 380 285.0 ± 67.5 
Lt kidney 189 148.0 ± 37.0 
Rt kidney 210 138.2 ± 29.2 
Liver 208 1396.7 ± 254.1 
Lt lung 58 457.9 ± 16.3 
Rt lung 54 549.2 ± 20.7 
Pancreas 150 101.2 ± 42.2 
pituitary 32 0.8 ± 0.3 
Spleen 204 179.5 ± 16.1 
Testes (1) 117 14.8 ± 4.2 
Thymus 113 36.2 ± 10.9 
Thyroid 309 18.2 ± 4.9 
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Table 4.3 Elemental compositon of body tissues % by weight 
Element Skeletal Lung Soft tissue Breast tissue 
H 7.00 10.00 10.00 11.00 
C 23.00 10.00 23.00 38.00 
N 3.90 2.80 2.30 0.00 
0 49.00 76.00 63.00 50.00 
Na 0.32 0.19 0.13 0.00 
Mg 0.11 0.01 0.02 0.00 
p 6.90 0.08 0.24 0.00 
S 0.17 0.23 0.22 0.00 
Cl 0.14 0.27 0.14 0.00 
K 0.15 0.20 0.21 0.00 




on these results, a 





















entitled 11 A study on 
phantom of Chinese 11 which 




Radiographers and Radiological Technologists was 
attached in Appendix G. 
A Comparison 
Tables 4.4, 4.5 and 4.6 compare the current 
study with other published data. 
Table 4.4 A Comparison of Body Height and Weight 
Height (cm) Weight (kg) 
Source 
Male Female Male Female 
Clu:."rent study 166 155 57 48 
Japan 165 152 60 51 
ICRP-23 170 160 70 58 
Table 4.5 A Comparison of Organ Mass (gm) 
Japan ICRP-23 Current study 
Organ 
M F M F M 
Adrenals(2) 13 13 14 14 11 
Brain 1400 1300 1400 1200 1400 
Heart 350 280 330 240 285 
Kidneys (2) 330 280 310 275 286 
Liver 1600 1400 1800 1400 1397 
Lungs 1100 900 1000 800 1007 
Pancreas 135 100 100 85 101 
Pituitary 0.6 0.6 0.6 0.7 0.8 
Spleen 130 120 180 15 180 
Gonads (2) 33 35 11 30 
Thymus 30 25 20 20 36 














Table 4.6 A Comparison of Elemental Composition 
Skeletal ·Lung tissue Soft tissue Breast tiss 
Current Current Current 
NRPB study NRPB study NRPB study NRPB 
7.04 7.00 10.21 10.00 10.47 10.00 11.70 
22.79 23.00 10.01 10.00 23.02 23.00 38.04 
3.87 3.90 2.80 2.S0 2.34 2.30 0.00 
48.56 49.00 75.96 76.00 63.21 63.00 50.26 
0.32 0.32 0.19 0.19 0.13 0.13 0.00 
0.11 0.11 0.01 0.01 0.02 0.02 0.00 
6.94 6.90 0.08 O.OS 0.24 0.24 0.00 
0.17 0.17 0.23 0.23 0.22 0.22 0.00 
0.14 0.14 0.27 0.27 0.14 0.14 0.00 
0.15 0.15 0.20 0.20 0.21 0.21 0.00 
9.91 9.90 0.01 0.01 0.00 0.00 0.00 
It can be ~een from Table 4. 4 that the body 
height and weight in this current study is 
comparable to Japanese. As compared to ICRP 
Reference Man, a standard Chinese man is 4 cm 
shorter and 13 kg lighter; while a st~ndard Chinese 
woman is 5 cm shorter and 10 kg lighter. 
As regards to organ mass, most of the organs 
in this current study are lighter than the ICRP 
Reference Man (ranging from 7S% to 92%). The only 
exceptions are lungs and thymus which are slightly 
heavier. 
The element composition of body tissues shows 
















It can then be concluded that the discrepancy 
in organ absorbed doses between the ICRP Reference 
Man and the Local Standard Chinese is mainly due to 
the heights and weights. In the following Chapter 
6, the organ doses and effective dose are estimated 
using this Local Standard Chinese phantom and the 
Monte Carlo simulation and comparison, can then be 
made with other published results. 
4.6 A SUMMARY 
The foregoing sections described the methods 
used in the current study to measure the ESOs 
directly with the use of TLOSi to extrapolate the 
ESDs into organ doses on a local mathematical 
phantom simulated by the Monte Carlo calculation. 
In the following chapters, the results are ' 
presented, analysed and compared with 
international published data. 
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5. POPULATION STUDIES 
5.1 INTRODUCTION 
In order to assess the radiation hazard 
arising from diagnostic radiology to the 
population of Hong Kong as a whole, the population 
dose has to be estimated. The doses measured should 
represent the full picture of the local situation. 
The following measures were taken to ensure these 
aims can be achieved. 
5.2 FREQUENCY SURVEY 
5.2.1 
Collective doses were calculated taking into 
account the annual frequency of radiodiagnostic 
procedures conducted in 1990. However, it was 
impossible to conduct a year-round full scale 
survey in each X-ray department, especially in 
private sectors, a modified sample survey was an 
alternative. 
Survey in Private sectors 
(1) Period of Survey 
The survey was to study the frequency of X-ray 
examinations conducted during the second week 
of December in 1990. The reason for this 
choice was because there was no bank holiday 
in that particualr week and, it was just 
before the Christmas vacation. It was a custom 
that local patients used to attend medical 
practitioners before long holidays and 
undertake investigations including X-ray 
examinations as advised. It could then be 
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5.2.2 
assumed a full workload in this week. The 
annual frequency was worked out simply 
multiplied by 50 to compensate the holidays in 
the year. 
(2) Number of Survey 
The survey was conducted in 207 private 
sectors including private hospitals, 
radiologists's clinics and X-ray laboratories. 
This represented 73% of the total radiation 
licencees registered in the year. 
Survey in Government Sectors 
The annual figures in government hospitals and 
polyclinics were obtained from the statistical 
report on the annual frequency of X-ray 
investigations together with detailed breakdown. 
The sum of these two survey gave the 
total annual frequency as presented in Table 5.1. 
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TABLE 5.1 ANNUAL FREQUENCY OF RADIODIAGNOSTIC PROCEDURES 
YEAR 
EXAM REGION 
1986 1987 1988 1989 1990 
GENERAL SKULL 138300 151751 151982 145404 139073 
DENTAL 4901 30386 40188 40678 37738 . 
CXSPINE 45389 51708 52388 51038 51170 
TXSPINE 14318 16160 16372 15951 16142 
LX SPINE 35509 39859 40383 . 39343 40032 
U.EX1REMETY 107367 136102 148828 143219 142153 
L.EXTREMETY 95400 108383 114804 117311 114690 
PELVIS 41968 44741 45796 45029 52143 
CHEST 748571 794175 842033 818664 865341 
MMIlMOGRAM 981 3701 3976 3478 3850 
ABDOMEN · 126390 135063 143798 13419~ 135112 
OBS 2939 2373 2406 2406 - 2300 
MIS 3699 4814 4431 4431 4539 
TOTAL 1365732 1519217 1607387 1561148 1604283 
SPECIAL SKULL 1420 1359 1624 1296 1194 
SPINE/LIMBS 2610 3681 4076 5996 3195 
CHEST 4593 4138 4693 5385 7699 
BA SWALLOW 3866 4183 3936 3798 4102 
BA MEAL 10184 9731 9026 7941 6692 
BA ENEMA 6759 7791 7942 7279 8334 
OC/IVC 16479 49892 40599 35550 28770 
IVU 19029 2265 23198 20287 21272 
ANGIOGRAM 2751 159 2416 2150 2307 
OSS 437 343 328 241 231 
MIS 2778 1851 2549 1946 1526 
TOTAL 70906 85393 100387 91870 85323 






Selection of Regions and Projections 
The following regions and projections were 
selected for ESD measurements : 
Regions Projections 
Skull AP/PA LAT 
Chest AP/PA LAT 
Cervical spine AP LAT 
Thoracic spine AP LAT 
Lumbar spine AP LAT 
Lumbo-sacral spine LAT 
Abdomen AP 
Pelvis AP 
The reason for chosing these regions and 
projections was because they contributed the 
highest frequency of examinations conducted in Hong 
Kong as shown in Table 5. 1. Their somatic and 
genetic effects were more significant as compared 
with other examinations such as extremeties. 
Selection of Hospitals and Laboratories 
The fact that exposures vary not only from 
case to case but also from department to department 
led to the need to obtain data from a range of 
hospitals and clinics. In order to have 
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representative data of the ESDs received by 
patients undergoing diagnostic radiological 
examinations co.nducted in Hong Kong, the survey 
were carried out in the following hospitals and 
laboratories : 
(1) Teaching hospital (one) 
(2) Government hopsital (one) 
Chest Survey Centres (five) 
(3) Subvented hospitals (five) 
(4) Private hopsitals (five) 
(5) Radiologist's clinics (ten) 
(6) Private X-ray laboratories (25) 
5.4 SAMPLE SIZE 
ESD measurements were 





selected projections conducted in one teaching 
hospital, one government hospital, five chest 
survey centres, five subvented hospitals, ten 
radiologists' clinics and 25 private X-ray 
laboratories from December 1990 to mid-1991. 
2 , 036 TLDs were exposed dur ing the survey, 
and their readings were provided by the Medical 






As mentioned in Chapters 4 and 5, the ESDs of 
15 radiographic projections of eight regions 
were measured with TLDs (lithium borate) at various 
selected centres. Organ doses and effective doses 
were then worked out using the Mont~ Carlo 
simulation on a local anthropomorphic phantom 
model. Photo 6.1 shows the TLDs in situ during 
chest X-ray examination. The results are presented 
in the following : 





1,634 adult patients 
projections of eight 
regions were studied at one teaching hospital, one 
government hospital, five subvented hospitals, ten 
radiologist's clinics and 25 private X-ray 
laboratories during the period of January to 
mid-1991. 
6.3 AGE BAND AND SEX DISTRIBUTION 
The age band and sex distribution of 9, 000 
patients for the examinations of skull, chest, 
spine, abdomen and pelvis are shown in Table 6.1 
and presented graphically in Figs. 6.1 to 6.4. 
It could be seen that most of the patients 
were from 30 to 44 age band. This was probably due 




Photo 6.1 TLD in situ during X-ray examination 
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TABLE 6.1 AGE BAND AND SEX DISTRIBUTION 
REGION SKULL CHEST SPINE ABD/PELVIS 
AGE BAND M F M F M F M F 
0-6 78 33 180 150 1 2 13 11 
7-19 52 28 290 380 11 5 8 3 
20-29 57 41 1090 960 44 31 20 37 
30-44 78 105 1400 950 94 95 79 73 
45-64 41 64 1030 620 42 35 52 52 
>64 4 13 310 250 9 6 16 15 










































































































































































































































































































































































































































































6.4 THE MEASURED ESDs 
6.4.1 
As mentioneq earlier, the published doses 
varied significantly. due to a number of factors 
such as the X-ray generator, rectification, 
radiographic technique, recording system" film 
processor and the methods of dose estimation. On 
top of all these, the patient size, perhaps was the 
dominating factor which determined the exposure 
needed and the hence affected the ESOs and organ 
doses accordingly. MAILLIE (1982) revealed that the 
thickness of the irradiated part was the most 
important parameters which would influence the 
average organ doses [6.1]. Analyses of the measured 
ESOs are presented in the following : 
Histograms of ESOs RY Projection 
Histograms of the 
Skull (AP/PA, LAT), Chest 
measured ESOs for 
(AP/PA, LAT), Cervical 
spine (AP, LAT), Thoracic Spine (AP, LAT), Lumbar 
spine (AP, LAT), Lumbo-sacral Spine (LAT) , Abdomen 
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FIG. 6.5 HISTOGRAM OF ESD, SKULL (AP/PA) 
MEAN 2.94 mGy 
S.D. 1.67 mGy 
RANGE 1.27 mGy - 4.61 mGy 










.............. : ...................... . 
.................... : .... 
• 
• 
3.75 : .......... . 




I .... + •••• l .... + •••• l .... + •••• l . ." .. + •••• I •. 0 •• + •••• I 
o 12 Z4 36 48 0 60 
Histogram Frequency 
FIG. 6.6 HISTOGRAM OF ESD, SKULL (LAT) 
MEAN 2.12 mGy 
S.D. 1.16 mGy 
RANGE 0.96 mGy - 3.28 mGy 
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FIG. 6.8 HISTOGRAM OF ESD, CHEST (LAT) 
MEAN 0.73 mGy 
, 
S.D. 0.47 mGy 
RANGE 0.76 mGy - 1.20 mGy 
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FIG. 6.10 HISTOGRAM OF ESD, CERVICAL SPINE (LAT) 
MEAN 0.51 mGy 
S.D. 0.17 mGy 
RANGE 0.34 mGy - 0.68 mGy 
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FIG. 6.11 HISTOGRAM OF ESD, THORACIC SPINE (AP) 
MEAN 2.73 mGy 
S.D. 0.91 mGy 
RANGE 1.82 mGy - 3.64 mGy 















................... : ....... 
• 
......................... : ......... 
--_ .... :_ .... 
_: .. -
: .. - -
I • • . . +. . . . I ·. . . • +. . • . I. • . • +. • . . I • • . • +. . . . I • • . . +. • . . I 
o 4 8 12 16 20 
Histogram Frequency 
FIG. 6.12 HISTOGRAM OF ESD, THORACIC SPINE (LAT) 
HEAN 4.29 mGy 
S.D. 2.01 mGy 
RANGE 2.28 mGy - 6.30 mGy 
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FIG. 6.13 HISTOGRAM OF ESD, LUMBAR SPINE (AP) 
MEAN 3.87 mGy 
S.D. 1.79 mGy 
RANGE 2.08 mGy - 5.66 mGy 
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FIG. 6.16 HISTOGRAM OF ESD, PELVIS (AP) 
MEAN 4.41 mGy 
S.D. 2.54 mGy 
RANGE 1.87 mGy - 6.95 mGy 
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Histogram Frequency 
FIG. 6.17 HISTOGRAM OF ESD, ABDOMEN ' (AP) 
MEAN 3.07 mGy 
S.D. 1.38 rnGy 
RANGE 1.69 mGy - 4.42 mGy 
. . . . . Gaussian Curve 
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6.4.2 A Comparison of ESDs Qy Projection 
A comparison of the measured ESDs by 
projection is shown in Table 6.2 and presented 
graphically in Fig. 6. 18. The key points are 
highlighted in the" following : 
(1) The lowest and highest ESOs 
The lowest and highest ESOs measured were 0.05 
mGy of Chest (AP/PA) and 34.78 mGy of 
Lumbo-sacral Spine (LAT). The latter was at 
least 3 orders of magnitude greater than the 
former. 
(2) The lowest and highest mean ESOs 
The lowest and highest mean ESDs were 0.20 mGy 
of Chest (AP/PA) and 16.35 mGy of Lumbo-sacral 
Spine. 
(3) The lowest and highest variances 
The lowest and highest variances were 0.02 mGy 
of Chest (AP/PA) and 39.4 mGy of Lumbo-sacral 
Spine. This could be explained that there was 
a wide range of transverse body thickness in 
the pelvic region. On the other hand, the 
variation in AP diameter of the chest seemed 
not affecting the exposure very much. This 
might be due' to the air content within the 
lung field which played an insignificant role 
in the absorption of X-ray photons. 
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It was well appreciated that the variances of 
the measured ESDs in Skull work were rather small 
as compared with other regions becaue there was not 
much difference in both the AP and transverse 
diameters. 
It might come to a conclusion that the effect 
of variations in transverse · diameter of body 
thickness on ESDs was much greater than AP diameter 
particularly in the pelvic and lumbo-sacral 
regions. This meant more exposures were required 
for those patients with big pelvis and hence a 
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Table 6.2 A COMPARISON OF ESD BY PROJECTION 
ESD (mGy) 
REGION PROJ 
MEAN MIN MAX S.D. VARIANCE 
SKULL flP/PA 2.94 1.19 7.10 1.67 2.83 
LAT 2.12 0.78 4.35 1.01 1.16 . 
CHEST flP/PA 0.20 .0. OS 0.93 0.13 0.02 
LAT 0.73 0.20 1.96 0.47 0.22 
ex SPINE pp 1.53 0.58 3.76 0.89 0.79 
LAT 0.51 0.25 0.92 0.17 0.03 
TXSPINE pp 2.73 1.40 4.40 0.91 0.83 
LAT 4.29 2.00 9.50 2.01 4.31 
LX SPINE flP 3.87 1.23 9.94 1.79 3.19 
LAT 6.72 3.36 9.85 2.18 4.73 
LSLAT 16.35 11.42 34.78 6 ~'3 39.40 
ABDOMEN pp 3.07 0.96 6.16 1.38 1.91 
PELVIS pp 4.41 0.97 9.56 2.F~ 6.46 
92 
6.4.3 A Comparison of Mean ESDs Qy Centre 
A comparison of the mean ESDs for the 15 
radiographic projections at the six centres is 
shown in Table 6. 3 and present~d graphically in 
Fig. 6.19. 
It could be seen that the government hospital 
and private X-ray laboratories accounted for four 
highest mean ESDs, i.e., Skull (AP/PA), Chest (PA, 
LAT), Abdomen (AP) and Skull (LAT) , Cervical Spine 
(AP, LAT), Pelvis (AP) respectively. Private 
hospitals accounted for two; Thoracic Spine (LAT) 
and Lumbar Spine (LAT). The other three highest 
mean ESDs were shared by Lumbar Spine (AP) at 
teaching hospital, Lumbo-sacral Spine (LAT) at 
subvented hospitals and Thorac:c Spine (AP) at 
radiologist's clinics. 
However, it is expected that the exposure to 
the lower abdomen and pelvic region would give 
the highest gonad dose to the patient. In this 
respect the private laboratories, subvented 
hospitals and private hospitals are responsible for 









































































































































































































































































































































TABLE 6.3 A COMPARISON OF ESD BY CENTRE 
MEAN ESD (mGy) VARIANCE 
(mGy) 
REGION · PROJ CENTRE 
T.H. G.H. S.H. P.H. DRS. LAB. 
SKULL PP/pA 3.07 3.59 2.34 2.00 2.98 3.20 0.30 
LAT 2.33 2.23 2.11 1.60 1.92 2.45 0.09 
CHEST PP/PA 0.26 0.32 0.24 ·0.17 0.21 0.12 0.00 
LAT 0.60 o.n · 0.55 1.84 0.57 0.75 0.20 
CXSPINE pp 1.52 1.30 0.85 1.55 0.95 3.35 0.89 
LAT '0.48 0.44 0.37 0.33 0.58 0.85 0.03 
TXSPINE pp 1.76 3.37 3.10 2.26 4.07 1.99 0.52 
LAT 2.53 3.92 3.98 9.79 8.57 2.74 8.62 
LX SPINE pp 4.69 2 t"\04 • t. . 4.59 3.73 4.18 4.36 0.48 
LAT 6.75 7.98 5.33 8.69 7.48 4.86 2.11 
LSLAT 16.59 14.05 19.20 15.94 18.87 16.64 3.68 
ABDOMEN ftP 3.52 3.58 2.64 3.22 2.29 1.39 0.61 
PELVIS AP 4.55 2.33 4.53 . 2.06 . 6.28 9.24 6.92 
95 
6.4.4 A Comparison of Collective ESDs Qy Centre 
Figures 6.20 to 6.25 illustrate graphically 
the effect of utilising the ESDs measured at only 
one site as being representative of the ESDs for 
the territory as a whole. 
It is immediately striking that this would 
give a wide variability of collective ESD 
estimations and confirms the need to obtain data 
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THE ESTIMATED ORGAN DOSES 
Introduction 
The ESOs presented in section 6.4 could only 
register the radiation dose absorbed by the pkin on 
the site of incidence. In order to evaluate the 
radiological hazard imposed on the patient as a 
whole, the individual organ doses are estimated and 
then multiplied by their corresponding tissue 
weighting factors to give the effective dose. This 
is a better index of risk to the patient. 
Method 
The ESO to organ dose conversion factors were 
worked out using the Monte Carlo simulation on the 
local mathematical phantom for the selected 15 
radiographic projections with the following 
parameters : 
103 
Region Proj Focus-skin Field size Centre # 
dist at midplane X Y Z 
. (cm) ( cm x cm ) (cm) 
Skull AP 75 20 x 25 0 0 8 
PA 75 20 x 25 0 0 8 
LAT 80 24 x20 0 0 8 
Chest AP 160 32 x 40 0 0 40 
PA 160 32 x 40 0 0 40 
LAT 145 30 x 40 0 0 40 
CX Spine AP 75 15 x 20 0 0 20 
LAT 75 15 x 20 0 5 20 
TX Spine AP 75 20 x 37 0 0 38 
LAT 60 15 x 37 0 5 38 
LX Spine AP 75 25 x 36 0 0 64 
LAT 60 15 x 34 0 0 64 
LSX Spine LAT 60 14 x 18 0 6 68 
Abdomen AP 75 30 x 40 0 0 70 
Pelvis AP 75 36 x 35 0 0 78 
# The co-ordinate system is based on the following . . 
(1) the origin is at the vertex of the phantom; 
(2) the X axis is directed towards the phantom's lefti 
(3) the Y axis is directed towards the phantom's posteriori 
(4) the Z axis is directed inwardly so that Z is positive 




Normalised Organ Doses 
The normalised organ absorbed dose depended 
on the tube voltage (constant potential) and total 
filtration ( mm Alumininum) which were measured 
with a NERO 6000M as described Appendix B. Using 
the tissue weighting factors specified in the ' ICRP 
Pub. 60 the effective dose was then worked out for 
each projection. 
Organ Doses per Projection 
The 
calculated 
actual organ absorbed 
by multiplication of the 
doses were 
normalised 
dose by the measured ESD. Twenty organ doses were 
worked out for each radiographic projection at 
mean, minimum and maximum ESDs together with their 
corresponding collective doses. These are shown in 
Tables 6. 4 to 6. 9 
Figs. 6.26 to 6.31. 
and presented graphically in 
The lowest and highest mean ESDs were 0.02 mGy 
of Chest (AP/PA) and 16.35 mGy of Lumbo-sacral 
spine (LAT) , while the lowest and highest mean 
collective doses were 0.013 mSv of Chest (PA) and 
0.705 mSv of Pelvis (AP). 
It was not surprising that the highest ESD did 
not match with the effective dose and vice versa. 
This was because the effective dose depended on the 
products of tissue weighting factors and organ 
doses which in turn, were determined by the 
distance separated from the primary beam. For 
example, Lumbo-sacral spine (LAT) had the highest 
ESD (16.35 mGy) , but some of the vital organs were 
105 
out of the primary beam such as the 
testes, resulting in an effective dose of 0.168 mSv 
only. While for Pelvis (AP), though the ESD was 
only 4 . 41 mGy, most of the vital organs 
particularly the gonads were within the primary 
beam, which gave the highest effective dose 
(0.705 mSv) among the 15 projections under 
investigation. 
A summary of the mean ESOs and effective doses 
is presented in the following . . 
Region Proj Mean ESO Mean effective dose 
(mGy) (mSv) 
Skull AP 2.94 0.025 
Skull PA 2.94 0.019 
Skull LAT 2.12 0.016 
Chest AP 0.20 0.028 
Chest PA 0.20 0.013 
Chest LAT 0.73 0.049 
C. Spine AP 1.53 0.027 
C. Spine LAT 0.51 0.002 
T. spine AP 2.73 0.232 
T. Spine LAT 4.29 0.106 
L. spine AP 3.87 0.500 
L. Spine LAT 6.72 0.166 
LS Spine LAT 16.35 0.258 
Abdomen AP 3.07 0.405 



























































































































































































































































































































TABLE 6.4 SKULL 
Pro Tection------AP (118)---------PA(118)---------LAT (184-) ----




BN 0.320 0.130 0.774 0.338 0.137 0.817 0.310 0.114 0.637 
BT ****** ****** ****** ****** ****** *****~ ****** ****** ****** 
HD 0.721 0.292 1.740 0.694 0.281 1.680 0.565 0.208 1.160 
KY ****** ****** ****** ****** ****** ****** ****** ****** ****** 
LB ****** ****** ****** ****** ****** ****** ****** ****** ****** 
LG 0.002 ****** 0.0060.002 ****** 0.005 ****** ****** 0.002 
LR ****** ****** ****** ****** ****** ****** ****** ****** ****** 
QY ****** ****** ****** ****** ****** ****** ****** ****** ****** 
PS ****** ****** ****** ****** ****** ****** ****** ****** ****** 




****** ****** ****** ****** ****** ****** ****** ****** ****** 






































****** ****** ****** 0.002 
****** ****** ****** ****** ****** ****** ****** ****** ****** 
****** ****** ****** ****** ****** ****** ****** ****** ****** 
****** ****** ****** ****** ****** ****** ****** ****** ****** 
-------------------------------------------------
Effective 
. dose(mSv) 0.025 0.010 0.060 0.019 0.008 0.046 0.016 0.006 0.034 
----. ---------------------------------------------
KEY: BD = BLADDER 
BN = BRAIN 
BT = BREAST 
HD = HEAD 
KY = KIDNEY 
LB = LOWER LARGE BOWEL 
LG = LUNG 
LR = LIVER 
OY = OVARY 
PS = PANCREAS 
RM = RED BONE MARROW 
SB = SMALL BOWEL 
SH = STOMACH 
SN = SKIN 
TB = TOTAL BONE 
TD = THYROID 
TK = TRUNK 
TS = TESTES 
UB = UPPER LARGE BOWEL 
US = UTERUS 
Figures in parenthesis are sample sizes 






















































































































































































































































































































































































































TABLE 6.5 CHEST 





















****** ****** ****** ****** ****** ****** ****** ****** ****** 
****** ****** ****** ****** ****** ****** ****** ****** 0.002 
0.116 0.017 0.569 0.007 0.001 0.003 0.181 0.050 0.505 
0.008 0.001 0.037 0.008 0.001 0.038 0.025 0.007 0.070 
0.005 ****** 0.024 0.061 0.009 0.299 0.043 0.012 0.119 
****** ****** 0.001 ****** ****** ****** ****** ****** 0.002 
0.044 0.007 0.218 0.048 0.007 0.235 0.140 0.031 0.316 
0.040 0.006 0.198 0.022 0.003 0.109 0.092 0.025 0.256 
****** ****** 0.001 ****** ****** ****** ****** ****** 0.001 
·0.022 0.003 0.107 0.017 0.003 0.085 0.052 0.014 0.143 
0.009 0.001 0.043 0.014 0.002 0.068 0.027 0.007 0.074 
0.001 ****** 0.006 ****** ****** ****** 0.003 ****** 0.009 
0.051 0.008 0.248 0.010 0.001 0.047 0.062 0.017 0.173 
0.021 0.003 0.102 0.020 0.003 0.098 0.071 0.019 0.196 
0.028 0.004 0.138 0.043 0.006 0.210 0.074 0.020 0.206 
0.101 0.015 0.497 0.004 ****** 0.017 0.100 0.027 0.278 
0.029 0.004 0.140 0.030 0.004 0.144 0.068 0.019 0.188 
****** ****** ****** ****** ****** ****** ****** ****** ****** 
. 0.002 ****** 0.011 0.001 ****** 0.007 0.004 0.001 





dose(mSv) 0.028 0.004 0.136 0.013 0.002 0.068 0.049 0.013 0.135 
-------------------------------------------------
KEY: BD = BLADDER 
BN = BRAIN 
BT = BREAST 
HO = HEAD 
KY = KIDNEY 
LB = LOWER LARGE BOWEL 
LG = LUNG 
LR = LIVER 
OY = OVARY 
PS = PANCREAS 
RM = RED BONE MARROW 
SB = SMALL BOWEL 
SH = STOMACH 
SN = SKIN 
TB = TOTAL BONE 
TO = THYROID 
TK ~ TRUNK 
TS = TESTES 
UB = UPPER LARGE BOWEL 
US = UTERUS 
Figures in parenthesis are sample sizes 







































































































































































































































































































































TABLE 6.6 CERVICAL SPINE 
Projection------AP(65)----------LAT(64)------
------------------------------------
BD ****** ****** ****** ****** ****** ****** 
BN 0.012 0.004 0.029 0.007 0.003 0.013 
o BT 0.001 ****** 0.003 ****** ****** ****** 
HO 0.218 0.083 0.535 0.061 0.030 0.116 
KY ****** ****** ****** ****** ****** ****** 
LB ****** ****** ****** ****** ****** ****** 
R LG 0.012 . 0.004 0.029 0.002 ****** 0.004 
LR ****** ****** ****** ****** ****** ****** 
OY ****** ****** ****** ****** ****** ****** 
PS ****** ****** ****** ****** ****** ****** 
G RM 0.018 0.007 0.044 0.005 0.002 0.009 
SB ****** ****** ****** ****** ****** ****** 
SH ****** ****** ****** ****** ****** ****** 
SN 0.047 0.018 0.114 0.015 0.007 0.029 
A TB 0.086 0.033 0.212 0.022 0.011 0.042 
TO 0.953 0.361 2.340 0.010 0.005 0.019 
TK 0.021 0.008 0.051 0.006 0.003 0.011 
TS ****** ****** ****** ****** ****** ****** 
NUB ****** ****** ****** ****** ****** ****** 
US ****** ****** ****** ****** ****** ****** 
------------------------------------
Effective 
dose(mSv) 0.027 0.010 0.066 0.002 0.001 ·0.004 
------------------------------------
KEY: BD = BLADDER 
BN = BRAIN 
BT = BREAST 
HO = HEAD 
KY = KIDNEY 
LB = LOWER LARGE BOWEL 
LG = LUNG 
LR = LIVER 
OY = OVARY 
PS = PANCREAS 
RM = RED BONE MARROW 
SB = SMALL BOWEL 
SH = STOMACH 
SN = SKIN 
TB = TOTAL BONE 
TO = THYROID 
TK = TRUNK 
TS = TESTES 
UB = UPPER lARGE BOWEL 
US = UTERUS 
Figures in parenthesis are sample sizes 
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TABLE 6.7 THORACIC SPINE 
Pro Tection------AP (59}----------LAT (64) ------
---------Mean --Mln--Max--Mean--- Min --Max-
------------------------------------
BD ****** ****** ****** ****** ****** ****** 
BN 0.003 0.001 0.004 0.004 0.002 0.007 
0 BT 0.850 0.451 1.400 0.022 0.010 0.048 
HD 0.091 0.049 0.151 0.071 0.032 0.152 
KY 0.040 0.021 0.065 0.084 0.037 0.178 
LB 0.001 ****** 0.002 ****** ****** 0.002 
R LG 0.480 0.255 0.791 0.463 0.206 0.984 
LR 0.317 0.168 0.522 0.215 0.096 0.456 
OY ****** ****** 0.002 ****** ****** 0.002 
PS 0.259 0.137 0.427 0.211 0.094 0.488 
G RM 0.080 0.042 0.131 0.107 0.048 0.228 
SB 0.006 0.003 0.011 ·0.005 0.002 0.010 
SH 0.349 0.185 0.575 0.064 0.029 0.136 
SN 0.140 0.075 0.231 0.186 0.083 0.396 
A TB 0.222 0.118 0.365 0.291 0.130 0.618 
TD 1.200 0.638 1.980 0.043 0.019 0.092 
TK 0.225 0.120 0.372 0.217 0.097 0.461 
TS ****** ****** ****** ****** ****** ****** 
N UB 0.010 0.005 0.017 0.006 0.003 0.013 
US 0.002 ****** 0.003 ****** ****** 0.002 
------------------------------------
Effective 
dose(mSv) 0.232 0.123 0.383 0.106 0.047 0.226 
------------------------------------
KEY: BD = BLADDER 
BN = BRAIN 
BT = BREAST 
HD = HEAD 
KY = KIDNEY 
LB = LOWER LARGE BOWEL 
LG = LUNG 
LR = LIVER 
OY = OVARY 
PS = PANCREAS 
RM = RED BONE MARROW 
SB = SMALL BOWEL 
SH = STOMACH 
SN = SKIN 
TB = TOTAL BONE 
TD = THYROID 
TK = TRUNK 
TS = TESTES 
UB = UPPER LARGE BOWEL 
US = UTERUS 
Figures in parenthesis are sample sizes 





































































































































































































































































































































































































TABLE 6.8 LUMBAR SPINE 
Pro Tection------AP (205)---------LA,. (95) ---------LSLA T (120-) --
-------------------------------------------------
Mean Min Max Mean Min Max Mean Min Max 
-------------------------------------------------
ESD(mGy) 3.87 1.23 9.94 6.72 3.36 10.45 16.35 11.42 34.78 
-------------------------------------------------
IBD 0.798 0.253 2.040 · 0.065 0.032 0.101 0.068 0.048 0.146 
IBN ****** ****** ****** ****** ****** ****** ****** ****** ****** 
0 BT 0.020 0.006 0.052 0.006 0.003 0.010 0.001 ****** 0.002 
HD ****** ****** ****** ****** ****** ****** ****** ****** ****** 
KY 0.160 0.051 0.410 0.657 0.329 1.020 0.627 0.438 1.330 
LB 0.442 0.141 1.140 0.253 0.180 0.366 0.319 0.223 0.679 
R LG 0.138 0.044 0.354 0.053 0.027 0.080 0.008 0.006 0.018 
LR 0.797 0.253 2.050 0.569 0.285 0.885 0.188 0.131 0.400 
OY 0.569 0.181 1.460 0.361 0.180 0.561 0.731 0.511 1.560 
PS 0.507 0.161 1.300 0.416 0.208 0.647 0.095 0.067 0.203 
G RM 0.097 0.031 0.250 0.164 0.822 0.256 0.251 0.176 0.535 
SB 0.760 0.242 1.950 0.345 0.173 0.537 0.696 0.486 1.480 
SH 1.250 0.396 3.200 0.219 0.109 0.340 0.121 0.084 0.257 
SN 0.223 0.071 0.573 0.252 0.126 0.391 0.324 0.226 0.689 
A TB 0.173 0.055 0.445 0.205 0.103 0.319 0.245 0.171 0.522 
TD ****** ****** ****** ****** ****** ****** ****** ****** ****** 
TK 0.437 0.139 1.120 0.331 0.165 0.514 0.413 0.288 0.879 
TS 0.026 0.008 0.066 0.007 0.004 0.011 0.007 0.005 0.015 
N UB 0.953 0.303 2.450 0.326 0.163 0.508 0.545 0.381 1.160 
US 0.729 0.232 1.870 0.196 0.098 . 0.304 0.331 0.231 0.705 
-------------------------------------------------
Effective 
dose(mSv) 0.500 0.159 1.280 0.166 0.083 0.258 0.168 0.117 0.357 
--------------------------_. ----------------------
KEY: BD = BLADDER 
BN = BRAIN 
BT = BREAST 
HD = HEAD 
KY = KIDNEY 
LB = LOWER LARGE BOWEL 
LG = LUNG 
LR = LIVER 
OY = OVARY 
PS = PANCREAS 
RM = RED BONE MARROW 
SB = SMALL BOWEL 
SH = STOMACH 
SN = SKIN 
TB = TOTAL BONE 
TD = THYROID 
TK = TRUNK 
TS = TESTES 
UB = UffPER LARGE BOWEL 
US = UTERUS 
Figures in parenthesis are sample sizes 




















































































































































































































































































































































































TABLE 6.9 ABDOMEN/PELVIS 
-----------ABD OM EN----'------P EL viS------
Pro jection -----AP (2-46)---------AP (92) -------
---------Mean --Mln--Max--Mean--- Min --Max-
------------------------------------
BD 1.020 0.320 2.470 1.690 0.371 3.980 
BN ****** ****** ****** ****** ****** ****** 
0 BT 0.007 0.002 0.017 0.002 ****** 0.005 
HD ****** ****** ****** ****** ****** ****** 
KY 0.111 0.035 0.269 0.081 0.016 0.190 
LB 0.440 0.138 1.060 0.734 0.161 1.730 
R LG 0.028 0.009 0.068 0.004 ****** 0.010 
LR 0.524 0.164 1.260 0.116 0.026 0.273 
OY 0.421 0.132 1.010 0.735 0.162 1.730 
PS 0.322 0.101 0.775 0.052 0.014 0.122 
G RM 0.079 0.025 0.190 0.114 0.027 0.268 
SB 0.577 0.181 1.390 0.892 0.196 2.100 
SH 0.860 0.169 2.070 0.215 0.047 0.506 
SN 0.239 0.075 0.577 0.446 0.098 1.050 
A TB 0.146 0.046 0.352 0.296 0.065 0.697 
TD ****** ****** ****** ****** ****** ****** . 
TK 0.405 0.127 0.977 0.520 0.114 1.220 
TS 0.240 0.075 0.578 2.990 0.657 ·7.040 
N UB 0.724 0.226 1.740 1.080 0.239 2.550 
US 0.559 0.175 1.350 0.977 0.215 2.300 
------------------------------------
Effective 
dose(mSv) 0.405 0.127 0.975 0.705 0.155 1.660 
------------------------------------
KEY: BD = BLADDER RM = RED BONE MARROW 
BN = BRAIN SB = SMALL BOWEL 
BT = BREAST SH = STOMACH 
HD = HEAD SN = SKIN 
KY = KIDNEY TB = TOTAL BONE 
LB = LOWER LARGE BOWEL TD = THYROID 
LG = LUNG TK = TRUNK 
LR = LIVER TS = TESTES 
OY = OVARY UB = UPPER LARGE BOWEL 
PS = PANCREAS US = UTERUS 
Figures in parenthesis are sample sizes 
****** indicates a dose < 0.001 mGy 
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6.5.5 A Computerised Programme 
A computerised programme had been established 
based on the normalised organ doses in section 
6.5.3 and was presented at the 8th Asian Conference 
for Radiographers and Radiological Technologists in 
1991. 
In this programme, beam quality parameters are 
key- in as input including phase of generator (1~ 
or 3~), tube voltage in kV and total filtration in 
mm Al together with patient identification, region 
of examination, and projection. The normalised 
organ doses are estimated taking into account of 
the beam quality parameters, which are in turn 
multiplied by the key-in ESD to give the actual 
organ doses. The effective dose is then worked out 
as described in the Working Scheme (Section 4.2). 
These organ doses together with effective dose are 
displayed numerically and graphically using ten 
colour codes. Direct comparison on organ and 
effective doses of two different projections could 
be made easily. with this programme in hand one 
could predict the organ doses and effective dose to 
a particular patient using a pre-set exposure 
factors. 
A detailed discussion on the organ doses in 
each examination is given below together with 
colour graphic presentation. 
119 
(1) Skull 
A graphic comparison of the organ doses per 
projection with colour codes is presented in 
Figs. 6.32 to 6.37. 
In skull examination, both AP and PA 
projections had identical mean ESDs (2.~4 mGy) 
but the former effective dose was 1.3 times 
more than the latter. This could be explained 
by the fact that in AP projection, the total 
bone received a dose of 0.276 mGy,while in PA 
projection, this dose was only 0.198 mGy (Fig. 
6 • 35) • 
Another organ which experienced marked 
discrepancy in absorbed dose was the thyroid 
(at least 4.7 times higher than PA 
projection) . 
This confirms the accepted teaching that PA 
projection should be encouraged for any skull 
worK (except for Townes view) · because of a 
lower effective dose to the patient. 
120 
FIG. 6.32 
Colour display of organ doses, Skull (AP) 
121 
FIG. 6.33 




Colour display of organ doses, Skull (LAT) 
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FIG. 6.35 
Colour display of organ doses, Skull (AP,PA) 
124 
FIG. 6.36 
colour display of organ doses, Skull (AP,LAT) 
125 
FIG. 6.37 
Colour display of organ doses, Skull (PA,LAT) 
126 
(2) Chest 
A graphic comparison of the organ doses per 
projection with colour codes is presented in 
Figs. 6.38 . to 6.43. 
The situation in skull X-ray is similar to 
chest X-ray. Though the ESDs for AP and PA 
projections were 
effective dose of 
the same (0.20 mGy) , the 
AP was about two times 
greater than the PA projection. 
There were at least two. vital organs which 
, .. 
showed marked discrepancies in absorbed doses, 
namely the breast (17 times) (Fig. 6.33), · 
the thyroid (25 times). On the contrary, 
the lung dose in AP was slightly lower than in 
PA projection (0.044 against 0.048 mGy). 
However, this was outweighted by the breast 
and thyroid doses. This was perhaps a very 
strong reason to avoid AP projection · in chest 
work especially for women of child-bearing .age 
or suspected pregnancy. 
127 
FIG. 6.38 
Colour display of organ doses, Chest (AP) 
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FIG. 6.39 
Colour display of organ doses, Chest (PA) 
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FIG. 6.40 
colour display of organ doses, Chest (LAT) 
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FIG. 6.41 
Colour display of organ doses, Chest (AP,PA) 
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FIG. 6.42 
colour display of organ doses, Chest (AP,LAT) 
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FIG. 6.43 
Colour display of organ doses, Chest (PA,LAT) 
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(3) Cervical Spine 
A graphic comparison of the organ doses per 
projection with colour codes is presented in 
Figs. 6.44 to 6.46. 
The ESD and effective dose for AP were 3 
times and 13 times greater "~han LAT 
projection, because the former received a much 
higher organ doses ( from 2.5 times to as high 
as 52 times) than the latter. The Focus-film 
distance used in AP projection was 100 cm 
with Bucky. More exposure was needed. While in 
LAT . projection, no Bucky was used with a 
longer Focus-film distance of 180 cm. This 




colour display of organ doses, C.Spine(AP) 
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FIG. 6.45 
colour display of organ doses, C.Spine(LAT) 
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FIG. 6.46 
Colour display of organ doses, C.Spine(AP,LAT) 
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(4) Thoracic Spine 
·A graphic comparison of the organ doses per 
projection with colour codes is presented in 
Figs. 6.47 to 6.49. 
In LAT projection, the ESD was about two times 
of that for AP projection, but the effective 
dose was the converse. Because of the incresed 
thickness of the trunk to be penetrated in the 
LAT projection, a much higher exposure was 
used resulting in a greater ESD of 4.29 mGy, 
However, the X-ray field was collimated to 
cover just the vertebrae durini- the exposure, 
this excluded most of the organs from the 
primary beam, in particular the thyroid, 
breast and upper large bowel. 
It should be emphysed that the effective dose 
depended very much on the X-ray field size 
and the extent of volume or organs being 
irradiated. If the X-ray field was not 
collimated to its minimum, more organs were 
irradiated directly rather by the scattered 
radia~ion, a much - higher effective dose was 
unavoidable. This emphasizes that X-ray field 




Colour display of organ doses, T.Spine(AP) 
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FIG. 6.48 
Colour display of organ doses, T.Spine(LAT) 
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FIG. 6.49 
Colour display of organ doses, T.Spine(AP,LAT) 
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(5) Lumbar Spine 
A graphic comparison of the organ doses per 
projection with colour codes is presented in 
Figs. 6.50 to 6.52. 
The situation in Lumbar Spine was · exactly the 
same as Thoracic Spine. Moreover, since there 
were more vital organs included during AP 
projection, the effective dose was three times 
higher than that of LAT projection. The doses 
to the testes and · bladder in AP projection 
were 4 and 12 times higher than LAT 
.. 
projection. If these two organs were included 
in the primary beam during LAT 
projection due to either - malpractice 




Colour display of organ doses, L.Spine(AP) 
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FIG. 6.51 
Colour display of organ doses, L.Spine(LAT) 
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FIG. 6.52 
Colour display of organ doses, L.Spine(AP,LAT) 
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(6) Lumbo-sacral Spine 
A graphic presentation of the organ doses is 
shown in Fig. 6.53. 
Although the ESD for Lumbo-sacral Spine (LAT) 
was the greatest among the 15 projections, its 
effective dose was less than that of Abdomen 
(AP) and Pelvis (AP). However, due to the 
higher tube voltage used, the scattered 
radiation arising was of a higher photon 
energy, which meant the doses to those organs 
out of the primary beam would be 
increased. This brough~ its effective dose the 
fifth highest position. 
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FIG. 6.53 
colour display of organ doses, LS Spine (LAT) 
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(7) Abdomen and Pelvis 
A graphic comparison of the · organ doses per 
projection with colour codes is presented in 
Figs. 6.54 to 6.56. 
The ESDs and effective doses for Abdomen (AP) 
and Pelvis (AP) were comparable, except that 
more vital organs were included in the Pelvis 
(AP) projectioh especially the testes/ovaries. 
Together with Lumbar Spine (AP), they occupied 
the first three highest positions of effective 
doses. It was therefore strongly advised that 
.. 
the examinations should be justified, and 
repeat or retake should be avoided 
particularly for females of child~bearing age. 
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FIG. 6.54 
Colour display of organ doses, Abdomen (AP) 
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FIG. 6.55 
colour display of organ doses, Pelvis (AP) 
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FIG. 6.56 
colour display of organ doses, Abdomen (AP) & Pelvis (AP) 
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6.6 A COMPARISON OF ORGAN DOSES ESTIMATED ON LOCAL AND 
NRPB PHANTOM MODELS 
The global 'figures of organ doses estimated on 
the western Rando phantom do not allow for the 
anthropomorphic differences of the local racial 
habitus, it is therefore, of interest to study the 
organ doses using these two different mathematical 
models to see the actual effects. 
Table 6.10 compares the normalised organ doses 
between the NRPB calculation and the current study 
for the 15 selected radiographic projections under 
investigation. 
For those organs irradiated by the direct 
beam, the doses reported by the NRPB were 
underestimated by 0.10% to 80%. For those organs 
outside the direct beam, i.e., irradiation 
caused by Compton scattering, the percentages 
were even higher ( 19.1% to 94.9% ) ( Figs. 6.57 and 
6. 58) • 
These findings imply that for a given ESD, the 
organ doses estimated on a bigger mathematical 
model are underestimated, compared with the smaller 
phantom, in this case, the local Chinese. Those 
organs which are remote from the primary beam are 
subject to scattered radiation. The farther the 
distance apart, the smaller will be the dose 
received. This distance is longer in a big phantom 
resulting in a smaller dose and underestimation. 
Moreover this false underestimation will diminish 
the apparent radiation hazard risk and perhaps even 
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Fig. 6.58 A comparison of organ doses 
















7. SOURCES OF UNCERTAINTY 
7.1 UNCERTAINTITIES IN COMPUTATION 
7.1.1 
7.1.2 
The organ doses presented in Chapter 6 were 
estimated with the Monte Carlo simulation on a 
local anthropomorphic phantom. This computation 
suffers from a number of uncertainties as detailed 
by JONES and WALL (1985) [7.1]. This is described 
in the following : 
Inaccuarcy of the Justaposition of Complex Human 
Anatomy and the X-ray Beam 
These were due to the following : 
(1) Crude geometrical expressions to define 
structures and organs in mathematical phantom. 
(2) Inadequancies in the description of the X-ray 
source and the patient. 
(3) Juxtaposition of human anatomy and X-ray beam 
configurations with mathematical phantoms. 
statistical Uncertainties 
These were due to the random errors in the 
calculated organ doses. It was reduced by 
increasing the number of photons that deposited 
energy in each organs. However, there is a limit to 
the number of photon histories that could be 
followed in each calculation, set by the speed and 
availability of the central processor. A compromise 
was chosen of one million photon histories per 
calculation, which took approximately 4 hours of 
central processor time. This allowed the standard 
error in the organ dose conversion factors to fall 




receiving a significant proportion of the dose in 
any examination. 
Attenuation Coefficient uncertainties 
Linear attentuation coefficients were derived 
from 
(1) Atomic cross-sections : ± 2% uncertainties 
(2) Elemental compositions and densities of the 
tissues : 
the difference between various soft tissues in 
the body and those modelled in the phantom 
introduced an error of ± 10% . 
Anatomic Inexactitudes 
In the mathematical phantom, simple 
geometrical formulae are used to describe complex 
human anatomy. Dose rates fall rapidly outside the 
primary beam so that the dose to small organs close 
to the beam edge can chage dramatically with small 
changes in beam position. In addition, it is very 
difficult to define the required X-ray beam 
positions accurately with respect to the organs of 
interest. On average, the uncertainty in the 
derived organ doses are estimated to be ± 10%. 
7.2 ERRORS CONTRIBUTED BY TLDs (Section 4.3.5) 
The errors contributed by TLDs are ± 15%. 
7.3 TOTAL POSSIBLE ERROR 
The total possible errors would be the sum of 
these: ± 42%. 
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7.4 VERIFICATION OF THE RESULTS 
7.4.1 
7.4.2 
In view of the uncertainties described in 
Section 7.3, measures were taken to verify the 
results presented in this study. 
Verification of the Measured ESD 
It has been already been proved that direct 
measurements of ESDs with TLDs is the most accurate 
one as compared with other established methods. The 
TLDs adopted in this study were lithium borate with 
an effective atomic number of 7.4. The calibration 
and reading were carried out by professional 
experts at the National Radiological Protection 
Board of the United Kingdom. This TLD service 
is provided worldwide. The accuracy and precision 
of the TLD readings are thus standardized and 
internationally comparable. 
Verification of the Estimated Organ Doses 
In order to verify the results presented in 
section 6.5, the following procedures were taken: 
A local Chinese male corpse of 165 cm in 
height and 62 kg in weight was chosen, which was 
undertaken a post-mortem study at the Prince of 
-Wales Hospital. Masses- of several organs were 
recorded, namely the brain, thyroid, left lung, 
right lung , liver, left kidney, right kidney and 
testes. Photo 8.1 shows the corpse placed on top of 
a grid/cassette during an X-ray exposure of the 
abdomen with 15 TLDs in situ : 
158 
· Organ 
Lung Liver Kidney Testes ESD 
Lt. Rt. Lt. Rt. Lt. Rt. 
No. of TLDs 2 2 4 1 1 1 1 1 
A comparison of the masses and organ doses is 
presented in Table 7.1. 




















































Photo 7.1 The corpse at the Prince of Wales Hospital 
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The four selected organ masses of the corpse 
are comparable with their counterparts of the local 
mathematical phantom (Table 7.1). The estimated 
organ doses by indirect method in this study agree 
with the direct reading by + 7% to -30%. This was 
well within the possible total error. While the 
accuracy dropped sharply from -20% to -65% if the 
NRPB phantom was used. This was outside the 
measurement error range. With an identical ESD, the 
absorbed dose is higher for a smaller organ. 
It must be emphasized that the organ doses in 
one corpse estimated in this way can only be 
treated as an approximation. this is partly due to 
the reduction in volumes and masses of 
possibly dehydrated organs. 
The doses measured may not represent the organ 
doses as a whole especially for large organs such 
as the lung and liver. However, the result suggests 
that there is no significant discrepancy between 
the corpse and the local mathematical phantom. It 
may then be concluded that the doses presented in 
Chapter 6 can, be accepted and are representative 
of the doses received by the local adult patient. 
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, CHAPT! 8 
HEALTH I MPLICAT ONS 
8. HEALTH IMPLICATIONS 
8.1 INTRODUCTION 
The organ doses and effective doses shown in 
Chapter Seven gave an indication of th'e doses 
absorbed by individual organs and whole body 
effect:l.ve dose per projection. In order to further 
assess the the actual risk on the patients arising 
from these doses and the health implication on the 
population as a whole, the Somatic Significant Dose 
(SSD) , Leukaemic Significant Dose (LSD) and 
Genetically Significant Dose (GSD) were estimated. 
8.2 DATA SOURCE [8.1, 8.2, 8.3, 8.4, 8.5] 
The data required for the estimation of SSD, 
LSD and GSD were quoted from the following sources : 
.(1) Local population and age/sex grouping 
(2) Annual frequency of diagnostic radiological 
examinations 
(3) Fatal cancer factor of a specific group of 
population, Sgk 
(4) Leukaemia factor of a specific group of 
population, Lgk 






(1) The frequencies of examinations for a specific 
sex and age group was based on the 
proportionality of the figures in Table 4.1. 
(2) For a specific examination, an identical dose 
was assigned to both sex and all age groups 
except for gonad doses. The results were 
liable for over-estimation. 
(3) For Skull examination, the total dose was 
summed from PA andLAT projection. 
(4) For Chest examination, the dose of PA 
projection was taken as the total dose. 
(5) For Spine examination, the frequency was the 
sum of Cervical, Thoracic, Lumbar and 
Lumbo-sacral spine examinations. The dose for 
each examination was taken from AP and LAT 
projection except for Lumbo-sacral Spine where 
LAT was the only choice. The total dose was 
therefore a mean of these four examinations. 
(6) For Abdomen/Pelvis examination, the total dose 
was taken as the mean of these two 
examinations (AP projection only). 
SOMATIC RISK 
Somatically Significant Dose (SSD) [Ref. 8.6] 
Somatically Significant Dose is the radiation 
dose received by the whole body of an individual 
weighted according to the fatal cancer factor of 
162 
8.4.2 
that individual, i.e., the somatic effect of 
irradiation of an individual. 
It is given by 
SSD = L gjk Ngk Sgk HE,gjk (Eq. 8.1) 
Where, g, k and j are sex group, age band and 
types of examinations respectively; 
N is a specific group of population; 
S is the fatal cancer factor of a 
specific group of 'populationandi 
HE is the per caput effective dose 
of a specific population 
G
s 
per 106 = 0.125 x SSD / N (Eq. 8.2) 
Where, G is the estimated romatic risk 
s 
per 106 population; 
0.125 is a constant; 
N is the total population 
Results 
Table 8.1 and Fig. 8.1 present the SSD and Gs 

















































































TABLE 8.1 SOMATIC SIGNIFICANT DOSE 
REGION AGE FREQUENCY Mean He (uS v/a) Sgk N SSD(uSv/a) TOTAL % G(s) 
eff dose SSD per 
BAND M F (mSv) M F M F M F M F (uS v/a) million 
0-6 18262 7726 0.035 0.63 0.27 1.00 1.00 634200 589000 0.0184 0.0035 0.0220 
7-19 12175 65:6 0.035 0.42 0.23 0.91 0.93 229300 208000 0.0206 0.0067 0.0273 
20-29 13345 95se 0.035 0.46 0.34 0.70 0.78 537200 532000 0.0081 0.0047 0.0129 
SKULL 30-44 18262 24584 0.035 0.63 0.86 0.44 0.55 774700 718600 0.0066 0.0162 0.0228 
45-:-64 95se 14984 0.035 0.33 0.52 0.16 0.22 535000 481200 0.0010 0.0036 0.0046 
>64 937 3044 0.035 0.03 0.11 0.02 0.05 211700 253300 0.0000 0.0001 0.0001 
TOTAL 72580 66493 29221002782400 0.0547 0.0348 0.0896 2.68% 
0-6 20468 17057 0.013 0.26 0.22 1.00 1.00 634200 589000 0.0086 0.0064 0.0150 
7-19 32976 43210 0.013 0.42 0.56 0.91 0.93 229300 208000 0.0:61 0.1085 0.1646 
20-29 123345 109163 0.013 1.61 1.42 0.70 0.78 537200 532000 0.2602 0.2271 0.4874 
CHEST 30-44 159195 108025 0.013 2.06 1.40 0.44 0.55 774700 718600 0.18710.1161 0.3032 
45-64 117122 70501 0.013 1.52 0.92 0.16 0.22 535000 481200 0.0533 0.0295 0.0829 
>64 35250 28428 0.013 0.45 0.37 0.02 0.05 211700 253300 0.0015 0.0021 0.0036 
TOTAL 488957376384 29221 00 2782400 0.5669 0.4898 1.0:67 31.61% 
0-6 286 573 0.300 0.08 0.17 1.00 1.00 634200 589000 0.0000 0.0002 0.0002 
7-19 3149 1431 0.300 0.94 0.43 0.91 0.93 229300 208000 0.0118 0.0027 0.0146 
20-29 12595 8874 0.300 3.77 2.66 0.70 0.78 537200 532000 0.0620 0.0346 0.0966 
SPINE 30-44 26908 27194 0.300 8.07 8.16 0.44 0.55 774700 718600 0.1234 0.1698 0.2932 
45-64 12023 10019 0.300 3.60 3.01 0.16 0.22 535000 481200 0.0130 0.0138 0.0267 
>64 2576 1718 0.300 0.77 0.52 0.02 0.05 211700 253300 0.0002 0.0002 0.0004 
TOTAL 57536 49808 29221002782400 0.2104 0.2213 0.4317 12.91% 
0-6 6423 5435 0.555 3.56 3.02 1.00 1.00 634200 589000 0.0361 0.0278 0.0639 
7-19 3953 1482 0.555 2.19 0.82 0.91 0.93 229300 208000 0.0344 0.0055 0.0339 
20-29 9882 18281 0.555 5.48 10.15 0.70 0.78 537200 532000 0.0706 0.2719 0.3426 
ABDOMEN 30 - 44 39032 36068 0.555 21.6 20.02 0.44 0.55 774700 718600 0.4802 0.5526 1.0328 
/PELVIS 45-64 25692 25692 0.555 14.2 14.26 0.16 0.22 535000 481200 0.1096 0.1675 0.2770 
>64 7905 7411 0.555 4.38 4.11 0.02 0.05 211700 253600 0.0033 0.0060 0.0093 
TOTAL 92886 94369 29221002782400 0.7342 1.0313 1.7655 52 .81% 
GRAND 




The total SSD was estimated to be 3.34 ~Sv/a 
of whicb Abdomen/Pelvis contributed more than half 
(52.81%), followed by Chest (31.61%), Spine 
(12.91%) and Skull (2.68%). It was appreciated that 
the mean effective dose for Abdomen/Pelvis was the 
highest among these four category of examinations 
resulting in a greatest SSD. In Spine examination, 
the SSD was probably under-estimated because the 
inclusion of Cervical and Thoracic Spines . . The SSD 
of Chest examination was greater than Skull despite 
its rather low effective dose was probably a result 
of much greater numbers in frequencies. 
The Somatic Risk was estimated to be 0.007 per 
million of population. However, if the worst 
condition is assumed, i.e., all examinations were 
given the maximum ESDs, the SSD and G would be 
max s 
increased to 10.83 ~Sv/a ans 0.024 per million 
population respectively. 
LEUKAEMIC RISK 
Leukaemically Significant Dose (LSD) [Ref. 8.6] 
Leukaemically Significant Dose is the 
radiation dose received by the red bone marrow of 
an individual, weighted according to the leukaemia 
factor of that individual, i.e., the potential 




It is given by 
L 'k N k L k H , g] g g B,g]k (Eq. 8. 3) 
Where, g, j and k are sex group, age band and 
types of examination respectively; 
N is a specific group of population; 
L is leukemia factor of a specific 
group of population; 
HB is the per caput red bone marrow 




= 0.02 x LSD / N (Eq. 8.4) 
Where, Gl is the estimated Leukaemic risk 
per 106 population; 
0.02 is a constant; 
N is the total population 
Results 
Table 8.:r:. ~uld Fig. 8.2 present the LSD and Gl 





















































































TABLE 8.2 LEUKAEMIC SIGNIFICANT DOSE 
REGION AGE FREQUENCY Mean Hb(uSv/a) Lgk N LSD (uSv/a) TOTAL % GO) 
RBM dose LSD per 
BAND --M----F (mSv) M F M F M F M F (uSv/a) million 
0-6 18262 7726 0.072 1.31 0.:6 1.00 1.00 634200 589000 0.0379 0.0073 0.0452 
7-19 12175 6:e6 0.072 0.88 0.47 1.00 1.00 229300 208000 0.0465 0.0149 0.0614 ' 
20-29 13345 9589 0.072 0.96 0.69 0.98 0.98 537200 532000 0.0234 0.0122 0.03:6 
SKULL 30-44 18262 24584 0.072 1.31 1.77 0.95 0.97 774700 718600 0.0294 0.0587 0.0882 
45-64 9589 14984 0.072 0.69 1.08 0.74 0.83 535000 481 200 0.0092 0.0279 0.0371 
>64 937 3044 0.072 0.07 0.22 0.45 0.54 211 700 253300 0.0001 0.0014 0.0016 
TOTAL 72580 66493 29221 00 2782400 0.1466 0.1224 0.2690 8.44% 
0-6 20468 17057 0.014 0.29 0·.:0 1.00 1.00 634200 589000 0.0092 0.0161 0.0254 
7-19 32976 43210 0.014 0.46 0.47 1.00 1.00 229300 208000 0.0664 0.0981 0.1644 
20-29 123945 109163 0.014 1.74 0.69 0.98 0.98 537200 532000 0.3924 0.1390 0.eG13 
CHEST 30-44 159195 108025 0.014 2.23 1.77 0.95 0.97 774700 718600 0.4351 0.2581 0.6932 
45-64 117122 70501 0.014 1.64 1.07 0.74 0.83 535000 481200 0.26:6 0.1312 O'39ES 
>64 35250 28428 0.014 0.49 0.21 0.45 0.54 211700 253300 0.0370 0.0133 0.0502 
TOTAL 488957 376384 29221 00 2792400 1.2057 0.6557 1.9614 59.3g<'1o 
0-6 286 573 0.191 0.05 0.23 1.00 1.00 634200 599000 0.0000 0.0002 0.0003 
7-19 3149 1431 0.181 0.57 0.60 1.00 1.00 229300 209000 0.0079 0.0042 0.0120 
20-29 12595 8874 0.181 2.28 1.52 0.99 0.98 537200 532000 0.0524 0.02:0 0.0774 
SPINE 30-44 . 26908 27194 0.181 4.87 1.51 0.95 0.97 774700 718600 0.1607 0.05e6 0.2162 
45-64 12023 10019 0.181 2.18 0.98 0.74 0.83 535000 481200 0.0362 0.0171 0.0532 
>64 2576 1718 0.191 0.47 0.39 0.45 0.54 211700 253300 0.0026 0.0015 0.0040 
TOTAL 57:G6 49908 29221 00 2792400 0.2597 0.1034 0.3531 11.3g<'1o 
0-6 6423 5435 0.097 0.62 0.10 1.00 1.00 634200 589000 0.0063 0.0010 0.0073 
7-19 39:G 1482 0.097 0.38 0.25 1.00 1.00 229300 209000 0.0066 0.0018 0.0085 
20-29 9992 19281 0.097 0.96 1.60 0.99 0.99 537200 532000 0.0173 0.0541 0.0714 
ABD/ 30-44 39032 30068 0.097 3.79 4.92 0.95 0.97 774700 718600 0.1912 0.2396 0.4209 
PELVIS 45-64 25592 25592 0.097 2.49 1.81 0.74 0.93 535000 481200 0.0986 0.0804 0.1699 
>64 7905 7411 0.097 0.77 0.31 0.45 0.54 211700 253300 0.0129 0.0049 0.0179 
TOTAL 92996 94359 29221 00 2792400 0.3129 0.3919 0.6947 21.7g<'1o 
GRAND 




The estimated LSD (3.19 ~Sv/a) was comparable 
to SSD (3.34 ~Sv/a). Though Spine examination had 
the highest RBM dose (0.181 mGy), its LSD accounted 
for 11.39% only. Same as SSD, Chest examination of 
the lowest RBM dose (0.014 mGy) but contributed to 
58.39% of the total LSD. The sUb-total LSDs for 
Spine and Skull examinations were 11.39% and 8.44% 
respectively. 
The Leukaemic Risk was 0.001 per million 
population and increased to 0.004 per million as a 
result of a LSD
max of 10.72 ~Sv/a on the worst 
condition. 
GENETIC RISK 
Genetically Significant Dose (GSD) [Ref. 8.6] 
Genetically Significant Dose is the radiation 
dose received by the gonads of an individual, 
weighted according to the expected future number of 
children of that individual, i.e., the potential 
effect of irradiation of the gonads depends on the 
remaining fertility of that individual. 
It is given by : 
GSD = ~ N W H ok L gjk gk gk G,g] (Eq. 8. 5) 
Where, g, j and k are sex group, age band and 
types of examinations respectively; 
N is a specific group of population; 
W is the child expectancy of a 
specific group of population; 
HG is the per caput gonad dose of 
a specific group of population 
170 
8.6.2 
G per 106 = 0.08 x GSD / N 
. g (Eq. 8. 6) 
Where, G is the estimated genetic risk 
g 6 
per ·10 population; 
0.08 is a constant; 
N is the total population 
Results 
Table 8.3 and Fig. 8.3 present the GSD and Gg 























































































TABLE 8.3 GENETICALLY SIGNIFICANT DOSE· 
REGION-AGE--FREQUENCY---Meangonad"-Hg(uSv/a-) -Wgk----N-----GSD(uSv/a-) -TOTAL --%-G(9) 
dose(mGy) GSD per 
BAND --M---F-- M F -M"-F-M"-F--M---F----,VI--F- -(uSV/a) million 
----0-6--18262--7726-0.00 -0.00 -0.000.0012-1 120 634200-589000-0.00000.00000 .0000 ------
7-19 12175 6556 0.00 0.00 0.00 0.00 1.21 1.19229300 208000 0.0000 0.0000 0.0000 
20-29 13345 9599 0.00 0.00 0.00 0.00 1.11 1.33 537200 532000 0.0000 0.0000 0.0000' 
SKULL 30-44 18262 24584 0.00 0.00 0.00 0.00 0.38 0.37 774700 718600 0.0000 0.0000 0.0000 
45- 64 9599 14984 0.00 0.00 0.00 0.00 0.02 0.00 535000 481200 0.0000 0.0000 0.0000 
>64 937 3044 0.00 0.00 0.00 0.00 0.00 0.00 211700 253600 0.0000 0.0000 0.0000 
10T&-7258 0-66493--------------29221002782400-0.00 000.00000.0000-0.00% 
----0-6--20468-1"7057 -0.00 -0.00 -0.000.0012-1 120 634200-589000 -0.00000.000 00.0000----
7-19 32976 43210 0.00 0.00 0.00 0.00 1.21 1.19 229300208000 0.0000 0.0000 0.0000 
20-29 123945 109163 0.00 0.00 0.00 0.00 1.11 1.33 537200532000 0.0000 0.0000 0.0000 
CHEST 30-44 159195 108025 0.00 0.00 0.00 0.00 0.38 0.37 774700 718600 0.0000 0.0000 0.0000 
45- 64 117122 70501 0.00 0.00 0.00 0.00 0.02 0.00 535000 481200 0.0000 0.0000 0.0000 
>64 35250 28428 0.00 0.00 0.00 0.00 0.00 0.00 211700 2536()0 0.0000 0.0000 0.0000 
lOT &-488957-376384 --------------29221002782400-0.00000.00000.0000-0.00% 
----0-6---286"--573-0.00"5-0.208-0.000.0"6TooToo 634200-589000 -0.00000.000 1-0.0001----
7-19 3149 1431 0.005 0.208 0.01 0.15 1.00 1.00 229300 208000 0.0001 0.0010 0.0011 
20-29 12595 8874 0.005 0.208 0.03 0.92 0.98 0.98 537200 532000 0.0007 0.0150 0.0158 
SPINE 30-44 26908 27194 0.005 0.208 0.07 2.82 0.95 0.97 774700 718600 0.0022 0.1036 0.1058 
45-64 12023 10019 0.005 0.208 0.03 1.04 0.74 0.83 535000 481200 0.0005 0.0180 0.0185 
>64 2576 1718 0.005 0.208 0.01 0.18 0.45 0.54 211700 253600 0.0000 0.0007 0.0007 
TOT &-57536"-49808" --------------29221002782400 -0.003 6Q.13830T4.T9-3, 72 % 
----0-6 ---6423--5435 -1.615-0.578-5.191.571.001.00 634200-589000 -0.052 50.01450.0670----
7-19 3953 1482 1.615 0.578 3.19 0.43 1.00 1.00229300208000 0.0550 0.00310 .0581 
20- 29 9882 18281 1.615 0.578 7.98 5.28 0.98 0.98 537200 532000 0.1438 0.1779 0.3218 
ABDI 30-44 39032 36068 1.615 0.578 31.52 10.42 0.95 0.97 774700 718600 1.5086 0.5075 2.0161 
PELVIS 45- 64 25692 25692 1.615 0.578 20 .75 7.42 0.74 0.83 535000 481200 0.7373 0.3290 1.0663 
>64 7905 7411 1.615 0.578 6.38 2.14 0.45 0.54 211700 253600 0.1073 0.0338 0.1411 
10T&-92886-94369--------------29221002782400-2.6045To6583.6io'3-96 .28% 
GRAND--------------------------------------------------
TOTAL 5704500 3.8122 100.00% 0.005 
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It was not surprising that there was no 
contribution to GSD from Skull and Chest 
examinations because of their insignificant gonad 
doses. Most of the GSD therefore came from 
Abdomen/Pelvis ' examination (96.28%), while Spine 
examination shared the rest (3.72%). 
The total GSD (3.81IlSv/a) gave rise to a 
Genetic Risk of 0.005 per million population. On 
the worst condition, the GSD of 5.28 IlSvja would max 
increase this risk to 0.007 per million population. 
8.7 DISCUSSION 
As seen from sections 8.4, 8.5 and 8.6, the 
estimated SSD, LSD, GSD and the corresponding G
s
' 
GI , Gg on average arising from Skull, Chest, Spine 
and Abdomen/Pelvis examinations were 3.34, 3.19 
3 .81 IlSV / a and O. 007, O. 001, O. 005 per million 
population respectively. This translates into a 
possible number of lifetime fatal cancers to be 19. 
The worst case scenario would be where the SSD were 
10.83 IlSv/a almost causing 69 excess fatal cancers, 
a threefold increase. Even this figure does not 
match the NRPB global calculation of 85. 
Part of the explanation lies in the fact that 
not all radiographic, computed tomography and 
scintigraphic investigations have been included. 
However the importance of optimisation is stressed 
by the threefold difference. Even if one were to 
accept that 19 excess fatal cancers were 
"reasonable" then the further excess of another 42 
fatal cancers gives valid cause for concern. 
If one were to make a further extension of the 
worst case scenario by adding the possible sources 
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of error this could raise the excess fatal cancers 
to between 27 and 60 excess fatal cancers bring the 
figures much closer to the NRPB. If there were no 
Regulations/Local Rules to control exposures, the 
worst condition might or would happen. The higher 
risk would then be inevitable. The leukaemic risk 
and genetic risk would be increased by four times 
and 1.5 times higher than their mean values 
respectively. 
In order to extract more detail from the 
findings the doses and possible radiation hazards 
from each type of investigation on the ten most 
common malignancies in Hong Kong were dissected. 
From the Histogram (Fig. 8.4), it can be seen 
that the ten most common malignancies are those of 
lung, liver, colon, stomach, nasopharynx, 
oesophagus, rectum, breast, pancreas and leukaemia 
in that order. 
setting aside Hepatocellular carcinoma and 
Nasopharyngeal carcinoma in which the 
aetiological features are reasonably well 







to be significant 
extent. 
in the 
Examination of the previous decade trends 
(Figs. B.5 - 8.14) shows that six of these organs 
are rising in frequency (lung, colon, stomach, 
rectum, breast and pancreas) · 
The hypothetical possibility that some of this 
rise may be contributed to by the increase in 
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The beauty of the technique used in this study 
is that each organ's absorbed dose could be 
calculated for each type of investigation. Figs. 
8.15 to 8.24 show the mean and population doses of 
the breast, head, liver, lower large bowel, lung, 
pancreas, red bone marrow and stomach for the 15 
selected radiographic projections respectively. 
Please note that the dosage is plotted on a 
logarithmic scale. Those projections with the high 










Upper large bowel 
Lower large bowel 
Red bone marrow 
Projection 
Mean Dose 
Thoracic Spine (AP) 
Skull (AP) 
Thoracic Spine (AP) 
Thoracic Spine (AP) 
Lumbar Spine (AP) 
Lumbar spine (AP) 
Lumbar Spine (AP) 
Lumbar spine (AP) 
Pelvis (AP) 












It could ' be seen among the 15 radiographic 
projections, Lumbar Spine (AP) was responsible for 
high risk of induction of cancers of the stomach, 
liver, pancreas and colon. Thoracic Spine (AP) 
may induce high cancer risk of the thyroid, breast 
and lung. Skull (AP) gave the highest mean head 
187 
dose which may increase the risk of nasopharyngeal 
carcinoma. Pelvis (AP) and LS Spine (LAT) accounted 
for high· risk of carcinoma of rectum and leukaemia 
respectively. 
In terms of population dose, Chest (LAT) 
because of a big number of annual frequency, was 
responsible for induction of cancers of five 
regions, namely, the thyroid, breast, lung, 
pancreas and red bone marrow. Abdomen (AP) gave 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In Hong Kong in 1990 for a midyear population 
of 5,704,500 there were 1,689,606 radiodiagnostic 
examinations performed in public facilities. 1,634 
adult patients undergoing any of 15 selected 
radiographic projections had the ESDs measured with 
TLDs. The ESDs were converted into organ and 
effective doses with the use of the Monte Carlo 
simulation based on a racially appropriate . local 
anthropomorphic phantom. 
9.1 MEAN ESDs PER PROJECTION 
The mean ESDs per projection, given in 
decreasing order of magnitude were shown in Table 
9. 1 : 
Table 9.1 The mean ESDs per projection in 













































9.2 A COMPARISON OF MEAN ESDs BETWEEN LOCAL CENTRES 
There are obviously great difference between 
countries, which are not always consistently higher 
or lower. The differences must be caused by 
different qualities of equipment, different patient 
habitus and radiographic habits or techniques, the 
possible addition of other supplementary views 
being added to the figures and of course different 
techniques of actual measurement. However in Hong 
Kong itself there is a wide variation in ESDs for 
the same projection between different establish-
ments (Fig. 9.1). The variances between 
establishments ranging from 0.03 to 3.68 mGy. 
There were no " overall differences " in Hong 
Kong. The highest mean ESDs 
between each of the categories 





Table 9.2 1~e highest mean ESD per projection per centre 
Mean ESDs (mGy) 
Projection T.H. G.H. S.H. P.H. DRS LAB 
Skull (AP/PA) 3.59 
Skull (LAT) 2.45 
Chest (AP/PA) 0.32 
Chest (LAT) 1.84 
Cervical Spine (AP) 3.35 
Cervical Spine (LAT) 0.85 
Thoracic Spine(AP) 4.07 
Thoracic Spine(LAT) 9.79 
Lumbar Spine(AP) 4.69 
Lumbar Spine(LAT) 8.69 
Lumbo-sacral Spine (LAT) 19.2 
Abdomen (AP) 3.58 









































































































































































































































































































9.3 A COMPARISON OF MEAN ESDs BETWEEN COUNTRIES 
When comparing the mean ESDs between countries 
[9.1, 9.2, 9.3, 9.4, 9.5] comparison of published 
data with Hong Kong's 1990 data (Table 9.3) shows 
some striking differences. To highlight a few : the 
skull X-rays taken in Japan (1972) were 2.6 times 
higher; the chest X-rays taken in Guangzhou (1991) 
were 2. 7 times higher, abdominal radiographs in 
France (1988) were 5.3 times higher! 
Whereas the cervical spines taken in Guangzhou 
(1991) were 5.3 times lower and the lateral 
lumbo-sacral spines in Japan were 1.5 times lower. 
Table 9.3 A comparison of mean ESDs between countries 
FRANCE GUANGZHOU 





U.K. U.K. H.K. 
(1969) (1988) (1990) 
SKULL AP 3.16 7.70 2.00 2.94 
LAT 1.70 5.20 1.10 2.12 
CHEST PA 0.54 0.25 0.13 0.20 
LAT 1.85 0.90 0.48 0.73 
C.SPINE AP 0.29 2.50 0.88 1.53 
LAT 0.40 0.43 0.51 
T.SPINE AP 2.17 4.00 2.50 2.73 
LAT 4.04 8.00 4.90 4.29 
L.SPINE AP 3.07 6.00 9.50 4.10 9.20 3.87 
LAT 6.72 
LS SPINE LAT 11.81 10.60 25.00 12.90 39.00 16.35 
ABO AP 16.30 1.87 8.10 1.90 8.40 3.07 
PELVIS AP 13.70 2.73 11.00 3.30 6.60 4.41 
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9.4 EFFECTIVE DOSE PER EXAMINATION 
The total effective dose per examination 
was shown in Table 9.4. : 
Table 9.4 The total effective dose per examination 
Examination 
Skull (PA + LAT) 
Chest (PA) 
Cervical Spine (AP + LAT) 
Thoracic Spine (AP + LAT) 














compares the effective 
this study with other 
dose per 
published 
data [9.5, 9.7, 9.8, 9.9, 9.10, 9.11, 9.12, 9.13]. 
It could be seen that the local figures for most of 
the examinations were on the low side. However, 
only routine projections were counted in the 
current study, while supplementary projections were 
taken into account in other countries which gave 
results of much higher doses per examination. 
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Table 9.5 A comparison of effective dose per examination 
Effective dose (mSv) 
Exam China France Italy Japan Spain USSR US ( 1981) (1982) (1983) (1986) (1986) (1982) (1980) 
Skull 1.35 0.22 0.09 0.20 0.17 0.13 
Chest 0.21 0.28 0.18 0.05 0.16 0.36 0.07 
C. Spine 1.35 0.14 0.30 1.00 0.23 0.20 
T. Spine 2.24 1.34 1.00 3.55 
L. Spine 1.00 
LS Spine 4.73 2.51 0.60 1.00 4.42 1.27 
Abdomen 4.50 2.56 1.92 0.29 1.50 1.52 0.56 
Pelvis 1.59 3.20 0.25 2.30 1.45 0.60 
Notes . (1) = PA/AP + LAT . 
(2) = PA 
(3 ) = AP + LAT 
(4) = LAT 
(5) = AP 
9.5 NEED FOR LOCAL ANTHROPOMORPHIC PHANTOM 
Study of the effective dose does not alter 
very much the comparative information which appears 
to be es~~,tially similar to that shown by the ESD. 
In order to achieve the estimated organ doses, 
one of the objectives of this study was to develop 
a local anthropomorphic phantom model which is to 
be used together with the Monte Carlo simulation to 
estimate organ doses arising from diagnostic X-ray 
exposures. There should be some discrepancy between 
the doses estimated with the traditional Rando 
phantom or the one developed by the NRPB and the 
local phantom. This discrepancy is due to the 
differences in body weight, organ volumes and their 
interrelationship. However, the degree of 












From Table 6.10, it could be seen that the 
organ doses estimated on the NRPB phantom (170 cm 
and 70 kg) were under-estimated by 0.1% to 94.9%. 
An explanation of this under-estimation has been 
given in Section 6.6. It can be further elaborated 
that the under-estimation is even worse for those 
organs outside the useful beam (45% on average). 
This will have an adverse effect on radiological 
protection and more important, the implementation 
of dose optimisation. 
9.6 ORGAN DOSES WITH HIGH CANCER INDUCTION 
Once the established organ doses have been 
dervied the relationship between exposures and 
organ doses was seen clearly. Ten organs with known 
high cancer induction were selected and the highest 
mean dose per projection identified (Table 9.6). 
Table 9.6 The highest mean organ dose per projection 
MeaL Absorbed Dose, mGy 
Skull T. spine L. spine LS Spine Pelvis 












The high dose to the breast from thoracic 
spine films and that to the stomach from lumbar 
spine films serve as examples of "high risk 
examinations" where relationship between the view 
taken and the exposure dose to a sensitive organ 
may not always be appreciated by the radiographers. 
However calculations of the collective dose for 
each projection identified those investigations 
causing the major share of radiation burden. 
9.7 A DISTRIBUTION OF COLLECTIVE DOSES 
The total collective doses arising from these 
examinations amounted to 438 man Sv, ' taking into 
account the annual frequency tabulated in Table 
5.1. A distribution is ~resented in Fig. 9.2. 
Abdomen examination contributed to the major 
share (37%) because of its high frequency and an 
effective dose of 0.405 mSv. This was followed by 
Pelvis (24.9~) and Lumbar Spine (22.6%). Chest 
X-ray, despite of its highest frequency (66.6% of 
the total) contributed to only 7.6% because of a 
small effective dose (0.013 mSv) . The rest 
were shared by Thoracic spine (3.7%), Skull (3.3%), 
while Cervical Spine was the least. 
These findings indicate that the Abdomen is 
the examination, which gives the greatest 
collective dose with concern to stomach and liver. 
Lumbar spine (including Lumbo-sacral Spine) gave 
rise to the highest absorbed dose to the stomach, 
liver, pancreas, lower large . bowel and red bone 
marrow and accounted for about one quarter of the 
total collective dose. Pelvic examination is 
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responsible for the lower large bowel dose 
which is also about one quarter of the total. 
In view of the predicted high cancer induction 
in the organs concerned, these three examination 
should be treated with first priority in the 
optimisation of patient doses. 
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9.8 A DISTRIBUTION OF SSD, LSD AND GSD 
These results could be reviewed in a slightly 
different way by seeing the contribution each 
group of radiographs made to SSD, LSD and GSD. 
Table 9.7 is a summary of the SSD, LSD and GSD 
as described in Chapter 8, and is presented 
graphically in Fig. 9.3. 
Table 9.7 A contribution of SSD, LSD and GSD 
Exam SSD,/.lSv/a(%) LSD,/.lSv/a(%) GSD,/.lSv/a(%) 
Skull 0.09 (2. 7 ~ 0.27 (8.4) 0.00 (0.0) 
Chest 1.06 (31.6) 1.86 (58.4) 0.00 (0.0) 
Spine 0.43 (12.9) 0.36 (11.4) 0.14 (3.7) 
Abd/Pelvis 1.77 (52.9) 0.69 (21.8) 3.67 (96.3) 
Total 3.34 3.19 3.81 
It could be seen that in skull examination, 
there is no contribution to GSD because of the 
gonads are quite remote from the direct beam. As 
regards to SSD and LSD, the percentages of 
contribution were only 2.7% and 8.4% respectively. 
In chest examination, the situation is more or 
less the same as skull. However, due to the greater 
annual frequency, the contribution to SSD and LSD 
amounted to 31.6% and 58.4% respectively. 
The percentages of contribution to SSD, LSD 
and GSD in spine examination were 12.9%, 11.4% and 
3.7% respectively. 
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The greatest contribution to GSD (96.3%) 
came from abdomen and pelvis examinations. It is 
understandable that the gonads are irradiated 
directly in these projections. The SSD and LSD 
accounted for 52.9% and 21.8% respectively. This 
could be explained that the useful X-ray beam 
fields were quite large and most of the vital 
organs were exposed to a great extent. 
These findings together with those high organ 
doses described earlier confirms the justification 







































































































9.9 OVERALL RISK ESTIMATION 
The overall risk estimated from this data 
suggested an excess of 19 fatal cancers per year, 
possibly rising to 42 cases if the worst case of 
poorly controlled radiography were to occur,. This 
numbers still falls short of the figure of 
86 estimated from global data which started this 
quest. 
The investigations included in this study did 
make up the majority (77%) if the grand total of 
investigations conducted in 1990. But one must not 
forget this does not include fluoroscopy, ~ontrast 
studies including angiography, interventional 
radiology, computed tomography and nuclear 
medicine. Although lesser in number theseare likely 
to give much higher doses to patients and staff. 
A comparison of effective doses in plain film 
study, computed. tomography and fluoroscopy is shown 













Effective dose (mSv) 





















(a) Current study (b) NRPB Document Vol. 3, No.4, 1992 
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9.10 POPULATION ORGAN DOSES 
The population effective doses of some organs 
require special attention. The highest 'population 
doses to the thyroid, breast, lung, stomach, liver, 
colon and bone marrow were 87, 15663, 121, 116, 71, 
98 and 23 man Sv respectively. These figures were 
derived from the data illustrated in Figs. 8.12 to 
8.21. 
According to the fatal probability 
coefficients tabulated in Table 1.2, the number of 
cancer deaths per one million population can be 
estimated to be : 







Red bone marrow 12 
Obviously, the breast deserves the first 
priority of dose optimisation. This should be 
followed by the lung, stomach and colon. 
These figures at least give a more focused 
breakdown of where the brunt of the imposed 
malignancy falls. Of interest is the two areas of 
magni tude difference between induction of breast 
cancer and that of leukaemia. Yet if one were to 
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9.11 
ask any large body of radiographers and 
radiologists of the relative risks of 
certain types of malignancy leukaemia 
placed high on the list ! 
suffering 
would be 
The investigations of greatest risk to the 
breast were : 
(1) Thoracic Spine (AP); 
(2) Chest (LAT) and; 
(3) Chest (AP). 
other investigations with high organ doses 
were : 
(1) Thyroid dose in Thoracic Spine (AP); 
(2) Head dose in Skull (AP); 
(3) Lung dose in Thoracic Spine (AP); 
(4) Stomach dose in Lumbar Spine (AP); 
(5) Liver dose in Lumbar Spine (AP); 
(6) Pancreas dose in Lumbar Spine (AP); 
(7) Upper large bowel dose in Lumbar Spine (AP); 
(8) Lower large bowel dose in Pelvis (AP) and; 
(9) Red bone marrow dose in Lumbo-sacral Spine (LAT) 
SUMMARY 
Up to this stage, it is quite clear that 
priority of exposure optimisation should be given 
to those organs, radiographic projections and 
examinations which experience high absorbed doses 
and subject to high somatic and genetic effects. 
Leukaemic effects may be less important in the 
adult population studied here. 
214 
There are three different approaches to 
optimisation , namely, instrumental, technical and 
administrative. The adoption of any of these 
methods is again, subject to the departmental 
decision. However, the instruments involved are 
rather expensive and is often found to be not cost-
effective. The percentages of dose reduction were 
found to be about 10 to 20 for most of the 
facilities available at the moment [9.1]. 
The remaining choices are therefore, technical 
and administrative approaches. The influence of 
technology in manipulation of the exposure and 
hence the patient dose is well recognised. The 
cost of this approach concerns training and 
education, which is insignificant as compared with 
the cost of expensive instruments. 
Regarding the administrative approach, the 
implementation of a quality assurance programme 
will definitely ensure the exposures are 
made accurately. The only cost of this programme is 
a NERO 6000M which costs about HK$100,000 together 
with built-in microprocessor, ionisation chamber, 
cables, filter~ and printer for hard copies. 
Reject analysis is so far, the most 
inexpensive approach, which will minimise any 
unncessary exposures to the patient resulting from 
repeats and or retakes X-rays as described in 
Appendix D. It is therefore~ suggested to establish 
a standard protocol to be used at all centres, so 
that comparisons and future references can be made. 
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Building on the suggestion that if the 
majority of departments can achieve diagnostic 
quality radiography below the third quartile of 
exposure then the encouragement of departments 
exposing into the fourth quartile to reduce 
exposures would reduce hazards significantly leads 
one to question exposures in the first quartile. To 
give greater flexibility one may extend these 
boundaries to one standard deviation. 
Exposures above one standard deviation from 
the mean are unacceptable overexposure but surely 
exposures below one standard deviation from the 
mean must also be considered. They are likely to 
deposit a dose into the patient without producing 
diagnostic resluts. Yet this dose contributes to 
the irradiation load. 
In fact the number of excess deaths caused by 
radiation dose imposed outside one standard 
deviation could be from 15 for the lower end, and 




This study revealed that the use of TLDs and 
the Monte Carlo simulation is both practical and 
also revealed some less well appreciated hazards. 
For instance the high dose to the breast from the 
lateral chest film. 
The use of a racially appropriate anthropo-
morphic phantom is necessary for improved accuracy, 
as the standard western phantom could lead to 
serious underestimations of organ doses. 
The measurements of ESO alone gives a 
misleading impression of hazard. For ~nstance the 
Lateral Lumbar Spine radiograph has a highest ESO 
than an AP Chest X-ray but the effective dose is 
higher for the Chest X-ray than the Lumbar Spine. 
That ESDs are not as significant as organ 
doses and that a much better '"':,::,--~ciation of 
relative importance of organ dose is obtained when 
the figures are weighted by frequency of usage of 
particular examinations. For instance when 
comparing the X-ray of the Lateral Chest with the 
AP Thoracic Spine the individual projection dose 
suggests that the Thoracic' Spine is much more 
hazardous but the total usage dose showed that the 
Lateral Chest X-ray was considerably more 
hazardous. 
There is a wide range of radiation in 
exposures not only between different countries but 
also between different establishments within this 
country. These would give rise to at least a 
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threefold increase in somatic effect and a fourfold 
increase in leukaemic effect but only a 50% 
increase 'in genetic effect. 
There are certain investigations which stand 
out as being particularly hazardous by virtue of 
either the dose they impose, their relative 
frequency of usage or a combination of both. 
Attention to these alone may significantly 
alter the radiation burden on the population in a 
more cost-effective manner than expensive equipment 
modif ications in less hazardous areas. The more 
hazardous investigations were : 
( 1) Thoracic Spine (AP) ; 
(2) Lumbar Spine (AP) ; 
(3) Lumbo-sacral Spine (LAT) ; 
(4) Abdomen (AP) and; 
(5) Pelvis (AP) . 
In 1990, the overall exposures were likely to 
result in causing at least 19 excess cancers, 
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APPENDIX A . 
RADIATION QUANTITIES USED IN PATIENT DOSIMETRY 
APPENDIX A 
RADIATION QUANTITIES USED IN PATIENT DOSIMETRY 
1. INTRODUCTION 
Radiation can be measured in terms of a number 
of quantities and units. In order to have. a full 
picture of these measurements and their 
applications in patient dosimetry, a detailed 
description is given below 
Fig. A.l shows the interrelations between 












Absorbed dose in air 
Air kerma 
Dose-area product 
PATIENT DOSE QUANTITIES 
Entrance surface dose 
(with or without fi·ltration) 
~~~-=---+--------Depth dose 
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The .source quantity is a function of the tube 
current (roA), exposure time (sec), applied tube 
potential (kV
cp ) and the total filtration (inherent 
and added filtration ih mm AI). 
EEXPOSURE (X) 
Exposure is the radiation emitted from an 
X-ray tube. It may be quantified in terms of : 
(1) radiation energy fluence ~, o~ 
(2) exposure, measured by obtaining the amount of 




X = dQ/dm 
= J ( ~en/P)air e/Wair (Eq. A.1) 
(~en/P)air is the mass energy absorption 
coefficient for air, 
e is the electronic charge, and 
w. is the .mean energy per ion pair 
a1r 
formed. 
The unit of exposure is coulomb per 
kilogram (C kg-i) and the previously used special 
unit was the roentgen (R). 
1 R = 2.58 x 10-4 C kg-1 
A 2 
4. ABSORBED DOSE (D) 
The absorbed dose is defined as the mean 
energy imparted by ionising radiation to material 
of mass, i.e., D = dc/dm. 
The energy imparted to air by 
released from a mass m, 
dm = dQ/e W . 
a1r 
electrons 
The energy is not deposited in the identical 
mass of air from which the secondary electrons 
originated. If electronic equilibrium is 
established, the energy deposited in each mass dm 
of air is the same. 
Therefore, 
... 
Energy imparted per unit mass = X Wair/e 
(Eq. A. 2) 
where, W . /e is a constant for electrons in air 
a1r -1 
with a value of 33.85 JC , 
except at very low energi~s. 
The unit of absorbed dose is the joule per 
kilogram (J kg-1 ) , given the special name of gray 
(Gy) in the SI system. Previously the rad, 
equal to 10-2 J kg- 1 was the special unit for 
absorbed dose. 




RELATION BETWEEN EXPOSURE X AND ABSORBED DOSE(DA. ) l.r 
or, 
1 Coulomb /kg of Exposure = 33.85 Gy 
-1 33.85 Gy/ C kg . 
in air 
The approximate 1:1 relationship between 
exposure in terms of roentgen (R), and the absorbed 
dose expressed in rad, no longer applies. It would 
be preferable for ionisation chambers to be 
calibrated in terms of absorbed dose in air rather 
than exposure, so that the large factor of 33.85 is 
avoided. 
AIR KERMA 
Kerma is an acronym for Kinetic Energy 
Released per unit Mass. It relates to the first 
stage of the process that occurs when indirectly 











In diagnostic radiology, dosimeters whose 
calibration is traceable to national primary 
standard of air kerma, can be regarded as measuring 
absorbed dose in air. 
EXPOSURE AREA PRODUCT (EAP) 
It is defined as the product of 
cross-sectional area of incident X-ray beam and 
average radiation exposure across that area. If the 
cross-section is completely intercepted by the 
patient, the relation between exposure area product 
and total energy absorbed by the patient is 
dependent upon X-ray beam qaulity. 
2 The unit of EAP is R cm . 
SURFACE ABSORBED DOSE (ENTRANCE SKIN DOSE, ESD) 
Surface absorbed dose is defined as the 
absorbed dose on the surface of the patient, or on 
the surface of a phantom simulating the patient. It 
can be estimated by : 
(1) direct measurement with a suitable dosimeter 
or, 
(2) calculation from the exposure or absorbed 
dose measured in free air. 
The absorbing medium is taken to be soft 





(Eq. A. 3) 
A 5 
Where, (~en/P)muscle and (~en/P)air 
energy absorption coefficients 
and air respectively. 
are mass 
for muscle 
Practically, the backscatter radiation should 
be taken into account in the calculation of surface 
absorbed dose. 
(~en/P)muscle 
Dsurface = Dair -------------(1/FSD)2 BSF (Eq. A.4) 
where, D f is the entrance surface absorbed sur ace 
dose in muscle, 
D. is the absorbed dose in air at al.r 
distance 1 from the tube focus and, 
BSF is the backscatter factor. 
The BSF depends primarily on the X-ray quality 
and · beam area, and to a lesser extent, on the 
thickness of ~ the part of patient being irradiated 
and the composition of the underlying tissues. 
Entrance skin doses are often quoted that are 
based on free-in-air measurements and do not 
include backscatter from the patient. It is 
therefore important to state clearly whether 
backscatter has been included or not in any 
statement of patient entrance surface doses. 
ESD - Incident beam dose x Back-scatter factor 
The unit is gray (Gy) in the SI system or rad. 
A 6 
9. DEPTH DOSE 
Depth dose is defined as the dose delivered at 
a particular depth beneath the surface of the 
body. It can be estimated by : 
(1) using the Empirical Percentage Depth, Dose 
(PDD) obtained in a water phantom, 
Ddepth = Dsurface PDD/100 (Eq. A. 5) 





------ [l/FSD + d]2 TAR (Eq. A.6) 
(Il/P) air 
D 
air is the absorbed do~e in air 
measurement at a known distance 
from the 'focus, 
TAR is the tissue-air-ratio, 
FSD ' is the focus to skin distance and, 
d is the depth along the central axis. 
is a function of ( 1) beam quality, 
(2) field size at the surface, 
(3) FSD and, 
(4) the depth of interest. 
TAR is independent of the FSD, 
the field size is specific at 
interest. 
provided that 
the depth of 
The unit is the same as absorbed dose. 
A 7 
10. ORGAN DOSE 
Organ dose is the absorbed dose averaged over 
the entire organ. It is the most appropriate 
quantity for predicting the probability of a 
stochastic effect occurring. The unit is the same 
as absobed dose. 
11. DOSE EQUIVALENT (H) 
A concept defined for radiation protection 
purposes by ICRP as : 
H = DQN 
where D is the adsorbed dose at a point in tissue; 
Q is the quality factor, wnich for ~,~ and 
X-ray is assigned th~ value of 1; 
N is the product of all other modifying 
factors specified by ICRP (such as 
fractionation, dose rate) also assigned 
the value of 1. 
For diagnostic X-rays therefore an absorbed 
dose in Gray (Gy) is numerically equal to the dose 
equivaent in Sivert (Sv). 
12. EFFECTIVE DOSE EQUIVALENT ( EFFECTIVE DOSE HE ) 
It is an index, defined by the ICRP, of risk 
to an irradiated person which takes account of dose 
to each irradiated organ, radiation sensitivity of 
the tissue of each organ, and risk of any 
malignancies which may result from the irradiation. 
A 8 
The Effective Dose Equivalent was originally 
intended by the ICRP to apply to occupationally 
exposed groups, but has now been extended by 
UNSCEAR to assess the risks of radiation medicine. 
It is ca~ulated by determining the dose to 12 
sensitive organs, and five other organs, applying 
tissue weighting factors to these organs, and 
adding up the weighted contribution from each ogan. 
The tissue weighting factors (Wt ) are given · in 
Table A.1. 
Table A.1 
Tissue or organ 
Gonads 












Tissue weighting factors 














13. COLLECTIVE DOSE (S) 
It is defined by the expression 
where, 
S = Li Hi Pi 
H. is the per caput effective dose 
1. 
equivalent in the whole body; 
P. is members of subgroup i of the 
1. 
the exposed population. 
A 9 
This gives a measure of detriment to the 
population, and the units are man-Sv~ 
14. EXIT DOSE 
Exit dose is the surface dose on opposite 
surface of the body to that on which the radiation 
is incident. The unit is gray (Gy) or rad. 
15. A SUMMARY 
In this study, the following measurements are 
to be used : 
(1) Entrance skin dose (ESD) 
The ESD of an X-ray exposure is to be measured 
directly with the use of thermoluminescent 
dosimeter on the patient's skin surface. 
(2) Organ dose 
The measured ESD is converted to organ doses 
using the Monte Carlo simulation on a 
mathematical phantom. 
(3) Dose equivalent (H) 
The organ dose is then converted to dose 
equivalent. In diagnostic radiology, the organ 
dose is numerically equal to dose equivalent. 
A 10 
(4) Effective dose (H) 
E 
In order. to assess the risk to the organs 
exposed, organ doses are multipied by their 
corresponding tissue weighting factors. The 
sum of the weighted contribution from each 
organ gives the effective dose as a whole. 
(5) Collective dose (S) 
This is to be used to compare the population 
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Quality assurance forms an integral part of 
optimisation of diagnostic radiation exposure. 
Also, the normalised organ doses delivered from an 
exposure depend upon the following parameters : 
(1) phase of generator; 
(2) tube voltage in terms of kVPi 
(3) total filtration in terms of mm Al and; 
(4) the measured ESD. 
It is therefore essential to evaluate the 
first three parameters of the X-ray unit concerned 
in order to estimate accurately the organ doses and 
hence the effective dose. 
JUSTIFICATION 
It is well appreciated that there were wide 
variations in patient exposure for the majority of 
different types of radiological investigations when 
undertaken on X-ray equipment situated in different 
locations with a factor of 100 in skin exposure for 
certain examinations. These are due to the 
following factors : 
(1) variations in tube voltages; 
(2) variations in tube outputs; 
(3) variations in total filtrations; 
B 1 
3. 
(4) variations in film-screen 
grids and; 
combinations and 
(5) variations in performance of particular items of 
X-ray equipment. 
OBJECTIVES 
Quality assurance aims at reducing patient 
dose and costs whilst maintaining a high level of 
imaging qaulity and diagnostic benefit. The X-ray 
system should perform satisfactorily so that : 
(1) To ensure that irradiation 
is controlled and, 
to the patient 
(2) Radiologists are assured that the quality of 
the information is the best possible. 
4. METHODOLOGY 
4.1 INSTRUMENT 
A NERG-6000M ( Non-invasive Evaluation 
Radiation Output) was used to assess the quality 
of all X-ray systems in this study. It consists of 
a micro-processor control unit, an ionisation 
chamber and various thickness of aluminium filters 
4.2 PHYSICAL PARAMETERS TO BE ASSESSED 
(1) variation in radiation output of X-ray tube, 
(2) Radiation output consistency, 
(3) variation in radiation output with tube 
voltage, 




(5) variation in radiation output with exposure 
time, 
(6) Filtration and HVL (Half-value layer), 
(7) Variation in exposure time, 
(8) Tube voltage calibration. 
RESULTS AND DISCUSSION 
Analysis made on the attached 
print-outs shows that the results, on 
samples of 
the whole, 
agree with the following tolerance limits : 
Parameters Accuracy Precision 
Filtration (mm AI) ± 0.25 ± 0.10 
Exposure time (sec) ± 10% ± 5% 
Tube voltage (kVp) ± 5% ± 2% 
Radiation output (mR) ± 10% 
Tube current (mA) ± 15% ± 8% 
However, it is strongly suggested to conduct 
this programme at regular intervals, say once a 
year to record the performance of the X-ray 
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It is well appreciated that there are ' public 
demands for better health care world-wide and 
medical demands for more diagnostic information. On 
the other hand, resources such as equipment and 
finance are generally increased in some developing 
countries. 
The increase scope of medical radiography 
means a heavy rise in utilisation -- re~uiring more 
examinations, more special proedures and more 
exposures. It is therefore the responsibility of 
radiographers to ensure that a satisfactory balance 
between risk and benefit is maintained -- making 
images of good diagnostic quality, while minimising 
the patient dose. 
2. A PRACTICAL APPROACH 
2.1 THE USE OF FILTERS 
MASUDA Y. (1980) decribed a transparent 
plastic filter which were loaded with heavy atoms, 
such as lead, to equalise the filtration 
characteristics with aluminium or copper. It was 
reported that the quality of the radiograph and the 
degree of patient dose reduction were of the same 
with those of conventional metal filters. 
C 1 
WIEDER S. and ADAMS P.L. (1981) used an 
aluminium trough filter for phototimer chest 
radiography at 120 kVp. It was reported that 
excellent detail within the parenchyma of the lung 
was obtained with a 12 . 5% reduction in patient 
dose. 
ROSSI et al. (1982) reported that entrance 
exposure could be reduced by 30 - 40% and mid-plane 
exposure by approximately 24% through the use of a 
0.32 mm copper filter, with an accepatble increase 
in tube load and only minor changes in the 
appearance of the images. 
CHAKERA et al. (1982,) confirmed 
the dose reduction of approximately 
that that 
50% when 
the conventional aluminium filter was replaced with 
0.5 mm Al plus 0.1 mm erbium. 
BURGESS A.E. (1985) introduced the use of 
some heavy metal filters such as gadolinium, 
holmium, ytterbium and tungsten. 
KOEDOODER K. and VENEMA H.W. (1986) strongly 
suggested that the conclusions of a number of 
studies in which the use of K-edge filters was 
advocated need reconsideration. At least, with 
respect to the imaging of iodine content in 
relatively thick obj ects. A remarkable result was 
that dose and exposure reduction reduction cotild be 
achieved almost equally well with conventional 
filters as with a number of K-edge filters. 
C 2 
HORNER et al. (1988) reported that the 
overall dose reduction achieved in dental 
radiography with 0.1 mm erbium was less than 30% 
between 65 and 85 kVp, and 42% at 65 kVp. 
KOHN et al. (1988) stated that the ideal 
filter would selectively filter out the low energy 
photons that contribute to the radiation dose to 
the skin while maintaining acceptable image 
contrast for clinical interpretation. 
ASSELIN C. (1988) introduced the use of 
niobium filter (NIOBI-X) with dose reduction from 
25 to 70%. The majority of situations showed a 
reduction of between 25 to 50%. 
2.2 THE USE OF RARE-EARTH SYSTEM 
ROBINSON et al. (1982) compared the surface 
between the Par-speed screens with the Quanta-Ill 
Rare-earth screen (Lanthanum oxybromide phosphor). 
The latter was at least one order of magnitude less 
than the former. 
CHU et al. (1985) reporrted that the dose 
reduction in various examinations ranged from 33 -
66% with rare-earth systems. Departmental personnel 
radiation exposure was also reduced by more than 
40%. 
2.3 THE USE OF CARBON FIBRE REINFORCE PLASTIC (CFRP) 
NOBECLI T. (1981) firstly introduce a 
corporate material of carbon fibre (CF) whcih was 
found strong, light, durable, rigid, chemically and 
thermodynamically stable. It was most suitable for 
C 3 
radiation equipment material 
transmission capability. 
of good X-ray 
TREFLER M. (1982) reported that the use of 
CFRP in table-top radiography could reduce the 
exposure by 15 to 30%, and 10 to 20% for general 
radiography. 
SCHMIOT et al. (1983) compared the dose 
reductions between aluminium cassette with 
carbon-fibre cassette. A 28% and 17% at 60 and 120 
kV respectively were achieved with carbon-fibre 
cassette as compared with aluminium cassette. 
HUFTON et al. (1986) however, further 
elaborated that the dose reduction could be achived 
with the use of carbon-fibre table-top, cassette 
front and grid cover/interspace by 3 to 15%, 6 to 
12% and 20 to 30% respectively. 
3 • THE CURRENT STUDY 
A study of dose reduction with the use of a 
370 Ionisation Oosimeter and a specially designed 
phantom was conducted for various filtration, focal 
spot, tube voltage, current and exposure time, 
focal-film distance, film-screen combinations and 
X-ray field collimation. A paper entitled 11 A 
Project on radiation Dosage 11 was published in the 
Journal of Hong Kong Diagnostic Radiogarphers' 
Association is attached. 
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A PROJECT ON RADIATION DOSAGE 
Mr. M.W. Chan, 
Radiation Protection Officier, . Senior Lecturer of Hong Kong Polytechnic. 
OBJECTIVE 
To investigate the production of acceptable radiographs 








single phase fuB-wave rectification 
rotating anode with 1 mm and 2 mm 
foci 
inherent filtration 0.5 mm Al 
added filtration 2.0 mm Al 
maximum output voltage 125 kVp 
Extra futration ... 
Extra filtration were achieved by adding 
sheets of filter having 0.5 mm AI equi-
valent. 
Ph an tom (Fig. 1) 
A phantom· for the assessment of image 
quality and the measurement of radia-
tion dose. 





Dosemeter (Fig. 2) 
37 0 X-ray Dosemeter with 35 
ionizing chamber. 
,. , ----":::: I A~: .~ '" 
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X-ray Films 
24 x 30 cm standard speed X-ray fih 
(vi) Cassettes 
24 x 30 cm Kodak X-omatic cassettes 
with (a) Regular Screens 
and (b) Agfa Rare Earth Screens 
(vii) Automatic Processor 
90 sec. Rapid Processor 
(viii) Densitometer 
Portable Sakura Densitometer PDA-81 . 
PROCEDURE 
(1) The apparatus were set up as illustrated in F 
3,4and5. 









1.0 mm Focal Spot Size 
2.5 mm. Total Filtration 
100 cm Focus-film-distance 
Well-collimatated X-ray field 
Standard speed X-ray film w~th Regular 
Screens 
(3) The depth dose was measured and recorded using 
the 37D X-ray Dosemeter. 
(4) Repeat step (2) with the film-cassette removed. 
(5) 1l1e skin dose was measured and recorded with 
the 35 c.c. ionizing chamber placed on top of the 






The exposed fum at step (2) was processed in the 
90 sec. Rapid Processor. 
The fmished radiograph was then assessed object-
ively, in terms of contrast and sharpness with the 
Portable Sakura Densitomer. The density of the 
Aluminium step-wedge (step 5) was measured 
and recorded. 
The image quality of tills control radiograph 
served as a reference to be compared with the 
others using different parameters. 
11 other exposures were made with' one of the 
original parameters varied at each exposure. 
Repeat steps (3), (4), (5), (6) and (7) after each 
exposure. 
Each exposure was so adjusted that the image quality of 
the resultant radiograph should be the same of the 
control radiograph in terms of contrast, sharpness and 
density. 
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DATA OBTAINED 
N.,.o~ 1 2 3 4 5 6 1 Exposure 
kVp 70 100 47 70 100 100 70 
mAs 12.5 4.0 80.0 12.5 4.0 4.0 12.5 
p Focus 1 1 1 2 2 (mm) 2 2 A 
R T.F. A 
M {mm~ 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
E (AI 
T Col. E Yes Yes Yes Yes Yes No No 
R 
FFD S ( cm) 100 100 100 100 100 100 100 
Film S S S S S S S 
Screen R R R R R R R 
D Skin 580 340 1800 580 3)0 330 580 
0 (:nR) 
S Depth E (mR) 100 75 218 110 60 60 80 
DEDUCTION 
Cl j The higher the tube voltage, the lesser will be the 
patient dose, particularly the skin dose. 
JeVp 70 100 IDcn&"· in kVp 30 4~ 
S.D. CaR) 580 34° - Drop 1n S.D. (d) 240 . 41:' 
D.D. (IIIR) 100 75 Drop iD D.D. (mIl) 25 25~ 
JcVp 10 47 nacna.. 1n lcVp 2) 3~ 
S.D. (mIl) 500 1800 Rhe 1n 1220 21~ S.D. (d) 
D.D. (aR) 100 218 Rh. in 118 11~ D.D. (mIt) 
However, one cannot stick to the maxjmum tube 
voltage as provided by the generator for all 
examination. Firstly, the scattered radiation 
effect will be exaggerated at high kilovoltage 
range, and secondly, there will be a decrease in 
the linear attenuation coefficients of the irra-· 
diated tissues. These two factors account for a 
lower radiographic contrast and hence an overall 
degradation ·of the image quality of the resultant 
radiograph. In practice, the tube ·voltage selected 
should be the highest which is consistent with an 












9 10 11 12 
100 100 100 100 
10.0 10.0 5.0 4.0 
1 1 1 1 
2.5 3.5 3.5 2.5 
Yes Yes Yes Yes 
140 140 140 140 
S S S s · 
R R RE RE Key: 
T.F. Total Filtration 
280 220 120 80 Col Collimation 
S Standard ·film 
50 45 20 20 R Regular screens 
RE Rare-earth screens 
(2) The lower the. mAs given, the lesser will be the 
patient dose. 
aWl 12.5 eo IDCrea.. in e.l. 67.5 54Ci-
S.D. (aR) 500 1600 Rh. 1n 1220 21~ S.D. (mR) 
D.D. (mIl) 100 218 Rh. in 118 11 S,£ D.D • . (al.') 
..... 12.5 4 nacre .... in ..... 8.5 68,£ 
S.D. (IIIR) 500 )40 Drop in S.D. (mIl) 2.40 41~ 
D.D. (mIl) 100 75 Drop 1n D.D. (dl) ~5 25~ 
Practically when a lower mAs is given, a higher 
kVp must 'be used to compensate for the loss in 
. film density. Hence, the reduction in patient 
dose is due to the effect of a higher kVp rather 
than a lower mAs. 
The choice of focal spot size does not play a 
role in the reduction ot patient dose. 
(3) 
Focal spot 1I11III 2= 
Increase in 1 I11III 100,L 
Focal Spot 
~ .D. (IIIR) )40 ))0 Drop in S.D. (snR) 10 3f. 
D. D • • ( mR) 75 60 Drop iD D.D_ . (mR} 15 1~ 





The slight reduction in the doses measured, Le. 
3% reduction in skin dose, 13% reduction in 
depth dose, may be simply due to measurement 
deviation, or due to the crazing of the target 
tract, leading to a decrease in the X-ray output. 
Beam collimation does not affect the patient 
dose. 
Beam Collim .. hcl O/id.el),-CoUi_Hon '.~enecl 
S.D. (aR) 330 ))0 
D.D. (IIIR) 60 $0 I 
However, the gonad-dose will be increased with 
a widely-opened beam as in routine chest X-ray 
examination, just because of the shorter source-
gonad distance. 
40% increase in FFD resulted in 18% drop in skin 
dose, and 33% drop in depth dose. 
15% decrease in~ FFD resulted in 3.5% drop in 
skin dose, and 20% drop in depth dose. 
Tube yoltal$' : 70 kVp 
7FD 100 85 (ca) 
Decreas. iD 15 15.' FFD (cm) 
S.D. (aR) 500 560 Drop iD S.D. (mR) 20 ).5:' 
P.P. (aR) 100 00 DrOlf"'ill D.D. (d) 20 201-
,..~ YOl tac-' 100 kVp 
77"D 100 140 (ca) 
Increue .iD 40 4~ 1TD (a.) 
S.P. (d) )40 280 I>rop ill S.D. (aR) 60 1~ 
P.P. (d) 75 50 Drop iD D.D. (aR) 25 3~ I 
With a very long FFD, the e~posure required will 
be lying beyond the work load limit of the X-ray 
tube, and moreover, the greatly increased ex-
posure will certainly outweigh the reduction in 
patient dose. 
In the other hand, too short a FFD will lead to a 
very high skin dose. 
(6) An extra 10 mm AI futration resulted in 21% 
drop in skin dose, and 10% drop in depth dose. 
711 '\ raU 011 2.5 3.5 (_ Al) 
lDcreue iD FiltratioD 1.0 4(}/. (&ilia .u) 
S.D. (aR) 200 220 Drop in S.D. (mIl) 60 21~ 
D.D. (aB) 50 45 Drop in D.D. (mIl) 5 1~ 
Too great a filtration will cut down the intensity 
of the X-ray output, therefore, it is limited to 
between 2.0 to 3.5 mm Al. 
I 
i 
(7) The use of a Standard-fIlm/Rare-earth screens 
combination cut down the patient dose to more 
than a half without deterioration of the image 
quality. 
Total Filtration I 2.5 mm Al 
3-R , S-RE Drop D:'op .,. 
S.D. (mR) 200 I eo 200 11 
P.D. (aR) 50 I 20 , 30 60 
Total Filtration I 3.5 mm Al 
S-R I S-RE Drop Drop i-
S.D. (IDR) 220 I 120 100 45 
P.D. (II\R) 45 I 20 25 55 
CONCLUSION 
The most effective way ·to reduce the patient dose in 
diagnostic radiography is to apply a reasonably high 
kVp, a low mAs together with a relatively fast film-
screen combination. 
The beam collimation should be practised in the 
routine work so as to reduce the unnecessary radia-
tion to other body tissues lying outside the primary 
beam. 
The' reduction in patient dose depends very much 
upon the radiographer, taking into account the know-
ledge in radiological protection, past experience and on 
top of all his professional ethics. 







The avoidance of reject or repeat in X-ray 
examination can reduce unnecessary exposure to 
patients. An analysis on reject films serves ' : 
(1) to measure the total reject rate of the 
department under surveyed; 
(2) to compare the retake/repeat rate between 
X-ray rooms and; 
(3) to analyse the reasons for rejected 
radiographs. 
A paper entitled 11 A Reject Analysis in 
Diagnostic Radiography in Hong Kong 11 disp~ayed at 
the 8th Asian Conference for Radiographers and 
Radiological Technologists is attached. 
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A REJECT ANALYSIS IN DIAGNOSTIC RADIOGRAPHY 
IN 
HONG KONG 
C. Metreweli 1 DMRD, FRCR, FRCP 
and 
Paul M.W. Chan 2 HDCR, DNM, MSRP, M.Phil 
Faculty of Medicine, The Chinese University of Hong Kong 
2 Hong Kong Polytechnic 
Abstract 
A study of reject analysis of nine common 
radiodiagnostic examinations was conducted for a 
period of 4 weeks at 20 hospitals and X-ray 
laboratories in Hong Kong. The highest departmental 
overall reject rate was 12.1%. The study also 
revealed that the highest reject rate per examination 
went to skull work. A breakdown of reject reasons 
showed that patient movement accounted for 26.5% 
which was followed by underexposure (20.5%), 
positioning error (20.5%), ·overexposure (14.0%), 
operator error (9.4%), miscellaneous (6.2%) and 
processing fault (2.9%). 
Method 
Period of study and centres under survey 
A study on reject analysis of radiography was 
conducted for a period of four weeks from 3 to 29 
December 1990 in Hong Kong. Twenty X-ray centres 
_ were under investigation, including 5 hospitals, 13 
X-ray laboratories and 2 chest survey centres. 
D 2 
Selection of examinations 
The nine most common examinations were selected, 
namely, skull, chest, abdomen, vertebral column, oral 
cholecystogram. intravenous urogram, barium meal, 
barium enema and extremeties. 
Reject reasons 
The reject films were analysed under seven 
reasons 
(1) Overexposure, 
(2) Underexposure, ' 
(3) Positioning error, 
(4) Operator error, 
(5) Processing error, 
(6) Patient movement and, 
(7) Miscellaneous (film artefacts, fogging etc.) 
Collection of data 
Printed record sheets were distributed to the 
senior radiographers or radiographers in-charge 
concerned. The following data were entered : 
(1) Type of examination, 
(2) Number of cases of each examination, 
(3) Total number of films taken per case, 
(4) Number of good films per case, 
(5) Numbre of reject films (retake films) per 
case and, 
(6) Reject reason for each film rejected. 
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Calculation of reject rate 
The following formula (Nuss 1989) was adopted 
for the calculation of reject rate in this study : 
Reject rate = 
Number of reject films 
------------- x 100% 
Number of good films 
Reject rates were calculated for 
department, examination and reject reason. 
Result and Discussion 
Departmental and overall reject rates (Table 11 
each 
The departmental rej ect rates ranged from o. 0% 
to 12.1%, with a mean, median and standard deviation 
of 3.7%, 4.3% and 3.3% respectively. The 
comparatively high reject rates (12.1%, 10.5%, 7.6% 
and 7.5% ) may be due to the small number of cases 
taken in the corresponding centres. No reject 
films inCentr:es No. 19 and 20 can be explained 
that a limited types of examinations were conducted. 
the reject rates of the two chest survey centres ( 
No. 12 and 15) were 3.1% and 1.7% respectively, which 
were less than the mean value. It was understood that 
the radiographic technique and exposure parameters 
were standardised in these centres and hence error 
was reduced to a minimum. There was no signifiacnt 
difference of reject rates between hospitals and 
laboratories. 
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Reject rate per examination (Table £1 
The total films taken in skull work was only 
8 . 5% of the grand total, yet it accounted for the 
highest reject rate (11.1%). While chest X-ray was 
the major contributor (50% of the total films taken), 
its reject rate was only 2.3%. The CV (coeffici~nt of 
variation) of these two rates was as high as 133%. 
This implied that significant difference 'between the 
two examinations in terms of patient positioning and 
demand of accuracy. 
The second high reject rate went to spine work 
(8 . 3 %), which again demanded a high accuracy. This 
was followed by abdomen (5. 7 %), extremeties (4 .9%) , 
barium enema (4.0%). The lowest reject rate was only 
1.7% which belonged to barium meal. This could be 
explained that most of the films TI/ere taken during 
fluoroscopy by the radiologist and subject to a 
lesser technique-based error. 
A Bre&kdow~ of Reject Reasons per Examination (Fig.1) 
(1) Skull 
The major contributors were Positioning Error 
(32.8%) and Patient Movement (37.8%). The 
complicated anatomical structure in the skull 
demanded a critical positioning and centrring 
point. Even a minor discrepancy would result in a 
radiograph of inadequate information and repeat 
was inevitable. The patient tended to move during 
some awkward position such as paranasal sinuses, 
and this contributed to the lion share. 
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The rest of reject reasons were Underexposure 
(13.8%)~ Operator Error (2.6%), Processing Fault 
(1.7%) and Miscellaneous Reasons (0.9%). 
(2) Chest 
Patient movement contributed to 34.5% of the 
total reject films. This was understood that 
quite a number of patients could not hold their 
breath, 'particularly for those old aged patients. 
This was followed by Underexposure (15.8%), 
Operator Error (15.2%), Overexposure (11.5%), 
Positioning Error (11.5%), Miscellaneous (8.5%). 
Processing Fault ' was the lowest (3.0%). 
(3) Abd::. ~l1en 
Overexposure accounted for 42.1% of reject 
reasons in all abdomen examinations. There was a 
malpractice that radiographers tended to give a 
greater exposure without assessing the body 
thickness and density of the abdomen. This 
resulted in a greater chance of being overexposed 
rather than underexposed. Patient Movement and 
Positioning Error shared an identical percentage 
(10.5%), while Miscellaneous reasons was 21.1%. 
(4) Spine 
As a contrary to abdomen. the greatest reject 
reason for spine work was Underexposure (35.2%), 
in which under-penetration due to insufficient kV 
was more common than mAs. This was followed by 
positioning Error (19.7%), Overexposure (18.3%) 
and Patient Movement (14.1%). 
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The other three contributors were Operator 
Error (5.6%), Miscellaneous (4.2%) and Processing 
Fault (2.5%). 
(5) Extremeties 
Similar to spine work, Underexposure (31.0%) was 
also a common reason of reject films together 
with Pati~nt Movement (34.5%) for extremeties 
wihtout a reasonable explanation. Overexposure 
accounted for 24.1%, while the other two were 
Processing Fault (6.9%) and Positioning Error 
(3.4%) . 
(6) Oral Cholecystogram 
It was an unusual finding that Positioning Error 
was the greatest reject reason (70.6%). The only 
excuse might be due to the close anatomical 
relationship between the gall-bladder and the 
hepatic flexureof the large colon. Masking of the 
gall-bladder by the bowel content led to a poor 
quality radioc;::-a~r he ct'1er two reject reasons 
were Underexposure (23.5%) and Overexposure 
(5.9%) . 
(7) Intravenous Urogram 
Underexposure, Positioning Error and Operator 
Error shared an identical reject percentage 
(22.2%). Overexposure (16.7%) was followed by 
Miscellaneous (11.1%) and Patient Movement 
( 5 • 6%) . 
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(8) Barium Meal 
As in spine work, Underexposure was the major 
reject reason (40.0%) in barium meal study. There 
might be a breakdown in communication between the 
radiologist and radiographer, in which the 
radiographer might not be aware of the obliquity 
of the patient during screening. Incorrect 
setting of exposure factors might happen 
resulting in underexposed films. The rest of 
reject reasons were Operator Error (24.0%), 
Miscellaneous (24.0%), Overexposure (4.0%) and 
Positioning Error (4.0%). 
(9) Barium Enema 
Unlike barium meal, Positioning Error (33.3%) was 
the most popular reject reason for barium enema 
study. The other reject reasons were 
Overexposure (14.8%), 
Underexposure (11.1%) 
(11. 1%) . 
Operator Error (14.8%), 
and Processing Error 
Overall Reject Reasons (Table dl 
The highest percentage of the seven reject 
reasons for all types of examinations was Patient 
Movement (26. 5%). This could be minimised by using 
the shortest exposure time with a higher output X-ray 
unit, preferably a three-phase generator. Other 
immoblisers such as compression band, head clamp 
etc., together with clear instructions and probably a 
rehearsal might be an advantage. 
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Underexposure and Overexposure contributed to 
20.5% and 14.0% respectively to the total films 
rejected. The installation of autoexposure timer 
seems to be the only counter-measure. Experience and 
the practice of measuring patient thickness are 
equally important. 
Positioning Error was of the same pe'rcentage as 
Exposure Error. It is no doubt that proper training 






in terms of 
Miscellaneous 






Fault (2.9%). However, these errors were 
equipment-oriented. A quality assurance programme for 
the X-ray unit, film-cassette system and film 
processor will further cut down the reject rate. 
A Comparison 
Table 4 compars the findings between this study 
and the hospitals in Wales (Roger et al., 1987). It 
can be seen that for skull examination, 
Error is the most common rej ect reason 
Positioning 
(32.8% and 
57.0%). In chest work, the most common error is 
Patient Movement (34.5%) in this study and 
Underexpsoure (56.0%) in Roger's study. A similar 
pattern is noted for spine work in that Overexposure 
accounted for 35.2% and 30.0% respectively. The 
Overexposure percentage for abdomen in this study is 
about two times that of Roger's. For intravenous 
urogram, Underexposure is only two-thirds of that in 
Roger's. 
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On the whole, the overall reject rate in this 
study is comparable to other survey. Perhaps emphysis 
should be made on the following : 
(1) Installation of autotimer, 
(2) Use of 3-phase high output X-ray generator, 
(3) Enhanced clinical training and, 
(4) A good established practice protocol. 
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TABLE 1 DEPARTMENTAL AND OVERALL REJECT RATES 
---------------- ----_. -----_. ----------------
NO. NO.OF NO.OF NO.OF REJECT 
CENTRES OF FILMS GOOD REJECT RATE 
CASES TAKEN FILMS FILMS % 
----------------------------------
1 (L) 18 37 33 4 12.1% 
2(H) 42 105 95 10 10.5% 
3(L) 58 127 118 9 7.6% 
4(l) 54 100 93 7 7.5% 
5(H) 1250 3673 3453 220 6.4% 
S(l) 121 434 411 23 5.6% 
7(L) 67 79 75 4 5.3% 
8(l) 417 980 934 46 4.9% 
9(H) 237 408 389 . 19 4.9% 
10(H) 108 333 319 14 4.4% 
11 (L) 165 372 357 15 4.2% 
12(C) 1580 1774 1720 54 3.1% 
13(H} 152 354 344 10 2.9% 
14(L) 64 142 139 3 2.2% 
15(C) 1610 1687 1658 29 1.7% 
16(L) 253 485 479 6 1~3% 
. . 
17(L) 725 734 729 5 0.7% 
18(L) 1194 1337 1328 9 0.70/0 
19(L) 349 357 357 0 0.0% 
20(L) 82 84 84 0 0.0% 
---------------
----







KEY: L = LABORA TORY 
H = HOSPITAL 
C = CHEST SURVEY CENTRE 
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TABLE 2 REJECT RATE P'ER EXAMINATION 
--------------------------------------------------------------------------------
NO.OF REJECT FILMS 
-------------~-------------------------------------------------- GRANC CENTRE EXAMINATION 
----------------------------------------------------------------
TOTAL 
SKULL CHEST ABO SPINE LIMBS OC IVU MEAL ENEMA 
--------------------------------------------------------------------1 0 0 1 1 0 0 0 2 0. 4 
2 4 2 0 3 0 0 1 0 0 10 
3 0 3 1 2 1 0 0. 0 2 9 
4 0 1 0 0 0 0 1 0 5 7 
5 86 40 8 42 10 16 8 2 8 220 
6 7 7 0 3 2 0 0 2 2 23 
7 0 0 0 0 4 0 a 0 a 4 
8 9 3 1 8 5 a 0 17 3 46 
9 1 8 3 1 1 0 2 a 3 19 
10. 3 2 0 1 3 0. 3 0 2 14 
11 ' 2 5 1 3 1 a 1 a 2 15 
12 0 54 0 0 0 0 0 a a 54 
13 a 1 2 3 2 a 1 1 a 10 
14 0 29 0 0 0 r, 1 0 0 30 
15 1 a 1 0 0 0 0 0 0. 2 
16 1 1 1 1 0 1 0 1 0 6 
17 0. 5 0 0 0 0 0 0 0 5 
18 2 4 0 3 . a 0 a a a 9 
19 a a 0 0 a a 0 a a 0 
20 a 0 0 0 0 0 0 0 0 0 














619 293 807 1510 700 13602 
590 276 789 1485 673 13115 
29 17 18 25 27 487 




3.2 1.1 1.4 2.9 1.7 5 .5 7.5 5.8 8.4 1.E 
------------------------------------------------------------------------------_. 









1 2 3 4 5 6 7 
SKULL 12 16 38 3 2 44 1 
CHEST 19 26 19 25 5 57 14 
ABO 8 3 2 0 0 2 4 
SPINE 13 25 14 4 2 10 3 
LIMBS 7 9 1 0 2 10 0 
OC 1 4 12 0 0 0 0 
IVU 3 4 4 4 0 1 2 
MEAL 1 10 1 6 0 1 6 
ENEMA 4 3 9 4 3 4 0 
REJECT 68 100 100 46 14 129 30 
FILM 
REJECT 14.0% 20.5% 20.5% 9.4% 2.9% 26.5% 6.2% 
RATE 
REJECT REASON KEY: 1 = OVEREXPOSURE 
," 
2 = UNDEREXPOSURE 
3 = POSITIONING ERROR 
4 = OPERATOR ERROR 
, 5 = PROCESSING FAULT 
6 = PATIENT MOVEMENT 








TABLE 4 A COMPARISON OF HIGHEST REJECT RATES 
FOR 5 COMMON EXAM BETWEEN H.K. AND WALES' HOSPITALS 
---------------------------------------------------------
REJECT SKULL CHEST SPINE ABDOMEN IVU 
REASON A B A B A B A B A 8 
1 42.1% 21.0% 
2 15.8% 56.0% 35.2% 30.0% 15.8% 26.0% 22.2% 33.0% 
3 32.8% 57.0% 
4 
5 
6 37.9% 0.0% 
7 
REJECT REASONS KEY: 
19.7% 46.0% 
--, ----------------
1 = OVEREXPOSURE .. 
2 = UNDEREXprSURE 
3 = POSITIONING ERROR 
4 = OPERATOR ERROR 
5 = PROCESSING FAULT 
6 = PATIENT MOVEMNET 
7 = MISCELLANEOUS 
A = THIS STUDY 























































































































































































































































































































































































































































































































































































































































































































PUBLISHED WORK IN DOSE MEASUREMENT 
APPENDIX E 
PUBLISHED WORK IN DOSE MEASUREMENT 
Martin (1947) 
Martin measured the output of X-ray ' tubes 
under several conditions such as filtration and 
focal-skin distance using a 25 r victoreen 
condenser chamber. A wax phantom was used to 
represent a real patient. The values of outputs in 
-1 -1 
r sec mA were plotted against filtration for 
several focal-skin-distances. 
Ardran (1952, 1953) 
Ardran described a similar method to measure 
theradiation delivered to the skin during 
diagnostic procedures. 
Webster et al. (1957) 
," 
Webster described a direct measurement of 
the gonadal 'dose using ionisation chambers and 
specially designed phantoms : 
(1) A laminated unit-density 
(30 cm x 30 cm) was used 
presswood phantom 
to simulate the 
pelvis and abdomen when subj ect to direct 
beam exposure. 
(2) The chest phantom consisted of .a 
mediastinal solid section 
half-density (5 cm x 30 cm). 
of presswood of 
(3) The pelvis/abdomen phantom was supplemented 
by the chest phantom for measuring the 
gonadal dose subject to scattered radiation. 
E 1 
Direct measurements of the gonadal doses were 
performed by chambers inserting into the 
corresponding phantoms. It was claimed that 
the accuracy was about +10%. 
Ardran et al. (1957) 
Ardran made use of a Mix-D phantom 
which was 9" thick equivalent to an . average 
patient and small ionisation chambers to perform 
direct measurement of gonadal dose similar to that 
decribed by Webster. 
Epp et al. (1961) 
Epp developed a realistic human phantom 
which consisted of a human skeleton inserted in a 
unit-density presswood medium made with reference 
to anatomical cross sections. Bone marrow was 
replaced with beeswax of unit density, while the 
lung tissues were simulated with cork of specific 
gravi ty of O. 3 . The phantom was designed 
toaccommodate specially-shaped ionisation chambers 
made of conducting polystyrene with an effective 
atomic number of 5.7. The locations of chambers 
for measuring bone marrow were selected at the 
vertebral bodies of C4, T6, T12 and L5i one at the 
sternum and one at the ilium. There were two sites 




pychlau et al. (1965) 
pychlau established a man-shaped phantom 
built up from natural bones and moulded in wax 
similar to the Alderson phantom. Measurements were 
described to show if the quantity R x cm2 or 
ergs or M joule were in the best relationship to 
the energy absorbed in a patient during 
radiodiagnosis. It was assumed that : 
E = E - E 
abs e sc 
Where, Eabs is the absorbed energy, 
Rogers (1969) 
Ee is the energy delivered to phantom and, 
Esc is the energy scattered out of phantom. 
Rogers described an indirect method of 
skin dose estimation 
(1) The output of the X-ray tube was first 
measured in terms of mR/mAs for a selection 
of kVs with a total filtration of 2.5 mm Al. 
It was reported that the effect of field size 
was negligible. 
(2) The values of the exposure, exclusive of 
back-scatter was calculated by the inverse 
square law using an estimated skin-ta-film 
distance. 
(3) Correction due to back-scattering was 
calculated. 
(4) The skin dose was converted using a roentgen 
to rad factor of 0.93. 
E 3 
However, if the dosage for a particular 
technique or a comparison of dosages between 
different techniques or views was required, then 
ideally these should be measured directly on the 
X-ray apparatus which was to be used or calculated 
from the output data for that X-ray beam. 
McCullough ·(1970) 
McCullough developed a computer programme to 
calculate the X-ray exposures at a focus-to-skin 
distance of 40 inches for a wide range of mAs, kVp 
and filtrations to cover the most diagnostic 
X-ray procedures. It was concluded that the 
computations agreed within 25% the limited number 
of measured values from the literature. 
Antoku et al. (1972) 
Antoku modified the 
accommodate small ionisation 
.r_ 
Mix-D phantom to 
3 
chambers of 1 cm 
in removable sections in the regions of the active 
bone marrow and in the locations of the gonads. A 
total number of 16 sites were used to measure the 
bone marrow dose, and 3 sites for gonadal dose. 
·A 37 cm3 chamber of the 37A Dosimeter was used 
to measure the surface dose and monitor the output 
of the X-ray tube. 
E 4 
Food and Drugs Administration (1976) 
FDA developed a computer programme "Nationwide 
Evaluation of X-ray Trends" based on the Organ Dose 
Index System. The ODIS system employed a 
standardized field survey technique for 
measuring the X-ray machine output from which 
exposure and organ doses to a standard patient were 
calculated. 
It was claimed that the variables introduced 
by the differences in patient size, weight could be 
eliminated. Moreover, the system could isolate 
the influence of such variations as differences in 
types of facility and equipment, examination 
technique and operator training. 
Chu (1980) 
Chu developed a computer programme using a 
desk-top calculator to estimate the skin doses 
received during diagnostic radiological procedures. 
The operating scheme of the programme was shown in 
the following: 
E 5 
Total units of Unit Exposures (mAs) 
Output/Unit Exposure (mR/mAs) 
@ 40 inches Focus-Skin Distance 
measured with a calibrated ion-chamber 
Correction for Backscatter 
measured with TLDs 
Skin Dose 
Ragozzino et al. (1981) 
Ragozzino described a simple method of 
estimating the faetal absorbed dose from common 
abdominal and pelvic radiographic examinations. 
with the aid 'bf sonography, the faetus location was 
determined. The uterine depth dose within an 
Alderson-Rando phantom for 70, 80 and 100 kVp beams 
were measured. Faetal dose was worked out using 
the normalised depth dose curves. 
Gray et al. (1981) 
Gray described a direct method of 
measurements for the absorbed doses to testes, 
ovaries, thyroid, eyes, uterus and active bone 
marrow with the use of Alderson Rando phantom and 
TLDs. 
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It was reported that the absolute error was 
less than 10% (including the effects of 
directionality and energy dependance of the 
TLDs) with standard deviation of 4.5% - 11% and 
0.6% - 7.8% for organs located outside and within 
the primary beam respect ively. 
The authors further stated that the 
discrepancies between the measured and the 
calculated doses might be attributed to the 
differences in the following 
(1) organ location, 
(2) distance from organ to the edge of X-ray 
beam, 





of air scatter and 




(5) the composition of the Alderson phantom 
ft 
compared with the mathematical phantom. 
Glaze et al. (1982) 
Glaze developed a computer-assisted procedure 
for estimating patient exposure and faetal dose in 
radiographic examinations whic,., was similiar to 
the previous work. 
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Harrison (1983) 
Harrison formulated the tissue-air ratios and 
scatter-air ratios for diagnostic radiography. The 
percentage depth dose (POD) and backscatter factor 
(BSF) data were re-cast in the form of TAR and SAR. 
It was reported that the uncertainties of 
TAR were ± 3%, ± 4% and ± 7% for depths at 0 - 5 
cm, 5 - 10 cm and> 10 cm respectively. 
Edmond (1984) 
Edmond formulated the skin dose 
calculation taking into account of the kVp, MS, 
t~tal filtration in mm Al, Focus-skin distance 
(FSD) and phase of the generator. 




I t ( liT + 0.114) 
where p is constants having values of 
2 for 1 ~ and 1 for 3 ~. 
The over-simplification of this formula 
resulting in either over or under estimation of the 
actual skin dose for single and three phase 
generators. 
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Huda et al. (1984) 
Huda descr ibed a direct measurements of 
mean organ doses using the Alderson Rando phantom. 
D = L fi(organ) x Di 
where, D is the mean organ dose, 
fi (organ) is the fraction of the total mass 
of the specific organ in Rando slice i, 
Di is the average radiation dose to 
the part of this organ within slice i. 
Hummel et al. (1985) 
Hummel developed a computerized X-ray 
dose- monitoring system, which received values from 
the generator through a specially designed 
electronic interface during an exposure. By means 
of calibrated data, the entrance exposure, area 
exposure product and integral dose were obtained 
and printed for each patient concerned. It was 
claimed that the overall accuracy was better than + 
20%. 
McGuire (1986) 
McGuire descr ibed a method which used a 
specially developed computer programme that enabled 
estimation of output parameters of an X-ray machine 
from a single exposure. Results shown that the 
estimation procedure was reasonably accurate. 
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Clarkson et al. (1987) 
Clarkson used a microcomputer to estimate 
the X-ray dose received by the faetus. It was 
assumed that the faetal dose to ' be equal to the 
dose to the uterus and was a function of the 
incident X-ray spectrum and irradiated area. This 
method was subject to inaccuracies arising from 
differences between phantom and individual patient, 
and the position of the uterus might vary as 
pregnancy progressed. However, it allowed 
considerable flexibility for variations in 
technique to be taken into account. 
Rosenstein et al. (1988) 
Rosenstein developed a computer programme 
based on the Monte Carlo simulation to estimate 
the absorbed doses to the lungs, active bone 
marrow, thyroid, female breasts, testes, ovaries 
and the total trunk of a refernce patient. The 
phantom was assigned with a grid system of 160 
elements ( 4 x 4 cm). The organs of interest 
were located in specif ic elements. The . doses 
delivered to the elements concerned were summed up 
to give the mean organ absorbed dose. 
Golikov et al. (1989) 
Golikov described a method of direct 
measurements with the use of Rando phantom which 




A computer program RADCOMP was developed 
recently to allow institutions to obtain in an 
accurate rapid and straight forward way, the 
Free-Air Entrance Exposures (FAE's) received by 
patients undergoing radiographic or fluoroscopic 
procedures. 
A summary and comparison of the fore-mentioned 
published work is presented in Table E.1. 
The published work fell into two categories, 
namely, direct and indirect methods. In the older 
days, direct method was generally adopted in which, 
ESD and organ doses were measured with chambers 
located in wax or presswood phantoms. The draws 
were two folds, i. e., the phantoms used were not 
tissue-equi valent and the chambers were too bulk:, 
to be inserted into correct locations for organ 
doses measurements. with the development of the 
Rando phantom and TLDs, the accuracy of 
measurements was much improved. However, the 
procedures involved numerous TLDs and measurements 
which was tedious and time-consuming. The use of 
computers definitely speeded up the calculation in 
dose estimation with an anthropomorphic phantom. 
This indirect dose estimation together with direct 
measurement of ESD with tissue-equivalent TLDs is, 
by far the most efficient and accurate method which 
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Thermoluminescent dosimeters (TLDs) have a 
number of useful features which make them 
particularly suitable for patient dosimetry. One of 
the most important is their small physical size 
which enables them to be conveniently and 
unobstructively attached to patients with very 
little interference with patient mobility or 
comfort. Moreover, 
body sections it 
in routine radiography of most 
is unlikely that a TLD will 
obscure useful diagnostic inform~tion " These 
advantages are in sharp contrast with the use of 
ionisation chambers, which are more bulky and 
usually requiring permanent connection to an 
electrometer, and are difficult to attach to 
patients, severely restrict mobility and cast 
interfering shauows ~n radi~graphs . 
In view of the foregoing mentioned 
super ior i ty , TLDs are adopted in this study to 
measure directly the entrance surface doses on 
patients' skin delivered from X-rays during 
diagnostic radiology. 
2. THERMOLUMINESCENT PROCESS 
2.1 ENERGY BANDS 
In solid substance, e. g. , crystal, the 
separate single discrete energy electronic levels 
F 1 
exist in individual atoms overlap tu form a quite 
wide band of possible eletron energies (Fig. F.l). 
(1) Conduction Band 
It is formed by some of the broadened outer 
energy levels of the atom constituting the crystal. 
Any electron which may happen to be in this band 
can move freely in the material and gives electric 
conduction. In fluorescent material, this band is 
empty, and hence non-conductor. 
(2) Forbidden Zone 
No energy levels over the energy range El - E2 
and no electron can exist in this zone. This 
corresponds to the region between the energy levels 
of a single atom. 
(3) Filled Band (Valence Band) 
It is continuous band of energy levels bewteen 
E2 and E3 . Electrons can have energy between this 
two limits. ~ll these levels are full (i. e., no 
room for more electron in this zone) except when 




Conduction Band CB 
El 
Forbidden Zone FZ 
E2 
Filled Band FB 
E2 
The electron band structure of a perfect 
and pure crystal of an insulating material 
F 2 
2.2 Mechanism 
(1) X-ray energy is absorbed and a secondary 
electron, either photo-electric and or Compton 
electron is produced. 
(2) The secondary electron causes many holes in the 
filled bands of atom through which it passes 
and so lifts many electrons into the conduction 
band. 
(3) These electrons may fall back into traps where 
they are held. 
(4) When the material is heated to a temperature of 
200 to 3 00 0 C, the trapped electrons can 
acquire sufficient energy to escape back into 
the conduction band. 
(5) Form the conduction band the electrons can fall 
back to fill holes (not necessarily the holes 
from which they came individually) in the 
filled band, visible photons being emitted in 
the process. 
(6) It will be noted that the traps occur at 
different levels in the forbidden zone. Escape 
from some is easier (i. e., is possible at a 
lower temperature) than from others. Light is 
emitted over a range of temperatures. The total 
amount of light emitted is proportional to the 
amount of radiation energy absorbed. This 
phenomenon is potentially the basis of a method 
of radiation dosimetry. 
The fore-mentioned mechanism 
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Fig. F.2 A diagramatic presentation of 
thermoluminescence process 
1 An electron absorbs sufficient energy from 
the radiation and moves from the valence band 
to the conduction band. 
2 It migrates through the conduction band. 
3 It falls into an electron trap in the 
forbidden zone and remains there provided 
that it does not acquire sufficient energy to 
escape. This will be determined by : 
(a) the depth of the trap and, 
(b) the temperature of the material. 
2' A hole is created in the valence band. 
3' The hole migrates to the forbidden zone. 
4 & 4' The trapped electron and hole return to the 
conduction and valency bands respectively 
when the material is subject to heat. 
5 & 5' Recombination of the electron-hole pair in 
the forbidden zone with the emission of 
thermoluminescence (TL). 
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2.3 BOLTZMANN EQUATION 
The probability p of an electron moving from a 
metastable state to an excited state is governed by 
the Boltzmann Equation 
p = S exp ( -/lE/ kT ) (Eq. F .1) 
Where, S is a constant, 
/lE is the energy difference between 
the levels, 
k is the Boltzmann constant and, 
T is the absolute temperature. 
The probability is increased by raising 
the temperature. This effectively accelerates the 
phosphorescence process as progressively deeper 
metastable states empty with increasing 
temperature. 
3. Th~RhaL~MINESC~NCE PARAMETERS 
3.1 THERMOLUMINESCENT MATERIALS 
Thermoluminescent materials include over 2000 
natural minerals; a range of inorganic crystals and 
glasses; pottery and flints used in archaeological 
dating; as well as some organic compounds which 
luminesce at low temperatures. However, only eight 
materials are commonly used which have 
characteristics suitable for use in applied 
radiation dosimetry. Some of the examples are given 
in the following 
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(1) Materials of low atomic numbers 
Lithium fluoride (LiF), 
Lithium borate (Li2B407)' 
Beryllium oxide (BeO) , 
Magnesium borate (MgB40 7 ). 
(2) Materials of higher atomic numbers 
Calcium sulphate (caS04 ), 
Calcium fluoride (CaF2 ), 






3.2 ACTIVATORS (DOPANTS) 
TL materials are often doped with various 
activators (dopant) which will increase the number 
of traps and hence the thermoluminescence 
efficiency of the material. Some examples are given 
in Table F.1. 
Table F.1 . Examples of TL materials and dopants 
TL material Dopant 
LiF Mg, Ti 
Mn 
Cu 











3.3 IMPURITIES AND DEFECTS 
An. ideal crystal consists of a regular array 
of atoms arranged in an infinite lattice structure. 
However, all real crystals contain lattice defects 
of the following categories : 
(1) thermal or intrinsic defects; 
(2) extrinsic defects or substitutional impurity 
defects and; 
(3) radiation induced defects. 
The presence of these impurities and defects 
create some extra electron energy levels in the 
forbidden zone. These levels are localized at 
definite places within the crystal and can trap and 
localize electrons. As illustrated in Equation 3.1, 
the probability of an electron moving from a 
metastable state to an excited state depends upon 
the the energy difference between the levels. The 
addition of these impurities can therefore, affect 
this probability and hence the sensitivity of 
.'. 
thermoluminescence. 
3.4 DOSE-RESPONSE CURVE 
The dose-response 
materials usually fall 
shown in Fig. F.3. 
F 7 
characteristics of 




The TL photon intensity is proportional to 
the dose received. For material irradiated 
with '1 or (3 radiation, the general shape of 
this curve is linear up to 5 Gy. In diagnostic 
X-rays, the doses encountered usually fall 
into this category. 
(2) Supralinear 
The TL photon intensity increased more than 
the dose received, resulting in dose over-
estimation. For material irradiated with '1 or 
~ radiation, the general shape of this curve 
is supralinear at intermediate dose levels 
between 5 to 1000 Gy. This increase is 
probably due to the radiation induced defects 
which create additional electron traps and 
hence makes the material more sensitive at the 
higher dose levels. This category does not 
apply to' diagnostic X-rays because the doses 
will not reach this high levels. 
(3) Sublinear 
The TL photon intensity increased less than 
the dose received, resulting in dose under-
estimation. For material irradiated with ex 
particles, the curve is generally linear-
sublinear. However, since diagnostic radiology 

















Fig. F.3 Dose-Response Curve 
Solid line : Superlinearity 
Dotted line: Linear 
• 
F 9 
3.5 ENERGY RESPONSE 
Theoretically, the 
should be independent 
response of TL materials 
of the radiation energy. 
However, some phosphors have a higher response at 
low to medium energy range. Table F. 2 and 
Fig. F. 4 shows a comparison of relative energy 
responses, i. e., the ratio ·of response to 30 keV 
and 1 MeV for some common available TL materials. 
The higher ratio means a higher energy dependence. 
Table F.2 A Comparison of Relative Energy Response 
Phosphor Relative Energy Repsonse (30 keV/1 Mev) 
BeO 0.9 - 1.0 
Li2B40 7 :CU 0.8 - 0.9 
Li2 B 4 0 7 :Mn 0.9 
(TLD 800) 
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The sensitivity et> per unit mass of irradiated '. 
material is given by 
4> = ( I - B ) / D (Eq. F.2) 
Where, I is the TL intensity, 
B is the mean background or zero dose signal, 
m is the mass of material. 
Table F.3 compares the sensitivities of some 
common available TL materials. 
Table F.3 A Comparison of Sensitivities 
Phosphor 
BeO 
Li2B40 7 :CU 
Li2B40 7 :Mn 
(TLD 800) 





MgB40 7 :Dy 







Sensitivity et> (Cs-137) per unit mass 
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4. SOURCES OF ERROR IN TL DOSIMETRY 
Sources of error fall into two recognized 
groups random and systematic. These are usually 
termed random uncertainties and systematic 
uncertainties. 
4.1 RANDOM UNCERTAINTITIES 
This group includes 
(1) Variation of sensitivity of dosimeters within 
a batch; 
(2) Sensitivity to light; 
(3) Inconsistant heat cycle; 
(4) Variabl~ thermal ~ontact betweeL th~ heater 
and detector; 
(5) Inconsistence light collection efficiency; 
(6) Variation in the gain of the electronics; 
(7) Variation in background readings and; 
(8) Inconsistent annealing. 
These uncertaintities are described in detail 
in the following : 
(1) Variation of sensitivity of dosimeters within 
a batch 
This will increase with time due to some loss 
of phospnor and changes in the optical 
properties of the detector. If it is 
required to keep the systematic error due 
to changes in sensitivity with time and use 
to less than ± 5%, the detection sensitivity 
should be rechecked at least after every 10th 
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cycle of use. On the other hand, if the 
detectors are calibrated before and after each 
measurement the resulting error is negligible. 
For a dose of 10 mGy, the coefficient of 
variation of the TL response of chips within a 
batch is nearly 3%. 
(2) Sensitivity to light 
TL materials are sensitive to light, i.e., in 
the ultra-violet component. The rate of fading 
can be increased substantially in an intense 
source of UV light, as a result, the 
background signal is increased. To ensure no 
light effect.s in the routine work, all TLDs 
are sealed in black polythene sachets of wall 
thickness 0.12 mm. The handling of dosimeters 
before enclosure in and after removal from the 
sachets is undertaken in subdued ambient 
lighting. 
(3) Inconsistant heat cycle 
Errors can originated in the reader as a 
result of unsuitable or inconsistent heat 
cycle. Heat cycle is required to release 
the stored signal in a reproducible manner 
while minimising the effects of fading and 
retains the original sensitivity of the 
detectors for subsequent use. It is therefore, 
recommended that the maximum temperature for 
readout must be kept in the range of 240 ± 
50 C. Higher or lower temperature value will 
lead to poorer reusability. 
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(4) Variable thermal contact between the heater 
and detector 
Reproducible contact between the detector and 
heating element is essential especially if 
high temperature anneal is carried out in the 
reader. Several successive reads ' without 
will give a reliable indication of heating 
efficiency. This should be at least 99% in 
order to maintain a threshold dose of 0.1 mSv 
for doses up to 10 mSv. 
(5) Inconsistent light collection efficiency 
The light collection efficiency of the system 
was kept constant. The reflectance of 
objects in the vicinity of the detector 
during readout should be checked regularly. 
At regular intervals standard samples of 
lithium borate are irradiated to a constant 
dose by means of a Sr-90 source in a special 
jig, and these are read out to check the· 
overall performance of the system. 
(6) variations in the gain of the electronics 
The gain of the electronics of modern 
is almost invariably checked with 
systems 
standard 
light sources. This stability of modern 
readers is generally better than 0.5%. The 
performance of the light measuring system is 
checked by means of a C-14 and plastic 
scintillation light source and any drift is 
compensated by adjustment of the 
photomultiplier tube voltage. 
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(7) Variations in background readings 
Variations in the background readings 
significantly affect the precision at low dose 
levels. To achieve low and constant 
background levels the detectors were batched 
in dry nitrogen during readout to reduce 
effects due to oxygen, triboluminescence and 
chemiluminescence to a minimum. 
(8) Inconsistent annealing 
The annealing procedure depends on the 
material being used. It was carried outout in 
a highly reproducible manner including the 
cooling rate following the high temperature 
anneal. 
4.2 SYSTTEMATIC UNCERTAINTIES 
This gro~p includes 
(1) Lack of tissue-equivalence; 
(2) Variation of detector response with radiation 
type and energy and; 
(3) Loss of signal due to fading. 
These uncertaintities are jescribed in detail 
in the following : 
(1) Lack oftissue-eguivalence 
since generally the absorbed dose received by 
the soft tissues of a patient are of 
interest, it is of considerable advantage to 
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use a dosimeter that consists of materials 
that are of the similar effective atomic 
number as soft tissue. These materials will 
absorb X-rays of different energies in same 
manner as soft tissues, i.e, they are tissue 
equivalent. 
The probability of an X-ray photon being 







/P) which is a 
of the photon energy and the 
in which the absorption takes 
Ideally, the ratio (I1/P)dosimeter/(I1/P)tissue 
should be a constant over the entire 
diagnostic X-ray energy range for the 
dosimeter to have a constant response or 
sensitivity per unit absorbed dose in tissue. 
Any deviation of the effective atomic number 
from that of soft tissue will therefore,result 
in ~i r .her under- or over- estimation of the 
dose received by the real patients. It is 
therefore TL materials with effective atomic 
number similar to that of body soft 
tissue (7.4) are suitable for patient dose 
measurement. 
(2) variation detector response with 
radiation type and energy 
This is a maj or source of systematic error 
which is inherent in the TL material and for 
photon radiations depends upon the variation 
of the mass energy absorption coefficient with 
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photon energy. At low energies, the thickness 
of the detector may cause an under-response 
due to self absorption. At high energies, it 
may also under-read because of a lack of 
electron equilibrium if it is too thin. 
Although there is a discrepancy between the 
calculated and experimental response curves in 
the region of 60 keV, it is clear that the 
essentially level of energy response of both 
lithium borate powder and discs must be -an 
important consideration in favour of these 
materials for the measurement of soft X-rays 
of wide energy spectrum. 
(3) Loss of signal due to fading 
Fading -is defined as the 





storage due to the escape of electrons from 
the shallow traps prior to readout. The 
probability of this fading depends upon : 
_,t-
(a) the lattice structure of the phosphor; 
(b) the depth of the traps : the deeper the 
traps, the less chance of escape, and; 
(c) the temperature at which the phosphor 
is stored. 
If fading of TL signal has occurred during use 
or storage of the irradiated material, the 
light intensity I is modified by the Fading 
Factor W, such that, 
(Eq. F. 3) 
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If the primary absorbed dose is received 
at time T= 0, and produces a signal 1 0 , 
then It is the signal at time T = t, 
= (I -o (Eq. F. 4) 
All TL materials suffer from fading of the 
stored signal to some extent, and this fading 
depends upon : 
(a) the depths of the traps and; 
(b) the heat treatment applied both during 
annealing and readout. 
Table F.4 shows a comparison of fading 
factors. 
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Table F.4 A Comparison of Fading Factors 
Phosphor Fading factor ~ % loss at 20 0 C 
BeO 5 (in 1 to 5 months) 
Li2B40 7 :CU < 5 (in 10 days) 
Li2B40 7 :Mn 5 (in 3 months) 
(TLD 800) 
Li 2B40 7 :Mn < 5 month-
1 
(general) 
LiF:Mg,Ti 5 year-1 
(TLD 100) 
LiF:Mg,Cu,P 5 (in 2 months) 
MgB40 7 :Dy < 5 month-
1 
A1 20 3 5 (in 14 days) 




CaF2 :Dy 10 
-1 
- day 
caF2 :NAT < 3 (in 9 months) 
cas04 :Mn 6 (in 6 months) 
cas04 :Dy 60 day 
-1 
Mg2si04 :Tb 3 
-1 
month 
since fading of TL signal will occur either 
during use or storage of the irradiated 
material. The reading were therefore corrected 
by the fading factor as calculated with Eq. 
3.4. The fading at 500 C after 1 month storage 
was found to be about 3% which is less than 
the requiremnt of ISQ-DP-8034 for radiation 
dosimetry. 
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5. PRECISION AND ACCURACY 
5.1 PRECISION 
Precision is a measure of the reproducibility 
of a dosimetry system and is governed by the 
influence of random uncertainties. Repeated 
measurements usually follow a normal distribution 
characterised by the standard deviation· (j on the 
set of results. For an infinite set of results 95% 
of the values obtained will fall within 2(j of the 
mean which is a commonly applied criterion for the 
specification of the reproducibility or precision 
of a system. 
5.2 ACCURACY 
Accuracy concerns . the likelihood of a 
measurement being within certain . limits of the true 
value and concerns systematic uncertainties. 
,"" 
5.3 USABLE DOSE RANGE 
The usable dose range for any particular type 
of TLD is usually limited at the lower end by lack 
of precision due to the variability in background 
noise from unexposed dosimeters, and at the upper 
end by inaccuracy due to the onset of 
supralinearity or saturation. 
5.4 DETECTION THRESHOLD 
Detection thresholq (Minimum Detectable Dose ) 
D is the mimimum dose that can be distinguished 
o 
from zero with 95% confidence. It is given by : 
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(Eq. F. 5) 
Where, ~B is the standard deviation about the 
background value at 95% confidence 'level. 
The lowest dose that can be measured with a 
specified degree · of accuracy may well be 
considerably higher. Table F.5 shows a comparison 
of threshold doses . . 
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A Comparison of Threshold Doses 
Phosphor Threshold Dose (~Gy) 
BeO < 100 
Li2B40 7 :CU 10 
Li2B40 7 :Mn 500 
(TLD 800) 





MgB40 7 :Dy 20 - 50 
Al 20 3 < 1000 
CaF2 :Mn 10 
caF2 :Dy - 1 
caF2 :NAT 1 - 10 
CaS04 :Mn < 0.3 
caS04 :Dy - 1 
Mg2Si04 : Tb:" 
,.., 1 
6. CHOICE OF TL MATERIAL 
6.1 IDEAL TL MATERIAL 
It is clear that an ideal TL material suitable 
for patient dose measurements should satisfy the 
following criteria : 
(1) It should be available in the 
appropriate physical form. 
F 23 
(2) It should have a flat energy response over 
a wide range of photon energies ( to within 
5 - 20% with respect to tissue over the 
range of photon energies 15 keV to 2 MeV. 
(3) A simple glow curve structure which will 
eliminate the need for complicated annealing 
regimes. 
(4) It should have a sufficiently high sensitivity 
~ and low variation in the background signal 
~B to enable dose threshold Do to be at least 
as low as 100 ~Gy to be measured with adequate 
precision. 
(5) It should have a usable dose range from 10 
J..LGy to 1 Gy. 
(6) It should exhibit negligible fading of the 
trapped dose information over the period of 
several weeks. 
Table F.6 summaries and compares the 
characteristics of some common TL materials. 
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0.2 - 1.0 
Threshold 
dose 





0.9 - 1.0 
Fading fact0f) l/J 
% loss at 20 C 
5 (in 1 to 5 m) 
Li2B40 7 :CU 2 10 0.8 - 0.9 < 5 (in 10 d) 
Li 2B40 7 :Mn < 0.1 500 0.9 - 5 (in 3 m) 
-1 Li2B40 7 :Mn 0.2 50 - 100 0.9 < 5 m 
LiF:Mg,Ti 1 50 1.3 5 -1 ,.., Y 
LiF:Mg,Cu,P 
-
20 5 (in 2 m) 
MgB40 7 :Dy 5 - 10 20 - 50 1.3 2.4 < 5 
-1 
- ID 
A1 2 0 3 0.5 - 5 < 1000 - 4.5 5 (in 14 d) 









caF2 :NAT 20 1 - 10 - 15 < 3 (in 9 m) 
caS04 :Mn 70 < 0.3 - 13 
6 (in 6 m) 
caS04 :Dy - 15 - 1 - 13 
60 d-1 
-1 
Mg2 SiC,4: Tb - 50 - 1 - 4.5 
3 m 
Scrutiny of the TL properties from Table F.6 
shows that there is no ideal material with 
characteristics suitable for general dosimetric 
application. Tissue equivalent materials required 
for medical · dosimetry are generally of low 
sensitivity. Whilst those materials of higher 
sensitivity, as often required for environmental 
measurements, over-respond at low photon energies. 
This is summarised in Table F.7. 
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Independent Low Large 
Independent Low Small 
Dependent Medium Small 
Dependent High Small 
Dependent Low Very large 
Hihgly dependent High Small 
Highly dependent Very high Very small 












1. WALL B'. F., HARRISON R. M. and SPIERS F. W. (1988) 
Patient Dosimetry 
Radiology 
ISPM Report No. 53, 18 
Techniques in Diagnostic 
2. Practical Aspect of Thermoluminescence Dosimetry 
Fundamental aspect of TLD materials 
HPA CRS-43, 1984 
3. LANGMEAD W.A. and WALL B.F. (1976) 
4. 
5. 
A TLD system based on lithium borate for the 
measurement of doses to patients undergoing 
medical irradiation 
Phys. Med. BioI. 
Vol. 21, No. 1, 39-51, 1976 
ZHA Z. et al. (1986) 
Measurement of extremely low level dose with 
LiF (Mg,Cu,P) TL chips 
Rad. Prot. Dosimetry 
Vol. 17, 415-418, 1986 
WANG S.S. et al. (1986) 
Newly developed hihgly sensitive LiF (Mg,Cu,P) 
TL chips with high signal-to-noise ratio 
Rad. Prot. Dosimetry 




A STUDY ON ANTHROPOMORPHIC PHANTOM 
Abstract 
APPENDIX G 
A STUDY ON ANTHROPOMORPHIC PHANTOM 
Dezhi Jiang and Paul M.W. Chan et al. 
A paper presented at the 8th ACRT, Hong Kong 
In this paper it is reported that an 
anthropomorphic phantom has been developed. In the 
phantom, muscle, liver, kidneys and lungs were made 
from chemical products. Mix-Dp was chosen for 
muscle, M3 for liver and kidneys, and the formed 
emulsion for lungs while the skeleton of the 
phantom was composed of human bones. The phantom 
was composed of of 13 organs without extremeties, 
which can be taken apart. The whole phantom is 
165 ± 6.55 cm high. Its weight is 56.9 ± 5.3 kg. 
The phantom can be used to detect tissue absorbed 
dose of theliuman body in medical exposure. When 
tissue equivalence value of materials composed are 
tested with CT, the error compared with that of 
water, is less than 5%. Compared the CT value of 
the phantom with that of the phantom developed by 
the Rando phantom, the result is satisfactory. The 
CT pictures confirm the accuracy of the positions 
of viscera. 
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Table G.1 A comparison specific gravity, electron 
density and atomic number of tissues and 
tissue-equivalent materials 
Tissue S.G . Electron density Atomic number 
23 
Brain 1.03 3.42 x 10 7.33 
23 
Muscle 0.99-1.03 3.36 x 10 7.42 
23 
Liver 1.06 3.35 x 10 7.19 
23 
Kidney 1.05 3.40 x 10 7.33 
23 
Fat 0.91 3.48 x 10 5.92 
23 




water 1.00 3.34 x 10 7.42 
23 
MixDp 1.02 3.36 x 10 ~ .~~ 
23 
M3 1.05 3.34 x 10 7.19 
Table G.2 Body measurements of adult males 
Region Measurement, X ± S, cm 
Height 160.0 ± 5.4 
Neck circumference 36.2 ± 1.9 
Shoulder width 42.3 ± 2.0 
Chest circumference 87.9 ± 5.1 
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Table G.3 Organ size and mass in phantom 
Organ Mass Length Width Height 
( g) (cm) (cm) (cm) 
Brain 1400 
Thyroid 18.0 4.7 2.5 1.7 
L. lung 470 29.0 6.5 5.5 
R. lung 520 32.0 7.0 6.0 
Liver 1647 20.0 11.0 10.0 
Pancreas 98.5 16.2 15.0 1.8 
L. kidney 150 9.0 5.2 4.0 
P kidney ~.40 9.0 5.0 3.5 
Stomach 360 14.0 7.0 4.0 
Intestine 1569 17.0 16.5 5.0 
Bladder 232 8.0 5.0 6.2 
Table G: 4 A comparison of eT values 
Living body This phantom Rando phantom 
Muscle 21 - 50 18 - 30 14 - 27 
Lung 800 - 682 750 - 680 701 - 650 
Bone cortex 150 - 1000 164 - 660 539 
Liver 18 - 70 50 - 70 
Kidney 11 - 60 30 - 50 
Spleen 19 - 70 20 - 60 
Pancreas 20 - 60 30 - 50 
G 3 
__ ___._ 
Table G.5 A comparison of relative electron density 
Organ Living body This phantom 
Muscle 1.02 - 1.05 1.02 - 1.03 
Lung 0.16 - 0.32 0.25 - 0.32 
Liver 1.02 - 1.07 1.06 - 1.07 
Kidney 1.01 - 1.06 1.03 - 1.05 
Spleen 1.02 - 1.07 1.02 - 1.06 
Pancreas 1.02 - 1.06 1.03 - 1.05 
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